10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2013

Commission File No. 333-150332

MACROSOLVE, INC.

(Exact name of registrant as specified in its charter)

Oklahoma	73-1518725
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
9521-B Riverside Parkway, #134 Tulsa, Oklahoma	74137                      (918) 932-2000
(Address of principal executive office)	(Zip Code)          (Registrant’s telephone number,                           including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:  None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act. Yeso   Nox

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yesx   Noo

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes o    Nox

Note: The Company is a voluntary filer but has filed all reports it would have been required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months if it was a mandatory filer.

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x   No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o	Accelerated filer o
Non-accelerated filer o	Smaller reporting company x
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso   Nox

The aggregate market value of the voting common equity held by non-affiliates as of June 28, 2013, based on the closing sales price of the Common Stock as quoted on the OTC Markets was $3,588,179. For purposes of this computation, all officers, directors, and 5 percent beneficial owners of the registrant are deemed to be affiliates.  Such determination should not be deemed an admission that such directors, officers, or 5 percent beneficial owners are, in fact, affiliates of the registrant.

As of March 24, 2014, there were 190,764,559 shares of registrant’s common stock outstanding.

1

TABLE OF CONTENTS

		PAGE
PART I
Item 1.	Business	4
Item 1A.	Risk Factors	7
Item 1B.	Unresolved Staff Comments	13
Item 2.	Properties	13
Item 3.	Legal Proceedings	13
Item 4.	Mine Safety Disclosures	14
PART II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	15
Item 6.	Selected Financial Data	16
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	20
Item 8.	Financial Statements and Supplementary Data	F-1- F-24
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosures	21
Item 9A	Controls and Procedures	21
Item 9B.	Other Information	22
PART III
Item 10.	Directors, Executive Officers and Corporate Governance	23
Item 11.	Executive Compensation	26
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	29
Item 13.	Certain Relationships and Related Transactions, and Director Independence	30
Item 14.	Principal Accounting Fees and Services	31
PART IV
Item 15.	Exhibits, Financial Statement Schedules	32
	Signatures	34

2

Cautionary Note Regarding Forward Looking Statements

This Annual Report on Form 10-K (the “Annual Report”) contains ‘‘forward-looking statements’’ that represent our beliefs, projections and predictions about future events. All statements other than statements of historical fact are ‘‘forward-looking statements’’, including any projections of earnings, revenue or other financial items, any statements of the plans, strategies and objectives of management for future operations, any statements concerning proposed new projects or other developments, any statements regarding future economic conditions or performance, any statements of management’s beliefs, goals, strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. Words such as ‘‘may’’, ‘‘will’’, ‘‘should’’, ‘‘could’’, ‘‘would’’, ‘‘predicts’’, ‘‘potential’’, ‘‘continue’’, ‘‘expects’’, ‘‘anticipates’’, ‘‘future’’, ‘‘intends’’, ‘‘plans’’, ‘‘believes’’, ‘‘estimates’’ and similar expressions, as well as statements in the future tense, identify forward-looking statements.

These statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements described in or implied by such statements. Actual results may differ materially from expected results described in our forward-looking statements, including with respect to correct measurement and identification of factors affecting our business or the extent of their likely impact, the accuracy and completeness of the publicly available information with respect to the factors upon which our business strategy is based or the success of our business. Furthermore, industry forecasts are likely to be inaccurate, especially over long periods of time and in relatively new and rapidly developing industries such as mobile solutions for businesses. Factors that may cause actual results, our performance or achievements, or industry results, to differ materially from those contemplated by such forward-looking statements include without limitation:

• competition in the market for mobile computing products and services;

• our ability to develop brand awareness and industry reputation;

• our ability to adapt to rapid evolution in technology and industry standards;

• our ability to attract and retain management and skilled personnel;

• our growth and marketing strategies;

• anticipated trends in our business;

• our future results of operations;

• our lack of profitable operations in recent periods;

• market conditions in the mobile solutions for business industry;

• the impact of government regulation;

• emerging viable and sustainable markets for wireless and mobile computing services;

• significant errors or security flaws in our products and services;

• insufficient protection for our intellectual property;

• Our ability to enforce our intellectual property, including a favorable resolution of the recent decision of the USPTO to reject the claims of our ‘816 patent;

• claims of infringement on third party intellectual property;

• our financial position, business strategy and other plans and objectives for future operations;

• economic conditions in the U.S. and worldwide; and

• the ability of our management team to execute its plans to meet its goals

Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of whether, or the times by which, our performance or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and management’s belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, those factors discussed under the headings ‘‘Risk factors’’, ‘‘Management’s discussion and analysis of financial condition and results of operations’’, ‘‘Business’’ and elsewhere in this report.

3

PART I

Item 1.  Business

Organization

MacroSolve, Inc. (“MacroSolve,” “we,” “us,” or the “Company”) is an Oklahoma corporation formed on January 17, 1997, under the laws of the State of Oklahoma.  Following the sale of Illume Mobile division on July 31, 2012, we have focused on intellectual property licensing and enforcement of our patent in the mobile app market development space.  We also offer consulting services related to mobile app development, marketing and financing of mobile app businesses. Our principal executive offices are located at 9521-B Riverside Parkway, #134, Tulsa, Oklahoma 74137.

MacroSolve has historically been a mobile applications development company, focused on enterprise applications, and has been an entrepreneurial force for over sixteen years. Our legacy customers, technology and development teams were profitably sold to DecisionPoint Systems for cash and equity in July 2012.  In the third quarter of 2012, the Company retained key executives and BOD members in order to take advantage of a new strategy, which uses the Company’s position as an experienced business advisory team for mobile app developers, fortified by intellectual property, which we believe can create substantial passive revenues and equity holdings.  DecisionPoint Systems was the first client in the portfolio we are creating under our new strategy. We hope to develop strategic relationships with large mobile app marketing and development companies in order to grow our portfolio.

Starting in March 2011, we began protecting our intellectual property rights against entities we identified as infringing our patent claims. This process was halted in March 2014 as a result of the USPTO Office Action, discussed below.  In October 2010, we received U.S. patent #7,822,816, which we refer to as the ‘816 patent, which covers certain mobile information collection systems across all wireless networks, smart phones, tablets, and rugged mobile devices, regardless of carrier and manufacturer. Complaints were filed against 101 defendants.  Out of these lawsuits, we received 68 settlements in the form of non-exclusive, perpetual paid-up licenses for licensed products or royalties based on a percentage of revenue.  Our objective in these enforcement actions was not to monopolize or prevent other companies from competing; it was to get a return on our investment in the intellectual property.

Currently, the Company has a web presence at ‘www.macrosolve.com’ and maintains multiple social media profiles.

Recent Developments

On March 7, 2014, the United States Patent and Trademark Office (“USPTO”) sent the Company an office action related to an ex parte reexamination of the ‘816 patent, which rejected all the claims in the patent (the “USPTO Office Action”). The Company has two months to file a request for the patent examiners to reconsider the USPTO Office Action.  In the event the examiners do not rescind the USPTO Office Action, the Company would have the option to file an appeal with the Patent Appeals Board. That process can be costly and take an indeterminate amount of time. As a result of the USPTO Office Action, the Company has withdrawn all outstanding litigation relating to the ‘816 patent without prejudice, which will allow it to refile such pending suits if the USPTO Office Action is rescinded or the Company’s rights under the ‘816 patent are restored. The Company will be unable to pursue any new lawsuits relating to the ‘816 patent until the USPTO Office Action is resolved.  The inability to pursue claims pursuant to its ‘816 patent until the USPTO Office Action is resolved will negatively impact the Company’s primary source of revenue.  Since the sale of Illume Mobile in July 2012, revenue from IP licensing has accounted for over 97% of the Company’s revenue. The Company is presently conferring with its legal counsel and evaluating its options with regard to the recent USPTO Office Action.

On August 5, 2013, the Company finalized an agreement with Dri-Eaz Products, Inc. for patent advisory services related to their launch of Dri-Plan, an iPad app dedicated to simplifying and automating job site documentation for restorers. As a part of those services, Dri-Eaz received a limited license to the ‘816’ patent in exchange for a royalty on the gross revenues received for the sale of licensed products. The app was marketed on a very limited release basis beginning late in 2013, resulting in minimal revenue to the Company in 2013.

The Company finalized an agreement on June 5, 2013 with Endexx Corporation (EDXC), a micro-cap company which collaborates with independent software developers, scientists, engineers and other companies to build businesses that can thrive collectively in the equity markets. During the six month engagement, the Company provided its virtual management team to assist Endexx with coordinating business planning, investor interests and intellectual property for a mobile app venture that uniquely addresses advertising market analytics. The Company also provided patent advisory services to Endexx. As part of those services, Endexx received a variable limited ‘816’ license during the course of the business advisory engagement while its app is in development with the agreement that a permanent license will be negotiated upon the app’s completion, estimated to be late in 2014. Endexx issued 125,000 shares of its restricted stock valued at $15,000 to the Company with the balance of $15,000 currently due.

4

The Company finalized an agreement on June 12, 2013 with RIJO Investment Group, a private company based in Los Angeles, California, to provide its virtual management team to assist RIJO with coordinating business planning, investor interests, content expertise and third party technology partners for a venture that uniquely optimizes historical content, GPS and social media. This was initially a two month project during the proof of concept phase and does not include patent advisory services or stock for services. The parties are working together towards a project extension to cover the initial funding and build out phase. Because of the size of the project and variety of potential funding sources, the next phases are expected to stretch into late 2014.

On March 12, 2013, the Company finalized an agreement with MEDL Mobile Holdings, Inc. (“MEDL”), a company involved in the creation, development, marketing and monetization of mobile apps. MEDL has the right to extend its license to the Company’s ‘816 patent to its app development clients on a ‘per install’ basis. The Company will receive a percentage of the passive revenues, which are subject to MEDL achieving minimum performance goals. As a part of the agreement, each Company received $50,000 worth of the other’s stock with the price per share determined by the Volume Weighted Average Price (“VWAP”) for each stock for the last twenty trading days prior to execution of the agreement. The Company received 147,692 shares of MEDL stock priced at $0.39 per share and MEDL received 2,500,000 shares of the Company’s stock priced at $0.02 per share. The shares were recorded at fair value on March 8, 2013 of $58,338. MEDL has not meet its minimum performance goals and has lost certain exclusivity conditions; however, the parties are working together to facilitate MEDL’s licensing strategy to its app development clients.

As previously reported, the Company sold substantially all of the assets relating to its Illume Mobile business on July 31, 2012 to DecisionPoint Systems, Inc.  Accordingly, all operating results disclosed in this annual report only include the results from continuing operations, and exclude the results for the Illume Mobile business, which are presented as discontinued operations.  

Overview

Market Opportunities

The mobile technology market is very large and research indicates that it will continue to expand.  As mobile applications supply and demand grow, so does our target market for consulting and patent licensing clients.

The mobile technology market is being driven by the value that mobile applications are providing to end users, their mobile devices and wireless networks.  According to CNET and Flurry research, app usage surged 115% in 2013, with over 1 trillion app sessions created by consumers.  TopApps predicts that 76 billion apps will be downloaded in 2014. There are an estimated 1 million apps available on app stores.  According to TechCrunch, Apple’s store generated over $10B in 2013 revenues.  Since the Apple store opened, $15B in revenue share payouts has been made to app developers.  TechCrunch also reported that in 2013, angel investments reached a new high, with investors crossing the billion-dollar threshold, committing $1.1 billion to entrepreneurs launching new tech companies. Venture capital markets have invested highly in the industry.  According to Entrepreneur magazine, venture capital invested approximately $6.2 billion in U.S. companies involved in software related ventures.

Global smartphone penetration continues to grow according to research firm IDC, which believes shipment volumes will grow at a compound annual growth rate of 16.0% before reaching a total of 1.5 billion units shipped in 2017.

Worldwide combined shipments of computing devices (PCs, tablets and mobile phones) were projected to reach 2.32 billion units in 2013, a 4.5% increase from 2012, according to Gartner, Inc. The market is being driven by a shift to lower-priced devices in nearly all device categories. Worldwide shipments of traditional PCs (desk-based and notebook) were forecast to total 303 million units in 2013, an 11.2% decline from 2012, and the PC market, including ultramobiles, was forecast to decline 8.4% in 2013. Tablet shipments are expected to grow 53.4 percent this year, with shipments reaching 184 million units.

According to the latest market study by ABI Research, users of enterprise B2E (business-to-employee) and B2C (business to customer) smartphone and media tablet mobile applications (apps) are forecast to grow at a compound annual growth rate of nearly 90 percent -- and exceed 830 million active worldwide users by 2016.

5

Growth Strategies

There are four foundational areas of concentration in the Company’s growth strategy:

· Identify and support mobile app ventures with advisory services and patent protection, building a portfolio of market leading solutions which generate near term revenue and substantial earnings at liquidity for the Company;

· Generate high margin potential, passive revenue by extending affordable patent protection to small and medium sized app developers through partnerships;

· Subject to favorable resolution of the USPTO Office Action, continue enforcing current intellectual property; and

· Subject to favorable resolution of the USPTO Office Action, increase intellectual property portfolio via continuation filings.

Consulting Services

Our consulting services are focused on clients who have needs to begin or grow a mobile app business.  We are advisors to the app entrepreneur on all aspects of starting and or expanding the venture. We do not engage in app development or app marketing but rely on partners in those industries for client referrals.

The consulting services that are offered include, but are not limited to:

· Visioning and Concepting – Exploring an app idea, its problem to solve and potential business models;

· Competitive Analysis – Thorough examination of the market place and funding sources growing the competition;

· Technology Evaluation – Discovery of best practices and platforms for mobile and web development;

· Customer Economics Modeling – Quantification of initial and long term costs to acquire and grow customer segments;

· Go-to-Market Strategy – Sales, marketing, channel, business and strategic partnership options review;

· Financial Planning – Assumption modeling and creation of balance sheet, income and cash flow statements;

· Funding Presentation and Coaching – Creation of PowerPoint and other communications materials in preparation for investor meetings;

· Intellectual Property Advisory – Analysis of IP and options to protect and grow;

· Management Team Evaluation and Augmentation – Review of strengths of management team along with growth plans. Virtual executive management team recommendations for interim periods;

· Digital and Social Marketing – Pre-launch and post-launch messaging and communications channel management; and

· Strategic Business Development – Focus on closing very large deals with strategic partners and/or clients which significantly enhance cash flow.

Competition

Almost all of the Company’s revenues has come from patent license fees. By definition, a patent provides the owner the right to exclude others from making, using, selling offering for sale, or importing the patented invention for the term of the patent. Assuming a favorable resolution of the USPTO Office Action, our objective in enforcing our patent is not to monopolize or prevent other companies from competing; it is to get a return on our investment in the intellectual property.

For our consulting business, many wireless carriers, application development technology leaders and major consulting companies provide mobile application consulting services.  Our target market is small and medium sized businesses (“SMB”) where competitors such as AT&T, Adobe and Accenture do not have an advantage due to affordability and agility.  We specifically target clients who do not have management in place who can grow a business around a mobile app, an underserved market which is cost-effective for us to serve in a way not feasible for large or national consultancies. Rocksauce Studios of Austin, Texas, a development partner with our former operating division, Illume Mobile, competes in this area by offering business plans tailored to specific mobile apps.  Similar consulting services are offered by BigInnovations of Hobe Sound, Florida, MasterPlans of Portland, Oregon and SocializeMobilize of San Francisco, California.

6

The competitors in the SMB target market include technology companies and mobile marketing companies. Applico, Silicus, 1MobileSolution, Diaspark are some of the companies whose services are fundamentally centered on application design, technology integration and developers who create and manage the solution. Brandignity, Appulat, Fiksu, AppTap and Flurry are companies with core competencies in marketing and branding applications and can indirectly compete with us. In many cases, these competitors’ business models compliment ours and have the potential to be business development partners. This is the case with Fiksu, a company which has established a mutual client referral agreement with us.

Customers and Suppliers

Illume Mobile’s customers were transitioned to DecisionPoint Systems, Inc. after the July 31, 2012 transaction. MacroSolve current customers consist of licensees who hold non-exclusive, perpetual paid-up licenses for licensed products, which are non-recurring revenues and consulting customers, which represented less than 3% of 2013 revenues as the Company continues to build its services offerings and prospects list of small or early-stage mobile app companies. The Company received payment in full on all perpetual paid-up licenses issued pursuant to settlement agreements; therefore, there is no commercial effect to the Company as a result of the recent USPTO Office Action for those licenses. However, regarding those clients who received patent advisory services and pay royalties based on agreements that are dependent upon the ‘816 patent, the failure to have the Office Action resolved in the Company’s favor could have an adverse impact on those royalty agreements. We do not rely on any single supplier.

Intellectual Property

The Company reviews each of its intellectual properties and makes a determination as to the best means to protect such property, by trademark, by copyright, by patent, by trade secret, or otherwise. The Corporation believes that it has taken appropriate steps to protect its intellectual properties, depending on its evaluation of the factors unique to each such property, but cannot guarantee that this is the case. The USPTO has issued U.S. Patent No. 7,822,816 to our company. The patent covers certain mobile information collection systems across all wireless networks, smart phones, tablets, and rugged mobile devices, regardless of carrier and manufacturer. On March 7, 2014, the USPTO sent the Company the USPTO Office Action relating to the ‘816 patent, which rejected all the claims in the ‘816 patent.  The Company is presently evaluating its options in appealing that decision.  If we are successful in overturning the USPTO Office Action, we will continue to pursue the monetization this patent and our other IP assets.   

In September 2011, the Company filed a continuation of U.S. Patent No. 7,822,816 which is assigned number 12/910,706; the Company is currently considering its options as related to this continuation.

The Company has intellectual property that relates to extending applications to multiple handsets operating on multiple wireless networks which it handles as a trade secret and which it considers to be valuable.

Government Regulation

Our principal products and services do not require any government approval.  We do not anticipate that existing or probable governmental regulations, including environmental laws, will have any effect on our business.

Employees

The Company has three full-time employees that comprise its executive management and accounting team. We have no labor union contracts and believe relations with our employees are satisfactory.

Item 1A.  Risk Factors

You should carefully consider the risks described below as well as other information provided to you in this document, including information in the section of this document entitled “Information Regarding Forward Looking Statements.” The risks and uncertainties described below are not the only ones facing the Company. Additional risks and uncertainties not presently known to the Company or that the Company currently believes are immaterial may also impair the Company’s business operations. If any of the following risks actually occur, the Company’s business, financial condition or results of operations could be materially adversely affected, the value of the Company’s Common Stock could decline, and you may lose all or part of your investment.

7

Risks Relating to Our Business and Industry

We recently received notice that the USPTO rejected the claims in our ‘816 patent, which has been our primary source of revenue.  If we are not successful in appealing the USPTO Office Action, it would have a material adverse effect on our business.

On March 7, 2014, the USPTO sent us the USPTO Office Action relating to the ‘816 patent, which rejected all the claims in the ‘816 patent. We have two months to file a request for the patent examiners to reconsider the USPTO Office Action.  In the event the examiners do not rescind the USPTO Office Action, we would have the option to file an appeal with the Patent Appeals Board. That process can be costly and take an indeterminate amount of time. The inability to pursue claims pursuant to its ‘816 patent until the USPTO Office Action is resolved will negatively impact our primary source of revenue.  Since the sale of Illume Mobile in July 2012, revenue from IP licensing has accounted for over 97% of our revenue. We are presently conferring with our legal counsel and evaluating our options with regard to the USPTO Office Action.  If we are unable to reverse the USPTO Office Action, it would have a material impact on our business and we would need to find new sources of revenue.  There are no assurances that we will be successful in reversing the USPTO Office Action in a timely manner, if at all.

We are currently unable to monetize our ‘816 patent due to the USPTO Office Action.

In October 2010, we received Patent #7,822,816, which covers certain mobile information collection systems across all wireless networks, smart phones, tablets, and rugged mobile devices, regardless of carrier and manufacturer. Efforts to monetize the ‘816 patent were initiated in March 2011 and the efforts continued through March 2014.  During 2013, over $1.4 million in licensing revenues were generated as a result of the ‘816 patent, representing approximately 97% of our revenues. Until the USPTO Office Action is resolved, we are not able to continue to enforce and monetize this patent.  We continue to make progress on our consulting business not directly related to patent licensing, however, the likelihood of it generating near term revenues sufficient to fund current operations is remote.

As a result of the USPTO Office Action, we may need to obtain additional funding.  If we are unable to obtain additional funding when needed, our business operations will be harmed and if we do obtain additional financing our then existing shareholders may suffer substantial dilution.

At December 31, 2013, we had total current assets of $777,596 and total current liabilities of $316,172 for working capital of $461,424.  While we currently believe we have sufficient capital to continue our operations for the next 12 months, we may incur significant expenses if we chose to appeal the USPTO Office Action.   If we appeal, we could deplete our cash and working capital more rapidly than expected, which could require additional funds to sustain our appeal of the USPTO Office Action and our operations. We do not have any contracts or commitments for additional funding, and there can be no assurance that financing will be available in amounts or on terms acceptable to us, if at all, if needed. The inability to obtain additional capital when needed will restrict our ability to appeal the USPTO Office Action and may reduce our ability to conduct business operations. If we are unable to obtain additional financing, we will likely be required to curtail our business operations. Any additional equity financing may involve substantial dilution to our then existing shareholders.

We have a history of losses which may continue and which may negatively impact our ability to achieve our business objectives.

We incurred net losses of $240,684 and $8,258,937 for the years ended December 31, 2013 and 2012, respectively.  The loss in 2012 included $5,875,562 in non-cash expenses related to derivatives. In addition, at December 31, 2013, we had an accumulated deficit of $21,173,815. Since our inception, we have experienced negative cash flow from operations; however, since divesting of Illume Mobile, we have been operationally cash flow positive. We cannot assure you that we can achieve profitability or sustain cash flow positive operations on a quarterly or annual basis in the future.  Our operations are subject to the risks and competition inherent in the establishment of a business enterprise. There can be no assurance that future operations will be profitable. Revenues and profits, if any, will depend upon various factors, including whether we will be able to continue expansion of our revenue. We may not achieve our business objectives and the failure to achieve such goals would have an adverse impact on us.

Insufficient protection for our intellectual property rights may have a material adverse effect on our results of operations or our ability to compete.

We attempt to protect our intellectual property rights in the United States through a combination of reliance on intellectual property laws (including copyright, patent, trademark and trade secret laws) as well as licensing and other agreements preventing the unauthorized disclosure and use of our intellectual property. Also, third parties may be able to successfully challenge, oppose, invalidate or circumvent our patents, trademarks, copyrights and trade secret rights. For example, on March 7, 2014, the USPTO sent the Company the USPTO Office Action relating to the ‘816 patent, which rejected all the claims in the ‘816 patent. Lack of protection of certain intellectual property rights for any reason could have a material adverse effect on our business, results of operations and financial condition. Moreover, monitoring and protecting our patented intellectual property rights is difficult and costly. During 2013, nearly $850,000 in patent enforcement fees and costs were incurred, representing approximately 59% of the Company’s revenues. From time to time, we may be required to initiate litigation or other action to enforce our intellectual property rights or to establish their validity, including taking action to overturn the USPTO Office Action.  Such action could result in substantial cost and diversion of resources and management attention and we cannot assure you that any such action will be successful.

8

If we fail to protect our intellectual property rights, our ability to pursue the development of our technologies and products would be negatively affected.

Our success will depend in part on our ability to obtain patents and maintain adequate protection of our technologies. Some foreign countries lack rules and methods for defending intellectual property rights and do not protect proprietary rights to the same extent as the United States. We have not filed for any patent protection rights outside the United States and many companies have had difficulty protecting their proprietary rights in these foreign countries. We may not be able to prevent misappropriation of our proprietary rights.

We have received, and are currently seeking, patent protection for mobile information collection systems across all wireless networks, smart phones, tablets, and rugged mobile devices. However, the patent process is subject to numerous risks and uncertainties, and there can be no assurance that we will be successful in protecting our technologies by obtaining and enforcing patents. These risks and uncertainties include the following: patents that may be issued or licensed may be challenged, invalidated, or circumvented, or otherwise may not provide any competitive advantage; our competitors, many of which have substantially greater resources than us and many of which have made significant investments in competing technologies, may seek, or may already have obtained, patents that will limit, interfere with, or eliminate our ability to make, use, and license our technologies either in the United States or in international markets; there may be significant pressure on the United States government and other international governmental bodies to limit the scope of patent protection both inside and outside the United States for technologies that prove successful as a matter of public policy regarding security concerns; countries other than the United States may have less restrictive patent laws than those upheld by United States courts, allowing foreign competitors the ability to exploit these laws to create, develop, and market competing products. On March 7, 2014, the USPTO sent the Company the USPTO Office Action relating to the ‘816 patent, which rejected all the claims in the ‘816 patent.  The Company is presently evaluating its options in appealing that decision.

Moreover, any patents issued to us may not provide us with meaningful protection, or others may challenge, circumvent or narrow our patents. Third parties may also independently develop technologies similar to ours or design around any patents on our technologies.

In addition, the USPTO and patent offices in other jurisdictions have often required that patent applications concerning software inventions be limited or narrowed substantially to cover only the specific innovations exemplified in the patent application, thereby limiting the scope of protection against competitive challenges. Thus, even if we or our licensors are able to obtain patents, the patents may be substantially narrower than anticipated.

Our success depends on our patents, patent applications that may be licensed exclusively to us and other patents to which we may obtain assignment or licenses. We may not be aware, however, of all patents, published applications or published literature that may affect our business either by blocking our ability to commercialize our products, by preventing the patentability of future products or services to us or our licensors, or by covering the same or similar technologies that may invalidate our patents, limit the scope of our future patent claims or adversely affect our ability to market our IP and services.

We rely on a combination of trade secrets, confidentiality, nondisclosure and other contractual provisions, and security measures to protect our confidential and proprietary information. These measures may not adequately protect our trade secrets or other proprietary information. If they do not adequately protect our rights, third parties could use our technology, and we could lose any competitive advantage we may have. In addition, others may independently develop similar proprietary information or techniques or otherwise gain access to our trade secrets, which could impair any competitive advantage we may have.

9

We may be involved in lawsuits to protect or enforce our intellectual property rights, which could be expensive and time consuming.

The software and telecom industries have been characterized by extensive litigation in recent years regarding patents and other intellectual property rights, and companies have employed intellectual property litigation to gain a competitive advantage. We may become subject to infringement claims or litigation arising out of patents and pending applications of our competitors, or additional interference proceedings declared by the USPTO to determine the priority of inventions. The defense and prosecution of intellectual property suits, USPTO proceedings, and related legal and administrative proceedings are costly and time-consuming to pursue, and their outcome is uncertain. Litigation may be necessary to enforce our intellectual property, to protect our trade secrets and know-how, or to determine the enforceability, scope, and validity of the proprietary rights of others. An adverse determination in litigation or interference proceedings to which we may become a party could subject us to significant liabilities, require us to obtain licenses from third parties, or restrict or prevent us from selling our products in certain markets. Although patent and intellectual property disputes might be settled through licensing or similar arrangements, the costs associated with such arrangements may be substantial and could include our paying large fixed payments and ongoing royalties. Furthermore, the necessary licenses may not be available on satisfactory terms or at all.

A third party may assert that our patents are invalid and/or unenforceable. On March 7, 2014, the USPTO sent the Company the USPTO Office Action relating to the ‘816 patent, which rejected all the claims in the ‘816 patent.  The Company is presently evaluating its options in appealing that decision.  Any litigation or claims against us, whether or not merited, may result in substantial costs, place a significant strain on our financial resources, divert the attention of management and harm our reputation. An adverse decision in litigation could result in inadequate protection for our products and/or reduce the value of any license agreements we have with third parties.

Interference proceedings brought before the U.S. Patent and Trademark Office may be necessary to determine priority of invention with respect to our patents or patent applications. During an interference proceeding, it may be determined that we do not have priority of invention for one or more aspects in our patents or patent applications and could result in the invalidation in part or whole of a patent or could put a patent application at risk of not issuing. Even if successful, an interference proceeding may result in substantial costs and distraction to our management.

Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation or interference proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If investors perceive these results to be negative, the price of our common stock could be adversely affected.

Our business and prospects depend, to a significant degree, on demand for wireless and other mobile computing devices.

The use of wireless and other mobile computing devices for retrieving, sharing and transferring information among businesses, consumers, suppliers and partners has begun to develop only in recent years. Our success will depend in large part on continued growth in the use of wireless and other mobile computing devices, including handheld computers, smart phones, pagers and other mobile devices. In addition, our markets face critical unresolved issues concerning the commercial use of wireless and other mobile computing devices, including security, reliability, cost, ease of access and use, quality of service, regulatory initiatives and necessary increases in bandwidth availability. Demand for, and market acceptance of, wireless and other mobile computing devices which require our products and services are subject to a high level of uncertainty and are dependent on a number of factors, including:

• growth in sales of handheld devices, smart phones and other mobile computing devices;

• emergence of a viable and sustainable market for wireless and mobile computing services;

• our product and services differentiation and quality;

• the development of technologies that facilitate interactive communication between organizations;

• the growth in access to, and market acceptance of, new interactive technologies;

• the effectiveness of our marketing strategy and efforts;

• our industry reputation; and

• general industry and economic conditions such as slowdowns in the computer or software markets or the economy.

We might experience significant errors or security flaws in our former products and services.

We ceased providing mobile software products and custom mobile app development services on July 31, 2012 when we sold Illume Mobile operations. We are not liable for errors or security flaws in Illume Mobile software products and services rendered after July 31, 2012. While we might be held liable for products and services rendered prior to July 31, 2012, we are unaware of any reported or unresolved problems regarding product liability, performance or warranty issues with our former customers.

10

If we fail to maintain or expand our relationships with strategic partners and indirect distribution channels our consulting revenues could decline.

Our consulting strategies depend in part on our ability to form strategic relationships with other technology companies. If these companies change their business focus, enter into strategic alliances with other companies or are acquired by our competitors or others, support for our products and services could be reduced or eliminated, which could have a material adverse effect on our business and financial condition.

Economic conditions in the U.S. and worldwide could adversely affect our revenues.

Our revenues and operating results depend on the overall demand for our technologies and services. If the U.S. and worldwide economies continue to weaken, either alone or in tandem with other factors beyond our control (including war, political unrest, shifts in market demand for our services, actions by competitors, etc.), we may not be able to maintain or expand our recent revenue growth.

We depend on key employees in a competitive market for skilled personnel.

The success of our business will continue to depend upon certain key executive management personnel who would be extremely difficult to replace. Competition for such personnel is intense, and we cannot be certain that we will be able to retain our existing key personnel. The loss of these officers and other or key employees in the future might adversely affect our business and impede the achievement of our business objectives. We believe our ability to achieve increased revenue will depend in part upon our ability to attract and retain highly skilled personnel. We may not be able to continue to attract and retain skilled and experienced personnel on acceptable terms. Our ability to hire and retain such personnel will depend in part upon our ability to raise capital or achieve increased revenue levels to fund the costs associated with such personnel. Failure to attract and retain key personnel may adversely affect our business.

Risks Relating to our Common Stock and its Market Value

The price of our Common Stock may be volatile.

The trading price of our common stock may be highly volatile and could be subject to fluctuations in response to a number of factors beyond our control. Some of these factors are:

• dilution caused by our issuance of additional shares of Common Stock and other forms of equity securities, which we expect to make in connection with future capital financings to fund our operations and business plans, to attract and retain valuable personnel and in connection with future strategic partnerships with other companies;

• our results of operations and the performance of our competitors;

• the public’s reaction to our press releases, our other public announcements and our filings with the Securities and Exchange Commission;

• changes in earnings estimates or recommendations by research analysts who follow, or may follow, us or other companies in our industry;

• changes in general economic conditions;

• changes in the valuation of similarly situated companies, both in our industry and in other industries;

• actions of our historical equity investors, including sales of common stock by our directors and executive officers;

• actions by institutional investors trading in our stock;

• disruption of our operations;

• any major change in our management team;

• significant sales of our common stock;

• other developments affecting us, our industry or our competitors; and

• U.S. and international economic, legal and regulatory factors unrelated to our performance.

These and other factors are largely beyond our control, and the impact of these risks, singly or in the aggregate, may result in material adverse changes to the market price of our Common Stock and/or our results of operations and financial condition.

11

Shareholders should be aware that, according to Commission Release No. 34-29093, the market for “penny stocks” has suffered in recent years from patterns of fraud and abuse.  Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses.  Our management is aware of the abuses that have occurred historically in the penny stock market.  Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities. The occurrence of these patterns or practices could increase the future volatility of our share price.

There is a limited market for our common stock which may make it more difficult for you to dispose of your stock.

Our common stock has been quoted under the symbol “MCVE” on the Pink Sheets since February 23, 2011 and prior to that, on the OTC Bulletin Board since August 15, 2008. There is a limited trading market for our common stock. Furthermore, the trading in our common stock maybe highly volatile, as for example, for the year ended December 31, 2013, our stock traded less than 104,000 shares on average per day. During that same period, the smallest number of shares trade in one day was zero and the largest number of shares traded in one day was 3,058,400. Out of the 252 trading days in 2013, zero shares traded on 36 days. On the 216 days that trading occurred, 73 days traded 20,000 shares or less and only 36 days traded 200,000 shares or more. Accordingly, there can be no assurance as to the liquidity of any markets that may develop for our common stock, the ability of holders of our common stock to sell our common stock, or the prices at which holders may be able to sell our common stock.

In recent years the stock market has experienced significant price and volume fluctuations. These fluctuations may be unrelated to the operating performance of particular companies. These broad market fluctuations may cause declines in the market price of our common stock. The price of our common stock could fluctuate based upon factors that have little or nothing to do with our company or our performance, and those fluctuations could materially reduce our common stock price.

Legislative actions, higher insurance costs and potential new accounting pronouncements may impact our future financial position and results of operations.

There have been regulatory changes, including the Sarbanes-Oxley Act of 2002, and there may potentially be new accounting pronouncements or additional regulatory rulings that will have an impact on our future financial position and results of operations. The Sarbanes-Oxley Act of 2002 and other rule changes as well as proposed legislative initiatives following the Enron bankruptcy are likely to increase general and administrative costs and expenses. In addition, insurers are likely to increase premiums as a result of high claims rates over the past several years, which we expect will increase our premiums for insurance policies. Further, there could be changes in certain accounting rules.  These and other potential changes could materially increase the expenses we report under generally accepted accounting principles, and adversely affect our operating results.

We have not paid dividends in the past and do not expect to pay dividends in the future. Any return on investment may be limited to the value of our common stock.

We have never paid cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. The payment of dividends on our common stock will depend on earnings, financial condition and other business and economic factors affecting it at such time as the Board of Directors may consider relevant.

Our common stock is subject to the "penny stock" rules of the SEC and the trading market in our securities is limited, which makes transactions in our stock cumbersome and may reduce the value of an investment in our stock.

The SEC has adopted Rule 15g-9 which establishes the definition of a "penny stock," for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require:

12

· that a broker or dealer approve a person's account for transactions in penny stocks; and

· the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

In order to approve a person's account for transactions in penny stocks, the broker or dealer must:

· obtain financial information and investment experience objectives of the person; and

· make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form:

· sets forth the basis on which the broker or dealer made the suitability determination; and

· that the broker or dealer received a signed, written agreement from the investor prior to the transaction.

Generally, brokers may be less willing to execute transactions in securities subject to the "penny stock" rules. This may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our stock.

Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

FINRA sales practice requirements may also limit a shareholder’s ability to buy and sell our stock.

In addition to the “penny stock” rules described above, FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for our shares.

Item 1B.  Unresolved Staff Comments

None.

Item 2.  Properties

           We maintain our mailing address at 9521-B Riverside Parkway, #134, Tulsa, Oklahoma 74137. Due to the small number of employees, we no longer maintain a physical workspace, but allow our employees to work remotely. The Company has no obligation under any operating lease.

Item 3.  Legal Proceedings.

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business.  We are not currently aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

We are currently not a party to any legal proceedings.  All proceedings related to the ‘816 patent have been dismissed without prejudice, meaning the cases can refiled upon a favorable resolution of the USPTO Office Action.  See “Part 1 – Business – Recent Developments” for a complete description of the USPTO Office Action.

13

A summary of the legal proceedings that have been resolved since last reported is as follows:

Filing Date	Defendant	Cas e Number	Status	Date of Dis pos itio n (if any)
21-Dec-11	American Airlines , Inc.	6:11-CV-685	(a)	3/24/2014
30-Jan-12	Newegg Inc.	6:12-CV-46	(b)	3/13/2014
17-Feb-12	GEICO Cas ualty Company and Government Employees Ins urance Company	6:12-CV-74	(b)	3/13/2014
17-Feb-12	GEICO Ins urance Agency, Inc.	6:12-CV-74	(b)	3/13/2014
4-Dec-12	Sears Holdings Management Corporation et al	6:12-CV-916	(b)	9/25/2013
21-Dec-12	SkyMall, Inc.	6:12-CV-977	(b)	9/11/2013
25-Feb-13	Cos tco Wholes ale Corporation	6:13-CV-198	(b)	1/2/2014
25-Feb-13	GameStop Corp, et al	6:13-CV-200	(b)	12/13/2013
25-Feb-13	Gilt Groupe Holdings , Inc. et al	6:13-CV-201	(b)	12/3/2013
25-Feb-13	Kohl's Department Stores , Inc. et al	6:13-CV-202	(b)	1/2/2014
26-Feb-13	Nords trom, Inc. et al	6:13-CV-204	(b)	12/13/2013
26-Feb-13	Pandora Media, Inc.	6:13-CV-205	(b)	1/2/2014
26-Feb-13	Staples , Inc. et al	6:13-CV-207	(b)	1/7/2014
12-Sep-13	Box, Inc.	6:13-CV-665	(b)	2/20/2014
12-Sep-13	Carls on Hotels , Inc., et al	6:13-CV-666	(a)	3/19/2014
12-Sep-13	Chipotle Mexican Grill, Inc. et al	6:13-CV-667	(a)	3/17/2014
12-Sep-13	Comcas t Corporation et al	6:13-CV-668	(a)	1/6/2014
12-Sep-13	Dis cover Financial Services , Inc. et al	6:13-CV-669	(b)	3/27/14
12-Sep-13	Dropbox, Inc.	6:13-CV-670	(a)	3/17/2014
12-Sep-13	Five Guys Enterpris es , LLC et al	6:13-CV-671	(a)	3/17/2014
12-Sep-13	Home Box Office, Inc.	6:13-CV-672	(a)	3/17/2014
12-Sep-13	MediaFire, LLC	6:13-CV-673	(a)	3/17/2014
12-Sep-13	Meetup, Inc.	6:13-CV-674	(a)	3/17/2014
12-Sep-13	Wyndham Hotel Group, LLC et al	6:13-CV-675	(b)	1/15/2014

(a)   Lawsuit dismissed without prejudice.

(b)   Lawsuit dismissed with prejudice pursuant to a settlement agreement.

Item 4.  Mine Safety Disclosures.

Not applicable.

14

PART II

Item 5.   Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

Market Information

The Company’s common stock is quoted on the Pink Sheets under the ticker symbol MCVE.  Prior to February 23, 2011, our common stock was quoted on the OTC Bulletin Board under the ticker symbol MCVE.

The following sets forth the range of the closing bid prices for our common stock for the quarters in the period starting January 1, 2012 through December 31, 2013. Such prices represent inter-dealer quotations, do not represent actual transactions, and do not include retail mark-ups, markdowns or commissions. Such prices were determined from information provided by a majority of the market makers for the Company’s common stock.

	2013				2012
	Sales Price				Sales Price
	High		Low		High		Low
Quarter Ended
March 31	$	0.04	$	0.01	$	0. 14	$	0. 06
June 30		0.06		0.02		0. 12		0. 05
September 30		0.04		0.01		0. 06		0. 02
December 31		0.04		0.02		0 .06		0. 01

Holders

As of March 24, 2014, there were approximately 905 stockholders of record of the Company’s Common Stock.

Dividends

We have not declared any common stock dividends to date. We have no present intention of paying any cash dividends on our common stock in the foreseeable future, as we intend to use earnings, if any, to generate growth. The payment by us of dividends, if any, in the future, rests within the discretion of our Board of Directors and will depend, among other things, upon our earnings, our capital requirements and our financial condition, as well as other relevant factors. There are no material restrictions in our certificate of incorporation or bylaws that restrict us from declaring dividends.

Equity Compensation Plan Information

Plan category	Number of securities to be issued upon exercise of outstanding options		Weighted-average exercise price of outstanding options		Securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
	(a)		(b)		(c)
Equity compensation plans approved by security holders	12,870,584		$	0.37	42,528,000
Equity compensation plans not approved by security holders		-		-	-
Total	12,870,584		$	0.37	42,528,000

15

Item 6.  Selected Financial Data.

Not required under Regulation S-K for “smaller reporting companies.”

Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Introduction

The following discussion and analysis of financial condition and results of operations should be read in conjunction with our historical financial statements and the notes to those statements that appear elsewhere in this report.  Certain statements in the discussion contain forward-looking statements based upon current expectations that involve risks and uncertainties, such as plans, objectives, expectations and intentions.  Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under “Item 1A.  Risk Factors.” and elsewhere in this report.

Business Overview

For this information please see Part 1, Item 1 “Business.”

Results of Operations

Year Ended December 31, 2013 Compared to Year Ended December 31, 2012 (all references are to fiscal years).

Total Net Revenues: Total net revenues decreased $980,000, or 40%, to $1,454,000 in 2013 from $2,434,000 for 2012. Sources of revenue were derived from our IP licensing and services.  Licensing revenues represented the majority of the net revenues with a decrease of $1,019,000, or 42%, in 2013 to $1,415,000 from $2,434,000 for the same period in 2012. IP licensing is subject to fluctuation based on the inherent nature of legal proceedings.

Cost of Revenues and Gross Profit:  Cost of revenues for 2013 decreased $176,000, or 17%, from $1,030,000 in 2012 to $854,000 in 2013. Legal fees and costs associated with licenses sold pursuant to intellectual property monetization were $850,000, or 99%, of the 2013 cost of sales. Contingent legal fees decreased $401,000 in 2013 in relation to the reduced IP licensing revenues. Other legal expenses related to ongoing litigation was $301,000, a $221,000 increase over 2012. During 2013, legal costs associated with our intellectual property monetization increased due to a Markman hearing, discovery and expert witnesses. The resulting gross profit for 2013 of $600,000 was a decrease of $804,000, or 57%, from the gross profit for 2012 of $1,404,000.  Gross profit margins were 41% and 58% for 2013 and 2012, respectively.

General and Administrative Expenses: General and administrative expenses decreased by $654,000, or 46%, in 2013 to $778,000 from $1,432,000 in 2012.  Management cash salaries increased by $40,000 in 2013 but were offset by a decrease in equity based compensation of $106,000, for a net compensation decrease of $66,000. The Company paid $29,000 in cash financial advisory fees to two former officers in 2013, a $568,000 decrease from 2012 financial advisory fees.  Directors received $16,000 in cash compensation and $70,250 in equity compensation in 2013 as compared to $0 in cash compensation and $100,205 in equity compensation in 2012, a net decrease of $14,000. The Company incurred $60,000 in legal expenses in 2013, a $45,000 decrease over legal expenses of $105,000 in 2012, primarily due to the additional legal expenses incurred in the sale of Illume Mobile in 2012. General and administrative services in 2012 were offset by $16,000 in transition services related to the sale of Illume Mobile; there were no offsets in 2013.

Loss from Operations: Loss from operations for 2013 of $178,000 was an increase of $150,000 over the loss from operations in 2012 of $28,000, which resulted primarily due to the decrease in gross profit of $804,000, offset by the decrease in G&A expenses of $654,000.

Other Income and Expense: Total other expenses of $63,000 in 2013 were $5,963,000, or 99% less than the total of $6,026,000 in 2012.  This decrease is due to a $4,000,000 non-cash expense for derivative accounting under ASC 815-15 “Derivative and Hedging” in 2012, amortization of debt discount of $1,800,000 in 2012 and higher non-cash interest expense of $100,000 for the Company debt in 2012.

16

Net Loss from Continuing Operations: Net loss of $241,000 in 2013 was $5,813,000 less than the net loss in 2012 of $6,054,000 primarily due to the factors previously discussed.

There was no provision for income taxes for the fiscal years ended 2013 and 2012 due to a valuation allowance of $4.6 million recorded for the years ended December 31, 2013 and 2012 on the total tax provision, as we believed that it is more likely than not that the tax asset will not be utilized during the next year.

Liquidity and Capital Resources

As of December 31, 2013, the Company had total current assets of $777,596 and total current liabilities of $316,172 for working capital of $461,424. As of December 31, 2013, the Company had cash and cash equivalents of $706,211 and an accumulated deficit of $21,173,815 since operations commenced in 1997.

Although there was a net loss of $240,684 in 2013, the Company's independent registered public accounting firm's audit report for the year ended December 31, 2013, included herein, did not contain a qualified opinion or an explanatory paragraph regarding the Company's ability to continue as a going concern.  The Company demonstrated profitability after the divestiture of Illume Mobile, improved its financial ratios, and management’s plan does not contemplate future debt or equity raises. The accompanying financial statements have been prepared assuming that the Company continues as a going concern and contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The ability of the Company to continue as a going concern on a long-term basis will be dependent upon its ability to resolve issues with the USPTO, including the rejection of claims 1-14 in the ‘816 patent and prosecution of continuation patents, to create and market innovative services and to sustain adequate working capital to finance its operations.

We have historically financed our operations through operating revenues, proceeds from bank loans, shareholder loans and sales of equity and debt securities to accredited investors. Since the divestiture of Illume Mobile and its deficit operation in July 2012, the Company has generated sufficient working capital through operations to support its requirements without additional debt or equity financing. However, the USPTO Office Action prevents us from continuing to generate licensing revenue from patent settlements. Unless we can obtain a reversal of the USPTO Office Action in the near future, it will have a material adverse effect on our operations. We continue to make progress on our business activities not directly related to patent licensing and we are proceeding with those segments of our business. However, we do not expect significant increases in revenues from our non-patent business activity in the near term.  While we currently believe we have sufficient capital to continue our operations for the next 12 months, we may incur significant expenses in appealing the USPTO Office Action.  As a result, we could deplete our cash and working capital more rapidly than expected, which could result in our need to curtail our operations.

2011 Debenture Financing

Between April and June 2011, the Company sold Convertible Debentures Series 2011 (the “2011 Class A Debentures”) with Class A Warrants for gross proceeds of $950,000 and the conversion of $725,000 of 2010 Debentures into 2011 Debentures. Between September and October 2011, the Company sold Convertible Debentures Series 2011 (the “2011 Class B Debentures” and together with the 2011 Class A Debentures, the “2011 Debentures”) with Class B Warrants for gross proceeds of $700,000 and the conversion of $25,000 in accrued compensation.

The 2011 Debentures, which mature on December 31, 2016, earn interest at an annual rate of 12%, which will be paid quarterly exclusively from the Debenture Account which has been established with a financial institution for the deposit of 25% of the net funds the Company receives from licensing its intellectual property (the “Debenture Account”).  Principal on the 2011 Debentures will be paid quarterly as the Debenture Account permits. As of March 24, 2014, the Debenture Account had a balance of $195,000.

The 2011 Class A Debentures may be converted into shares of Common Stock at the option of the holder. Upon conversion, the holder will be entitled to receive the number of shares of Common Stock that equal to two hundred percent (200%) of the face amount of the 2011 Class A Debentures, together with accrued and unpaid interest, divided by the conversion price, which is the weighted average price for the five-day trading period preceding the 2011 Class A Debenture investment. Any 2011 Class A Debentures that are outstanding on the maturity date that have not been repaid from the Debenture Account will be repaid by the issuance of shares of Common Stock at the conversion price. As of March 24, 2014, there was $100,000 principal amount of 2011 Class A Debentures outstanding that were convertible into approximately 1,587,302 shares of common stock.

17

The 2011 Class A Debenture investors also received common stock purchase warrants, designated by the Company as Class A Warrants, which expire on December 31, 2016.  As of March 24, 2014, there were Class A Warrants outstanding to purchase an aggregate of 18,475,827 shares of common stock at exercise prices ranging between $0.063 and $0.109.

The 2011 Class B Debentures may be converted into shares of Common Stock at the option of the holder. Upon conversion, the holder will be entitled to receive the number of shares of Common Stock that equal to two hundred percent (200%) of the face amount of the 2011 Class B Debentures, together with accrued and unpaid interest, divided by the conversion price, which is the weighted average price for the five-day trading period preceding the 2011 Class B Debenture investment, however the conversion price shall not be less than ten cents per share at any time and the conversion price shall not be more than ten cents per share for investments made prior to October 1, 2011. Any 2011 Class B Debentures that are outstanding on the maturity date that have not been repaid from the Debenture Account will be repaid by the issuance of shares of Common Stock at the conversion price. As of March 24, 2014, there were $50,000 principal amount of 2011 Class B Debentures outstanding that were convertible into approximately 1,000,000 shares of common stock.

The investors in 2011 Class B Debentures also received common stock purchase warrants, designated by the Company as Class B Warrants, which expire on December 31, 2016.  As of March 24, 2014, there were Class B Warrants outstanding to purchase an aggregate of 8,961,614 shares of common stock at exercise prices of $0.10.

Other

As of December 31, 2011, the Company had recorded $169,306 in notes payable to directors. During 2012, multiple directors advanced $778,300 on short-term notes bearing 12% interest rates. Four directors agreed to exchange $320,000 of their short-term notes for 2012 Convertible Debentures Series C. During the same year, $115,000 in notes was repaid in cash and $21,075 in accrued interest was reclassified as note payable. The total amount due to multiple directors of $533,681, including accrued interest, was rolled over into new notes dated September 30, 2012. The new notes are secured by the unencumbered 75% of patent settlement license fees and provide for accrued interest at 6% payable on maturity at January 1, 2015. The accrued interest at December 31, 2013 is $40,092.

To lower its required cash expenditures for the calendar year 2013, the Company issued 6,100,690 shares of common stock to directors and management for compensation for services.

Sources and Uses of Cash

	Years Ended Dec 31,
	2013			2012
Cash flows provided by (used in) operating activities	$	127,238		$	(588,190	)
Cash flows provided by investing activities		2,269			3.462
Cash flows (used in) provided by financing activities		(82.500	)		970.800
Net increase in cash and cash equivalents	$	47,007		$	386,072

Operating Activities:

Net cash provided by operating activities during the year ended December 31, 2013 was approximately $127,000, which was an increase in operating cash flow of approximately $715,000 from $588,000 net cash outflow from operating activities during the year ended December 31, 2012. The 2013 net loss of approximately $241,000 was $8,018,000 less than the 2012 loss of approximately $8,259,000, which included non-cash debt discount amortization of approximately $1,800,000, loss on derivative liability of approximately $4,029,000, higher equity based compensation expense of approximately $639,000 and higher amortization expense of approximately $514,000.

Investing Activities:

Net cash provided by investing activities during the year ended December 31, 2013 was approximately $2,000, which was a decrease of approximately $1,000 from approximately $3,000 net cash provided by investing activities during the year ended December 31, 2012. The Company divested Illume Mobile in 2012, resulting in $250,000 cash, which was offset by the cessation of software development costs of approximately $233,000 in 2012. The Company no longer develops software. The Company invested approximately $2,000 in equipment in 2013, a decrease of approximately $7,000 from approximately $9,000 invested in 2012. The Company invested approximately $9,000 in patent related fees in 2013, an approximately $4,000 increase over the approximately $5,000 invested in 2012. The Company collected approximately $13,000 in 2013 from a customer’s note receivable.

18

Financing Activities:

Net cash used in financing activities was $82,500 in 2013 compared with approximately $971,000 provided by financing activities for the same period in 2012, a decrease of approximately $1,000,000.  The Company reduced its Oklahoma Technology Commercialization Center note payable by $82,500 in 2013. Cash provided by financing activities in 2012 was primarily from $180,000 net proceeds from sales of convertible debentures, $250,000 net proceeds from sales of common stock, and approximately $778,000 proceeds from shareholder loans, which was offset by $100,000 repayment of the bank line of credit, $115,000 repayment of shareholder loans and $22,500 repayment of the Oklahoma Technology Commercialization Center loan.

Since our inception, we have experienced negative cash flow from operations. Although the Company has been experiencing positive cash flow from operations since divesting of Illume Mobile in July 2012, significant negative cash flow from operations are likely to occur in the future, as the USPTO office action rejecting our patent claims will have a material effect on our cash flow until the issue is resolved. Although we currently have adequate funds to sustain our operations in the near term, we have historically required additional funds to continue operations and may again in the future as a result of USPTO Office Action. We have no current plans to raise additional funds; however, if we need to raise additional funds through the issuance of equity, equity-related or convertible debt securities in the future, these securities may have rights, preferences or privileges senior to those of the rights of holders of our common stock and they may experience additional dilution. We cannot predict whether additional financing will be available to us on favorable terms when required, or at all. The issuance of additional common stock by our management may have the effect of further diluting the proportionate equity interest and voting power of holders of our common stock.  Historically, we have financed our cash needs by registered private placements of our securities. There is no assurance that we will be able to obtain financing on terms consistent with our past financings or satisfactory to us, if at all.

As of December 31, 2013, our common stock is the only class of stock outstanding and we have in $784,136 debt that consists of $150,000 convertible secured debentures offset by $54,545 in debt discount, $533,681 in shareholder notes payable, $22,500 in note payable – related party and a $132,500 note from the Oklahoma Technology Commercialization Center, of which $112,500 is classified as current maturities of long-term debt.

Off-Balance Sheet Arrangements

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures.

Critical Accounting Policies and Estimates

The Company’s accounting policies are more fully described in Note 1 of the Financial Statements. As disclosed in Note 1, the preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ significantly from those estimates. The Company believes that the following discussion addresses the Company’s most critical accounting policies, which are those that are most important to the portrayal of the Company’s financial condition and results of operations and require management’s most difficult, subjective and complex judgments.

Accounts Receivable and Credit Policies:

Trade accounts receivable consist of amounts due from the sale of patent licenses and consulting services.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  In many instances, the Company is extending trade terms to customers who have agreed to acquire IP licenses as a result of settlement agreements. At the years ended December 31, 2013 and 2012, the Company deems all trade receivable amounts recorded as collectible and, thus has not provided an allowance for uncollectible amounts.

19

Revenue Recognition and Unearned Income:

Revenues from intellectual property licenses are recognized upon receipt. When intellectual property licenses are received under a contingent fee agreement with the law firm of Antonelli, Harrington & Thompson LLP, the applicable contingent legal expense is recorded as a cost of sale.

Consulting services revenues consist primarily of advisory services to third party customers under contract for specific projects. Contracted projects that are fixed price are accounted for under the percentage-of-completion method of accounting. Revenue from contracted projects that are for provision of services is recognized at the time the service is provided.

Long-Lived Assets:

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  No impairment charges were incurred during the years ended December 31, 2013 and 2012.

Derivative Financial Instruments:

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, assuming maximum value, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Stock-Based Compensation:

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Compensation Costs”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period. The Company issues Restricted Stock Awards which vest over six month in the case of salary differential awards and over three years in the case of bonus plans to employees.

Recently Issued Accounting Pronouncements

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk.

Not required under Regulation S-K for “smaller reporting companies.”

Item 8.  Financial Statements and Supplementary Data.

Our financial statements, together with the independent registered public accounting firm's report of MaloneBailey LLP, begin on page F-1, immediately after the signature page.

20

Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

On August 14, 2013, we received notice of the resignation of Hood & Associates, CPAs, P.C. (“Hood”), as our independent registered public accounting firm. Hood’s resignation resulted from staffing considerations that resulted in Hood being unable to provide a concurring partner for review of the Company’s financial statements. In November 2013, The Public Accounting Oversight Board announced it had settled a disciplinary action against Hood. As a result, Hood was not permitted to reissue their audit opinion for the fiscal year ended December 31, 2012, which contained no adverse opinion or disclaimer of opinion nor was qualified or modified as to uncertainty, audit scope or accounting principles.

Effective August 19, 2013, we appointed MaloneBailey LLP (“MaloneBailey”) as our new independent registered public accounting firm. The decision to engage MaloneBailey was recommended and approved by our audit committee. As a result of Hood being prohibited from reissuing their audit opinion for the fiscal year ended December 31, 2012, MaloneBailey was engaged to reaudit that year in addition to the audit of fiscal year December 31, 2013. During the two most recent fiscal years and through the date of our engagement, we did not consult with MaloneBailey regarding either (1) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on our financial statements, or (2) any matter that was either the subject of a disagreement (as defined in Regulation S-K Item 304(a)(1)(v)), during the two most recent fiscal years.

Item 9A.  Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act that are designed to ensure that information required to be disclosed in our reports filed or submitted to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the SEC’s rules and forms, and that information is accumulated and communicated to management, including the principal executive and financial officer as appropriate, to allow timely decisions regarding required disclosures. Our principal executive officer and principal financial officer evaluated the effectiveness of disclosure controls and procedures as of December 31, 2013 pursuant to Rule 13a-15(b) under the Exchange Act.  Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were not effective to ensure that information required to be included in our periodic SEC filings is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms due to the material weaknesses identified below.  

A system of controls, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the system of controls are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Management's Annual Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.  Our internal control system was designed to, in general, provide reasonable assurance to the Company’s management and board regarding the preparation and fair presentation of published financial statements, but because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Our management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2013.  The framework used by management in making that assessment was the criteria set forth in the document entitled “ Internal Control – Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that assessment, our management has determined that as of December 31, 2013, the Company’s internal control over financial reporting were not effective for the purposes for which it is intended. Specifically, management’s evaluation was based on the following material weaknesses, which existed as of December 31, 2013:

21

· Financial Reporting Systems: We did not maintain a fully integrated financial consolidation and reporting system throughout the period and as a result, extensive manual analysis, reconciliation and adjustments were required in order to produce financial statements for external reporting purposes; and

· Segregation of Duties: We do not currently have a sufficient complement of technical accounting and external reporting personnel commensurate to support standalone external financial reporting under public company or SEC requirements. Specifically, the Company did not effective segregate certain accounting duties due to the small size of its accounting staff, and maintain a sufficient number of adequately trained personnel necessary to anticipate and identify risks critical to financial reporting and the closing process. In addition, there were inadequate reviews and approvals by the Company’s personnel of certain reconciliations and other processes in day-to-day operations due to the lack of a full complement of accounting staff.

As our current financial condition allows, we will analyze and develop processes for the establishment of formal policies and procedures with necessary segregation of duties, which will establish mitigating controls to compensate for the risk due to lack of segregation of duties.

This annual report does not include an attestation report by MaloneBailey LLP, our independent registered public accounting firm regarding internal control over financial reporting.  As a smaller reporting company, our management's report was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management's report in this annual report.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Item 9B.  Other Information.

None.

22

PART III

Item 10. Directors, Executive Officers, and Corporate Governance

The following table sets forth the names and ages of the members of our Board of Directors and our executive officers and the positions held by each, as of March 24, 2014. The board of directors elects our executive officers annually. A majority vote of the directors who are in office is required to fill vacancies. Each director is elected for the term of one year, and until his or her successor is elected and qualified, or until his or her earlier resignation or removal.  

Name	Age	Position
James C. McGill	70	Chairman of the Board of Directors, Chief Executive Officer and President
John Clerico	72	Director
David Humphrey	58	Director
Kendall Carpenter	58	Executive Vice President, Secretary and Chief Financial Officer

Executive Biographies:

James C. McGill, Chairman of the Board of Directors, Chief Executive Officer and President

Jim McGill was appointed President and Chief Executive Officer in October 2012. Mr. McGill has been a member of the Board of Directors of MacroSolve, Inc. since 1999.  Jim McGill is an investor with background in a wide variety of organizations, public and private, for profit, and not for profit.  Prior to joining the Company, Mr. McGill ran McGill Resources, Inc., a business consulting and investment firm with offices in Tulsa, Oklahoma and Sydney, Australia.  From 1970 to 1986, Mr. McGill was Chairman and Chief Executive Officer of McGill Environmental Systems, Inc., a company that he founded.  McGill Environmental Systems, Inc. was sold in 1986 to The IT Group and Mr. McGill served on the board of directors of The IT Group until 2003.  Mr. McGill currently serves on the Board of ADDvantage Technologies Group, Inc., several private boards, and the Board of Trustees of the University of Tulsa.  

John Clerico, Director

John Clerico joined the Board of Directors of MacroSolve, Inc., in 2006.  Mr. Clerico is the former Chairman of the Board of Global Industries, Ltd., a leading offshore solutions provider of offshore construction, engineering, project management and support services, a position he has held from October 2008 until the company was sold in December 2011. He also served on their Board of Directors since January 2006 through December 2011. Mr. Clerico was also Chief Executive Office of Global Industries from October 2008 until March 2010. John Clerico is chairman and a registered financial adviser at ChartMark Investments, Inc., an independent investment advisory firm that manages equity funds for individuals and small pension funds. Mr. Clerico co-founded ChartMark in 2001, where his current focus is on day-to-day portfolio management and strategic direction of the firm. Prior to founding ChartMark, Mr. Clerico served in numerous senior management capacities including Executive Vice President, Chief Financial Officer and Director of Praxair, Inc., a Fortune 200 company. In addition to his financial responsibilities, Mr. Clerico managed Praxair’s business operations in Europe and South America. Prior experience includes CFO of Union Carbide Corporation, Conoco, Inc. and Phillips Petroleum Co. Mr. Clerico was named as one of four "Leading Corporate Treasurers" by Corporate Finance Magazine in 1995 and "CFO of the Year" by CFO Magazine in 1997 and Business Week in 1998. He serves on the Board of Directors of Community Health Systems and Educational Development Corp. Mr. Clerico is a 1964 graduate of Oklahoma State University.

David Humphrey, Director

David Humphrey joined the Board of Directors in February 2014, and was previously a director of between 2004 and October 2012.  Mr. Humphrey has been the President and Chief Executive Officer of ADDvantage Technologies Group, Inc., a NASDAQ-listed supplier to the cable television industry throughout North America and Latin America since April 2012 and a director since April 2013.  Between 2010 and 2011, Mr. Humphrey was the CEO of TokenEx, an early stage company focused on tokenization as a service for the payment card industry. From 2004 to 2010, Mr. Humphrey was Chief Operating Officer of Oklahoma Equity Partners, a venture capital fund.  Oklahoma Equity Partners focused exclusively on Oklahoma venture opportunities and Mr. Humphrey was responsible for all investment operations.  Prior to joining Oklahoma Equity Partners, Mr. Humphrey served from 1997 to 2004 as a principal of Davis, Tuttle Venture Partners, one of Oklahoma’s largest and oldest venture capital firms.  From 1995 to 1997, Mr. Humphrey was a senior business development coordinator at Texaco Natural Gas Liquids.  During his two-year stay with Texaco, he led ten major acquisition and expansion projects.  Prior to joining Texaco in 1996, Mr. Humphrey spent thirteen years with Koch Industries, Inc. serving in a variety of management and business development initiatives. Mr. Humphrey earned his Bachelor of Science in Chemical Engineering from the University of Wisconsin and his Master of Business Administration from Texas A&M University. 

23

Kendall W. Carpenter, CPA, CGMA, CMA, Executive Vice President, Secretary and Chief Financial Officer

Kendall Carpenter joined the corporation in 2006 as Controller. She was promoted to Vice President and Chief Financial Officer in 2008. Ms. Carpenter’s previous experience includes Division Controller with Allied Waste Industries (AW) and over 10 years’ experience as top financial officer of an enterprise software company with an international customer base. Ms. Carpenter graduated with a Bachelor of Science degree in Accounting from Oklahoma State University and has earned the professional designations of Certified Public Accountant, Chartered Global Management Accountant and Certified Management Accountant.

Director Qualifications

When considering whether directors and nominees have the experience, qualifications, attributes and skills, the Company and the Board focused primarily on the information discussed in each of the directors’ individual biographies set forth above. With regard to Mr. McGill, the Board considered his strong background in the mobile technology sector and significant expertise and background as a director of both private and publicly traded companies and his significant experience around patented technology. With regard to Mr. Clerico, the Board considered his executive management experience with several large public companies, the recognitions of his accomplishments as a chief financial officer and corporate treasurer, and his investment advisory experience. With regard to Mr. Humphrey, the Board considered his financial and executive expertise with Oklahoma Equity Partners, his many years of experience in business development, his current position as CEO of a NASDAQ listed company and his extensive history with the Company.

Family Relationships

None.

Board Independence

We are not required to have any independent members of the board of directors. The board of directors has determined that (i) James McGill, has a relationship which, in the opinion of the board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and is not an “independent director” as defined in the Marketplace Rules of The NASDAQ Stock Market and (ii) John Clerico and David Humphrey are each an independent director as defined in the Marketplace Rules of The NASDAQ Stock Market.

Meetings and Committees of the Board of Directors

During the fiscal year ended December 31, 2013, our board of directors held five meetings and approved certain actions by unanimous written consent. The board as a whole carries out the functions of the nominating committee.  We expect our directors to attend all board and committee meetings and to spend the time needed and meet as frequently as necessary to properly discharge their responsibilities.

Board Committees

Following the sale of Illume Mobile in July 2012, the Board of Directors was reduced to three members. The current Board as a whole carries out the functions of the Audit Committee and Compensation Committee, which prior to 2013, were carried out by separate committees. Our Board is responsible for (1) the integrity of the financial reporting process, systems of internal controls and financial statements and reports of the Company, (2) the compliance by the Company with legal and regulatory requirements, (3) the appointment, compensation and oversight of the Company's independent auditor employed by the Company for the purpose of preparing or issuing an audit report or related work.  

24

Involvement in Certain Legal Proceedings

Except as disclosed above, our Directors and Executive Officers have not been involved in any of the following events during the past ten years:

1.	any bankruptcy petition filed by or against such person or any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
2.	any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
3.	being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him from or otherwise limiting his involvement in any type of business, securities or banking activities or to be associated with any person practicing in banking or securities activities;
4.	being found by a court of competent jurisdiction in a civil action, the Securities and Exchange Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
5.	being subject of, or a party to, any federal or state judicial or administrative order, judgment decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
6.	being subject of or party to any sanction or order, not subsequently reversed, suspended, or vacated, of any self-regulatory organization, any registered entity or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Section 16(a) Beneficial Owner Reporting Compliance

Since we are governed under Section 15(d) of the Exchange Act, we are not required to file reports of executive officers and directors and persons who own more than 10% of a registered class of our equity securities pursuant to Section 16(a) of the Exchange Act.

Code of Ethics

The Company has adopted a code of business conduct and ethics that applies to all its directors, officers (including its chief executive officer, chief financial officer and any person performing similar functions) and employees. The Company has made its Code of Conduct available on its website at www.macrosolve.com/investors/.

25

Item 11. Executive Compensation.

The following table provides certain summary information concerning compensation awarded to, earned by or paid to the Company’s Chief Executive Officer, the two highest paid executive officers and up to two other highest paid individuals whose total annual salary and bonus exceeded $100,000 for fiscal years 2013 and 2012.

Name and Principal Position	Year	Salary		Bonus		Option and Warrant Awards (5)		Non-Equity Incentive Plan Compen- sation		Change in Pension Value and Non- Qualified Deferred Compensation Earnings ($)		All other Compen- sation (6)		Total
James McGill,	2013	$	30,000	$	$0	$	$16,637	$	$0	$	$0	$	124,000	$	170,637
Chief Executive Officer,	2012	$	13,100		0		16,668		0		0	$	142,000	$	171,768
President and Director (1)
Kendall Carpenter, Executive Vice	2013	$	150,000	$	$0	$	$17,290	$	$0	$	$0	$	0	$	167,290
President, Chief Financial Officer	2012	$	133,075		0		15,771		0		0	$	51,376	$	200,222
and Secretary (2)
Steve Signoff, Former Chief Executive	2012	$	106,200	$	$0	$	$0	$	$0	$	$0	$	114,091	$	220,291
Officer, President and Director (3)
Randy Ritter,	2012	$	74,212	$	0	$	$0	$	$0	$	$0	$	90,908	$	165,120
former Chief Operating Officer (4)

(1) For services in 2013, Mr. McGill received 5,369,814 shares of restricted stock valued between $0.02 and $0.03 per share upon vesting of restricted stock awards. For services in 2012, Mr. McGill received 3,658,930 shares of restricted stock valued between $0.02 and $0.10 per share upon vesting of restricted stock awards. Mr. McGill received an option in 2012 under the 2011 Key Employee Stock Incentive Plan to acquire 1,250,000 shares of common stock which vest ratably in three increments based on the Company stock trading at $0.25, $0.40 and$0.60 per share over five trading days at the price of $0.125, $0.25 and $0.40, respectively. The option has not vested and expires on December 31, 2018.

(2) For services in 2012, Ms. Carpenter received 797,606 shares of restricted stock valued between $0.05 and $0.10 per share upon vesting of restricted stock awards. Ms. Carpenter received an option in 2012 under the 2011 Key Employee Stock Incentive Plan to acquire 1,250,000 shares of common stock which vest ratably in three increments based on the Company stock trading at $0.25, $0.40 and $0.60 per share over five trading days at the price of $0.125, $0.25 and $0.40, respectively. The option has not vested and expires on December 31, 2018.

(3) For services in 2012, Mr. Signoff received 1,033,721 shares of restricted stock valued between $0.06 and $0.10 per share upon vesting of restricted stock awards. Mr. Signoff received an option in 2012 under the 2011 Key Employee Stock Incentive Plan to acquire 10,000,000 shares of common stock which vest ratably in three increments based on the Company stock trading at $0.25, $0.40 and $0.60 per share over five trading days at the price of $0.125, $0.25 and $0.40, respectively. This option had not vested and was cancelled in August 2012 upon Mr. Signoff’s resignation.  Between August 1 and December 31, 2012, the Company paid Mr. Signoff $39,091 in consulting fees.

(4) Mr. Ritter received 861,434 shares of restricted stock valued between $0.06 and $0.10 per share upon vesting of restricted stock awards. Mr. Ritter received an option in 2012 under the 2011 Key Employee Stock Incentive Plan to acquire 7,500,000 shares of common stock which vest ratably in three increments based on the Company stock trading at $0.25, $0.40 and $0.60 per share over five trading days at the price of $0.125, $0.25 and $0.40, respectively. This option had not vested and was cancelled in August 2012 upon Mr. Ritter’s resignation.  Between August 1 and December 31, 2012, the Company paid Mr. Ritter $28,408 in consulting fees.

(5) In accordance with FASB ASC Topic 718, options granted and vested in 2013 and 2012 were expensed at $90,020 and $94,738, respectively.

 (6) Fair market value of stock awards based on the value-weighted volume average (VWAP) for the last five trading days in each calendar quarter and consulting fees.

26

Employment Contracts and Termination of Employment and Change-In-Control Arrangements

Contract with Kendall Carpenter

On October 23, 2012, the Company entered into an employment agreement (the “Agreement”) with Kendall Carpenter to serve as Executive Vice President, Chief Financial Officer and Secretary, which Agreement is effective as of October 1, 2012.  The Agreement can be terminated by Ms. Carpenter at any time or by the Company upon 90 days prior written notice.  The base salary under the Agreement was initially $150,000 (the “Base Salary”), which was paid in cash through December 31, 2012, and thereafter, in cash and notes payable.  Starting January 1, 2013, Ms. Carpenter will receive an initial salary of at least $96,000 per annum in cash (the “Cash Salary”) and notes payable (the “Notes”) in an amount equal to the difference between the Base Salary and the Cash Salary.  The Notes will accrue interest at a rate of 6% per annum and payment of outstanding Notes will be done quarterly as funds become available, as determined by the Board of Directors.  In addition, Ms. Carpenter is entitled to participate in any and all benefit plans, from time to time, in effect for the Company’s employees, along with vacation, sick and holiday pay in accordance with its policies established and in effect from time to time. On September 30, 2013, the Company issued a $13,500 note to Ms. Carpenter with a due date of September 30, 2014. On December 31, 2013, the Company issued a $9,000 note to Ms. Carpenter with a due date of December 31, 2014. The Company paid Ms. Carpenter $489 in interest during 2013 and there was no accrued interest due at December 31, 2013.

Grants of Plan-Based Awards   

None.

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth information for the named executive officers regarding the number of shares subject to both exercisable and unexercisable stock options, as well as the exercise prices and expiration dates thereof, as of December 31, 2013.

27

	OPTION AWARDS						STOCK AWARDS
Name	Option Grant Date	Number of Securities Underlying Unexercised Options (#) Exercisable	Number of Securities Underlying Unexercised Options (#) Unexer-cisable		Option Exercise Price ($)	Option Expiration Date	Number of Shares or Units of Stock That Have Not Vested (#)	Market Value of Shares or Units of Stock That Have Not Vested
James McGill	2013						4,350,583	$	87,012
James McGill	2012		416,667	$	0.125	5/18/2018
James McGill	2012		416,667	$	0.25	5/18/2018
James McGill	2012		416,666	$	0.40	5/18/2018
James McGill	2010
James McGill	2009	108,008		$	.53 - $2.21	9/11/2014
James McGill	2008	129,804		$	.60 - $2.50	9/11/2014
James McGill	2007	216,640		$	0.60	9/11/2014
James McGill	2006	236,640		$	0.60	9/11/2014
James McGill	2005	324,720		$	0.43	9/11/2014
James McGill	2004	337,360		$	0.43	9/11/2014
James McGill	2003	235,280		$	0.43	9/11/2014
James McGill	2002	145,340		$	0.34	9/11/2014
Kendall Carpenter	2012		416,667	$	0.125	5/18/2018
Kendall Carpenter	2012		416,667	$	0.25	5/18/2018
Kendall Carpenter	2012		416,666	$	0.40	5/18/2018
Kendall Carpenter	2010
Kendall Carpenter	2009	52,260		$	.53 - $2.21	9/11/2014
Kendall Carpenter	2008	23,946		$	.60 - $2.50	9/11/2014
Kendall Carpenter	2007	14,400		$	0.60	9/11/2014
Kendall Carpenter	2006	26,600		$	0.60	9/11/2014

Director Compensation

Directors received compensation for their services for the fiscal year ended December 31, 2013 as set forth below: 

Name	Fees Earned or Paid in Cash		Stock Awards ($) (1)		Total ($)
John Clerico	$	8,000	$	8,000	$	16,000
David R. Lawson, former Director	$	8,000	$	8,000	$	16,000
Total:	$	16,000	$	16,000	$	32,000

(1)   Each director received $4,000 per quarter served on the Board of Directors, paid in either cash or restricted common stock based on a five day VWAP at the end of each quarter.

28

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The following table sets forth the number of and percent of the Company's common stock beneficially owned by:

· all directors and nominees, naming them,

· our executive officers,

· our directors and executive officers as a group, without naming them, and

· persons or groups known by us to own beneficially 5% or more of our Common Stock or our Preferred Stock having voting rights:

The business address of each of the beneficial owners listed below is c/o MacroSolve, Inc. 9521-B Riverside Parkway, #134, Tulsa, Oklahoma 74137.

	Title of Class	Number of Shares Beneficially Owned (1)		Percentage of Class (2)
James C. McGill (3)	Common Stock		35,814,247	15.81%
Kendall Carpenter (4)	Common Stock		4,895,314	2.50%
John Clerico (5)	Common Stock		53,049,198	21.76%
David Humphrey (6)	Common Stock		1,703,362	*
Officers and Directors as a Group	Common Stock		95,462,121	33.35%

________________________________

* Denotes less than 1%

(1)	This column represents the total number of votes each named stockholder is entitled to vote upon matters presented to the shareholders for a vote.
(2)	The percentages in the table have been calculated on the basis of treating as outstanding for a particular person, all shares of our capital stock outstanding on March 24, 2014.  On March 24, 2014, there were 190,764,559 shares of our common stock outstanding.  To calculate a stockholder's percentage of beneficial ownership, we include in the numerator and denominator the common stock outstanding and all shares of our common stock issuable to that person in the event of the exercise of outstanding options and other derivative securities owned by that person which are exercisable within 60 days of March 24, 2014.  Common stock options and derivative securities held by other stockholders are disregarded in this calculation. Therefore, the denominator used in calculating beneficial ownership among our stockholders may differ. Unless we have indicated otherwise, each person named in the table below has sole voting power and investment power for the shares listed opposite such person's name.
(3)	Represents (i) 22,753,318 shares of common stock owned, (ii) 6,153,933 shares of common stock underlying outstanding warrants, (iii) 1,733,792 shares of common stock underlying options which are currently exercisable or become exercisable within 60 days, (iv) 3,481,731 shares of common stock issued under restrictive stock grants with voting rights, (v) 1,189,313 shares of common stock held by the Jean B. McGill Revocable Living Trust, and (vi) 502,160 shares of common stock underlying outstanding warrants held by the Jean B. McGill Revocable Living Trust.  Mr. McGill, as the Executor Trustee of the Jean B. McGill Revocable Living Trust, has investment and voting control over the shares held by this entity.
(4)	Represents (i) 4,646,562 shares of common stock owned, (ii) 131,546 shares of common stock underlying outstanding warrants, and (iii) 117,206 shares of common stock underlying options which are currently exercisable or become exercisable within 60 days.
(5)	Represents (i) 35,507,964 shares of common stock owned; (ii) 17,261,234 shares of common stock underlying outstanding warrants; and (iii) 280,000 shares of common stock underlying options which are currently exercisable or become exercisable within 60 days.
(6)	Represents (i) 928,362 shares of common stock owned; (ii) 240,000 shares of common stock underlying outstanding warrants; and (iii) 535,000 shares of common stock underlying options which are currently exercisable or become exercisable within 60 days.

29

Item 13.  Certain Relationships and Related Transactions, and Director Independence.

Other than as disclosed below, during the last two fiscal years, there have been no transactions, or proposed transactions, which have materially affected or will materially affect us in which any director, executive officer or beneficial holder of more than 5% of the outstanding common or preferred stock, or any of their respective relatives, spouses, associates or affiliates, has had or will have any direct or material indirect interest. We have no policy regarding entering into transactions with affiliated parties.

James McGill, the Company’s President, Chief Executive Officer and Chairman of the Board of Directors, made loans to the Company during 2012 for operating capital. In January 2012, Mr. McGill provided a short term loan of $100,000. The note was secured by 10% of net patent settlements and provided for interest of twelve percent (12%).  That loan, along with a $25,000 short term loan made in December 2011, was converted to a $125,000 investment in the 2012 Debenture Series C in February 2012. In March 2012, Mr. McGill provided a $50,000 short term loan under the same conditions which was repaid on March 30, 2012 with $246 in accrued interest. In April, 2012, Mr. McGill converted the $125,000 debenture and $1,811 accrued interest into 1,447,613 shares of restricted common stock.  During the second and third quarters, Mr. McGill provided short term loans of $149,667 under the same conditions. On October 1, 2012, Mr. McGill rolled the $149,667 note balances, $10,199 accrued interest and $6,000 accrued loan guarantee fee into a single long term loan of $165,866. The note is secured by the unencumbered 75% of patent settlement license fees and accounts receivable, provides for interest of six percent (6%) and is due on January 1, 2015.  Mr. McGill made a $65,000 short term unsecured loan with interest of twelve percent (12%) on December 22, 2011 which was repaid on January 3, 2012. Mr. McGill did not make any loans to the Company during 2013. Accrued interest at December 31, 2013 was $12,460.

David Lawson, a former Director, made loans to the Company during 2012 for operating capital. In January 2012, Mr. Lawson provided a short term loan of $20,000. The note was secured by 10% of net patent settlements and provided for interest of twelve percent (12%).  That loan, along with a $25,000 short term loan made in December 2011 and an $80,000 direct investment, was converted to a $125,000 investment in the 2012 Debenture Series C in February 2012. In April, 2012, Mr. Lawson converted the $125,000 debenture and $1,811 accrued interest into 1,447,613 shares of restricted common stock.  During the second and third quarters, Mr. Lawson provided short term loans of $149,667 under the same conditions. On October 1, 2012, Mr. Lawson rolled the $149,667 note balances, and $6,565 accrued interest into a single long term loan of $156,232. The note is secured by the unencumbered 75% of patent settlement license fees and accounts receivable, provides for interest of six percent (6%) and is due on January 1, 2015.  Mr. Lawson did not make any loans to the Company during 2013. Accrued interest as of December 31, 2013 was $11,737.

John Clerico, a Director of the Company, made loans to the Company during 2012 for operating capital. In February 2012, Mr. Clerico converted a $25,000 short term loan made in December 2011 and along with a $100,000 direct contribution invested a total of $125,000 in the 2012 Debenture Series C. In April, 2012, Mr. Clerico converted the $125,000 debenture and $1,811 accrued interest into 1,447,613 shares of restricted common stock.  During the second and third quarters of 2012, Mr. Clerico provided short term loans of $149,666 under the same conditions as Directors McGill and Lawson. On October 1, 2012, Mr. Clerico rolled the $149,666 note balances, $5,819 accrued interest and $3,000 accrued loan guarantee fee into a single long term loan of $158,785. The note is secured by the unencumbered 75% of patent settlement license fees and accounts receivable, provides for interest of six percent (6%) and is due on January 1, 2015. Mr. Clerico did not make any loans to the Company during 2013. Accrued interest as of December 31, 2013 was $11,929.

Howard Janzen, a former Director and Chairman of the Board, made loans to the Company during 2012 for operating capital. In January 2012, Mr. Janzen provided a short term loan of $20,000 and another $80,000 short term loan in February 2012. The notes were secured by 10% of net patent settlements and provided for interest of twelve percent (12%).  Those loans, along with the $25,000 loan from 2011, were converted to a $125,000 investment in the 2012 Debenture Series C in February 2012. In April, 2012, Mr. Janzen converted the $125,000 debenture and $1,811 accrued interest into 1,447,613 shares of restricted common stock.  During the second quarter of 2012, Mr. Janzen provided a $50,000 under the same conditions. On October 1, 2012, Mr. Janzen rolled the $50,000 note balance and $2,788 accrued interest into a single long term loan of $52,798. The note is secured by the unencumbered 75% of patent settlement license fees and accounts receivable, provides for interest of six percent (6%) and is due on January 1, 2015. Mr. Janzen did not make any loans to the Company during 2013. Accrued interest as of December 31, 2013 was $3,966.

30

The Company acquired an advancing term loan with a financial institution of up to $100,000 with interest only payable monthly at prime rate plus 1.0% (4.25% at December 31, 2011), until September 2012, and secured by substantially all assets of the company and the personal guarantee of James McGill, Vice Chairman. In exchange for the guarantees, Mr. McGill received a $3,000 commitment fee and a five year warrant to purchase $100,000 of stock with a strike price of ten cents ($0.10) per share. The loan was repaid in October 2012 and not renewed. Mr. McGill’s commitment fee was rolled into the current long-term loan in October 2012.

Item 14.  Principal Accountant Fees and Services.

The Audit Committee pre-approves all auditing services and all permitted non-auditing services (including the fees and terms thereof) to be performed by our independent registered public accounting firm.

Audit Fees

For the year ended December 31, 2013, the fees to MaloneBailey, LLP for audit services totaled approximately $21,000 for the annual audit and reviews of the Company’s quarterly reports on Form 10-Q.  For the year ended December 31, 2012, the fees to Hood & Associates, CPAs, P.C. (“Hood”) for audit services totaled approximately $16,421 which included approximately $16,320 associated with the annual audit and reviews of the Company’s quarterly reports on Form 10-Q and approximately $101 associated with the Company’s statutory and regulatory filings.  For the year ended December 31, 2012, the fees to MaloneBailey, LLP for audit services and restatement of the 2012 financials totaled approximately $15,000.

Audit Related Fees

We incurred fees to our independent auditors of $-0- for audit related fees during the fiscal years ended December 31, 2013 and 2012.  

Tax Fees

We incurred fees to Hood of $2,102 and $2,093 for tax preparation fees during the fiscal years ended December 31, 2013 and 2012, respectively.  

All Other Fees

We incurred fees to our independent auditors of $-0- for others fees during the fiscal years ended December 31, 2013 and 2012.  

31

PART IV

Item 15. Exhibits and Financial Statement Schedules.

The following documents are filed as a part of this report or incorporated herein by reference:

(1)	Our Financial Statements are listed on page F-1 of this Annual Report.
(2)	Financial Statement Schedules: None.

Exhibits:

3.01	Articles of Incorporation, filed as an exhibit to the Registration Statement on Form S-1, filed with the Securities and Exchange Commission (“Commission”) on April 18, 2008 and incorporated herein by reference.
3.02	Bylaws, filed as an exhibit to the Registration Statement on Form S-1, filed with the Commission on April 18, 2008 and incorporated herein by reference.
3.03	Certificate of Amendment to the Articles of Incorporation, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October 6, 2009 and incorporated herein by reference.
3.03	Certificate of Amendment to the Articles of Incorporation, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October 28, 2011 and incorporated herein by reference.
10.01	2009 Stock Compensation Plan, filed as an exhibit to the Registration Statement on Form S-8, filed with the Commission on October 13, 2009 and incorporated herein by reference.
10.02	Form of Subscription Agreement, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on February 21, 2012 and incorporated herein by reference.
10.03	Form of Convertible Debenture, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on February 21, 2012 and incorporated herein by reference.
10.04	Form of Warrant, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on February 21, 2012 and incorporated herein by reference.
10.05	Form of Subscription Agreement, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on March 29, 2012 and incorporated herein by reference.

32

10.06	Form of Warrant, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on March 29, 2012 and incorporated herein by reference.
10.07	Asset Purchase Agreement, dated as of July 31, 2012, by and between MacroSolve, Inc. and DecisionPoint Systems, Inc., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 6, 2012 and incorporated herein by reference.
10.08	License Agreement, dated as of July 31, 2012, by and between MacroSolve, Inc. and DecisionPoint Systems, Inc., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 6, 2012 and incorporated herein by reference.
10.09	Non-Competition and Non-Solicitation Agreement, dated as of July 31, 2012, by and between MacroSolve, Inc. and DecisionPoint Systems, Inc., filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on August 6, 2012 and incorporated herein by reference.
10.10	Employment Agreement, dated as of October 23, 2012, by and between MacroSolve, Inc. and Kendall Carpenter, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October 24, 2012 and incorporated herein by reference.
14.01	Code of Business Conduct and Ethics, filed as an exhibit to the Annual Report on Form 10-K, filed with the Commission on March 30, 2010 and incorporated herein by reference.
31.01	Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.02	Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.01	Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 INS	XBRL Instance Document
101 SCH	XBRL Taxonomy Extension Schema Document
101 CAL	XBRL Taxonomy Calculation Linkbase Document
101 LAB	XBRL Taxonomy Labels Linkbase Document
101 PRE	XBRL Taxonomy Presentation Linkbase Document
101 DEF	XBRL Taxonomy Extension Definition Linkbase Document

33

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MACROSOLVE, INC.
Date   March 28, 2014	By:	/s/ JAMES C. McGILL
		James C. McGill
		Chief Executive Officer (Principal Executive Officer)
Date:  March 28, 2014	By:	/s/ KENDALL CARPENTER
		Kendall Carpenter
		Chief Financial Officer (Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Name	Position	Date
/s/ JAMES C. MCGILL	Director	March 28, 2014
James C. McGill
/s/ JOHN CLERICO	Director	March 28, 2014
John Clerico
/s/ DAVID HUMPRHEY	Director	March 28, 2014
David Humphrey

34

MACROSOLVE, INC.

Financial Statements Together With

Report of Independent Registered Public Accounting Firm

For the Years Ended December 31, 2013 and 2012

MACROSOLVE, INC.

Financial Statements Together With

Report of Independent Registered Public Accounting Firm

For the Years Ended December 31, 2013 and 2012

Report of Independent Registered Public Accounting Firm	F-2
Balance Sheets as of December 31, 2013 and 2012	F-3
Statements of Operation for the Years Ended December 31, 2013 and 2012	F-4
Statements of Stockholders’ Equity for the Years Ended December 31, 2013 and 2012	F-5
Statements of Cash Flows for the Years Ended December 31, 2013 and 2012	F-6
Notes to Financial Statements	F-7

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors

MacroSolve, Inc.

Tulsa, Oklahoma

We have audited the accompanying balance sheets of MacroSolve, Inc. (the “Company”) as of December 31, 2013 and 2012, and the related statements of operations and comprehensive loss, stockholders’ equity, and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatements. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2013 and 2012, and the related results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

As disclosed in note 18 to the financial statements, the Company restated its previously issued financial statements as of December 31, 2012, and for the year then ended.

/s/ MaloneBailey, LLP

www.malone-bailey.com

Houston, Texas

March 28, 2014

F-2

MACROSOLVE, INC.

BALANCE SHEETS

	12/31/2013			12/31/2012
				(Restated)
ASSETS
CURRENT ASSETS:
Cash	$	706,211		$	659,204
Accounts receivable - trade		38,791			74,056
Prepaid expenses and notes receivable		32,594			19,330
Total current assets		777,596			752,590
PROPERTY AND EQUIPMENT, at cost:		4,237			21,651
Less - accumulated depreciation		(1,586	)		(19,462	)
Net property and equipment		2,651			2,189
OTHER ASSETS:
Available-for-sale investment - DecisionPoint Systems, Inc.		324,190			493,827
Available-for-sale investment - MEDL Mobile Holdings, Inc.		39,537			-
Available-for-sale Investment - Endexx Corporation		7,675			-
Intangible assets, net of amortization		70,223			64,227
Total other assets		441,625			558,054
TOTAL ASSETS	$	1,221,872		$	1,312,833
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Note Payable - Oklahoma Technology Commercialization Center- Current	$	112,500		$	90,000
Accounts payable - trade and accrued liabilities		181,172			82,226
Note payable - Related party		22,500			-
Total current liabilities		316,172			172,226
LONG-TERM DEBT, less current maturities
Note Payable - Shareholders		533,681			533,681
Note Payable - Oklahoma Technology Commercialization Center		20,000			125,000
Convertible debentures, net of discount of $54,545 and $72,727 respectively		95,455			77,273
Total long-term debt, less current maturities		649,136			735,954
TOTAL LIABILITIES	$	965,308		$	908,180
COMMITMENTS AND CONTINGENCIES		-			-
STOCKHOLDERS' EQUITY:
Preferred stock, $.01 par value; authorized 10,000,000 shares;
0 shares issued and outstanding, at
December 31, 2013 and 2012, respectively		-			-
Common stock, $.01 par value; authorized 500,000,000 shares;
issued and outstanding 190,764,586 and 182,163,896 shares, at
December 31, 2013 and 2012, respectively		1,907,645			1,821,638
Additional paid-in capital		19,922,670			19,720,319
Accumulated other comprehensive income		(399,936	)		(204,173	)
Accumulated deficit		(21,173,815	)		(20,933,131	)
Total stockholders' equity		256,564			404,653
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	1,221,872		$	1,312,833

The accompanying notes are an integral part of these statements.

F-3

MACROSOLVE, INC.

STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

For the Years Ended December 31,	2013			2012
				(Restated)
Revenues	$	1,454,337		$	2,433,745
Cost of revenues		854,471			1,029,985
Gross profit		599,866			1,403,760
General and administrative expense		777,920			1,431,869
Loss from operations		(178,054	)		(28,109	)
Other income (expense)
Interest income		6,681			164
Interest expense		(69,311	)		(1,998,429	)
Loss on Derivatives		-			(4,028,085	)
Total other expense		(62,630	)		(6,026,350	)
Net loss from continuing operations	$	(240,684	)	$	(6,054,459	)
DISCONTINUED OPERATIONS
Loss from operations of discontinued
Illume Mobile Operations		-			(2,097,940	)
Loss on sales of discontinued operations		-			(106,538	)
Net loss from discontinued operations		-			(2,204,478	)
NET LOSS	$	(240,684	)	$	(8,258,937	)
OTHER COMPREHENSIVE INCOME, net of tax
Unrealized holding loss arising during the period		(195,763	)		(204,173	)
COMPREHENSIVE LOSS	$	(436,447	)	$	(8,463,110	)
LOSS ALLOCABLE TO COMMON STOCKHOLDERS:
Net loss	$	(240,684	)	$	(8,258,937	)
Loss allocable to common stockholders	$	(240,684	)	$	(8,258,937	)
Weighted average number of common shares outstanding		185,938,398			163,405,338
Basic and diluted net income (loss) from continuing operations per share	$	(0.00	)	$	(0.04	)
Basic and diluted net loss from discontinued operations per share	$	-		$	(0.01	)
Basic and diluted net income (loss) per share	$	(0.00	)	$	(0.05	)

The accompanying notes are an integral part of these statements.

F-4

MACROSOLVE, INC.

STATEMENTS OF STOCKHOLDERS' EQUITY

For the Years Ended December 31, 2013 and 2012
									Accumulated
							Additional		Other
	Common Stock						Paid-in		Comprehensive			Accumulated
	Number of Shares			Amount			Capital		Loss			Deficit			Total
BALANCE, at December 31, 2011		122,386,894		$	1,223,869		$	10,059,029	$	-		$	(12,674,194	)	$	(1,391,296	)
Net Loss					-			-		-			(8,258,937	)		(8,258,937	)
Comprehensive Loss					-			-		(204,173	)		-			(204,173	)
Derivative liabiilties written off to additional paid-in capital					-			4,473,289		-			-			4,473,289
Debt discount recorded for beneficial conversion feature								1,475,000								1,475,000
Common Stock issued for Services		2,800,000			28,000			250,450		-			-			278,450
Common Stock issued for cash		2,500,000			25,000			225,000		-			-			250,000
Common Stock issued for conversion of debt and accrued interest		41,815,921			418,159			2,769,332								3,187,491
Compensation expense related to
stock awards		12,723,747			127,237			373,481		-			-			500,718
Option expense								94,738		-						94,738
Cancellation of shares		(62,666	)		(627	)										(627	)
BALANCE, at December 31, 2012 (Restated)		182,163,896		$	1,821,638		$	19,720,319	$	(204,173	)	$	(20,933,131	)	$	404,653
Net Loss					-			-		-			(240,684	)		(240,684	)
Comprehensive Loss					-			-		(195,763	)		-			(195,763	)
Stock issued in exchange for available-for-sale securities		2,500,000			25,000			33,338		-			-			58,338
Compensation expense related to
stock awards		6,100,690			61,007			78,993		-						140,000
Option expense								90,020								90,020
BALANCE, at December 31, 2013		190,764,586		$	1,907,645		$	19,922,670	$	(399,936	)	$	(21,173,815	)	$	256,564

The accompanying notes are an integral part of these statements.

F-5

MACROSOLVE, INC.

STATEMENTS OF CASH FLOWS

For the Years Ended December 31,	2013			2012
OPERATING ACTIVITIES:				(Restated)
Net loss	$	(240,684	)	$	(8,258,937	)
Adjustments to reconcile net loss to net cash
provided by (used in) operating activities:
Depreciation and amortization		3,384			517,509
Loss on disposal of fixed assets		435			4,245
Loss on sales of assets to DecisionPoint		-			106,538
Bad debt expense		-			141,277
Amortization of debt discount		18,182			1,847,477
Loss on derivative liability		-			4,028,085
Equity based compensation		140,000			779,168
Option expense		90,020			94,738
Cancellation of shares		-			(627	)
Stock received from Endexx Corporation for revenue		(15,000	)		-
Changes in current assets and liabilities:
Decrease in accounts receivable - trade		9,998			195,969
Decrease (Increase) in prepaid expenses and other		(543	)		223,747
Increase (decrease) in accounts payable - trade and
accrued liabilities		121,446			(272,950	)
(Decrease) increase in unearned income		-			5,571
Net cash provided by (used in) operating activities		127,238			(588,190	)
INVESTING ACTIVITIES:
Cash received from notes receivable		12,546			-
Purchase of equipment		(1,467	)		(8,580	)
Cash received from sale of Illume Mobile		-			250,000
Software development costs		-			(233,390	)
Patent application fees		(8,810	)		(4,568	)
Net cash provided by investing activities		2,269			3,462
FINANCING ACTIVITIES:
Proceeds from convertible debt		-			180,000
Proceeds from shareholder loan		-			778,300
Proceeds from sale of common stock		-			250,000
Repayments of shareholder loan		-			(115,000	)
Repayments of notes payable		(82,500	)		(22,500	)
Repayment of bank line of credit					(100,000	)
Net cash (used in) provided by financing activities		(82,500	)		970,800
NET INCREASE IN CASH		47,007			386,072
CASH, beginning of period		659,204			273,132
CASH, end of period	$	706,211		$	659,204
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the years ended December 31:
Interest	$	1,059		$	27,071
Income taxes	$	-		$	-
Noncash investing and financing activities for the year ended December 31:
Stock issued for conversion of debt and accrued interest	$			$	3,187,491
Stock issued in exchange for available-for-sale securities	$	58,338		$	-
Stock received from DecisionPoint Systems for sale of
Illume Mobile assets	$	-		$	698,000
Change in fair value  for available-for-sale securities	$	(195,763	)	$	(204,173	)
Re-classification of accounts receivable to note receivable	$	25,267		$	-
Re-classification of accrued salary to noted payable to related party	$	22,500		$	-
Re-classification of shareholders loan from Short term to Long term	$			$	169,306
Re-classification of shareholders loan from long term to convertible debt	$			$	320,000
Re-classification of accrued interest to note payable - shareholders	$			$	21,075
Debt discount recorded for derivative liability	$			$	100,000
Debt discount recorded for beneficial conversion feature	$			$	1,475,000
Derivative liabilities written off to Additional paid in capital	$			$	4,473,289

The accompanying notes are an integral part of these statements.

F-6

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations:

MacroSolve, Inc. is an Oklahoma corporation formed on January 17, 1997, under the laws of the State of Oklahoma.  We are focused on intellectual property licensing and enforcement of our patent in the mobile app market development space.  We also offer consulting services related to mobile app development, marketing and financing of mobile app businesses. In addition, until July 31, 2012, we conducted business as Illume Mobile, engaged in the design, delivery and integration of custom solutions for the application of mobile technology in business processes.

Reclassifications:

Certain prior year amounts have been reclassified to conform to the current year presentation.

Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Concentration of Credit Risk:

Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.

Cash Equivalents:

Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2013 and 2012.

Accounts and Notes Receivable and Credit Policies:

Trade accounts receivable consist of amounts due from the sale of solution services and software licenses.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  At December 31, 2013 and 2012, the Company deems $0 and $5,700 as uncollectible, respectively. Bad debts expense was $0 in 2013 and $141,277 in 2012 of which $135,577 consisted of a customer note receivable that the Company deemed uncollectible following the sale of Illume Mobile.

On June 1, 2013, one customer issued a promissory note for an amount of $25,268 to the Company, to replace the accounts receivable owed to the Company. As of December 31, 2013, the note receivable has a balance of $12,721, will mature on May 31, 2014 and with interest calculated at the prime interest rate published in the Wall Street Journal plus five percent.

F-7

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

Property and Equipment:

Property and equipment is recorded at cost when acquired.  Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.  Leasehold improvements are being amortized over a 7 year estimated useful life.  A majority of the company’s fixed assets were associated with Illume Mobile, a division which was sold to DecisionPoint Systems, Inc. on July 31, 2012. Property and equipment consists of the following at December 31, 2013 and 2012:

	2013		2012
Computer hardware	$	3,639	$	16,197
Furniture and fixtures		598		5,454
		4,237		21,651
Less - accumulated depreciation		1,586		19,462
	$	2,651	$	2,189

Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.

Marketable Securities:

All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss.

Long-Lived Assets:

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  No impairment charges were incurred during the periods ended December 31, 2013 and 2012.

Derivative Financial Instruments:

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, assuming maximum value, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Beneficial Conversion Features:

The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.

F-8

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

Fair Value of Financial Instruments:

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1    –  Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

Level 2     -  Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

Level 3     –  Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of December 31, 2013 and 2012:

Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
December 31, 2013
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	371,402		-		-	$	371,402
December 31, 2012
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	493,827		-		-	$	493,827

Revenue Recognition and Unearned Revenue:

The Company recognizes revenue only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. Revenues from intellectual property licenses are recognized upon issuance of the license. When intellectual property licenses are received under a contingent fee agreement with the law firm of Antonelli, Harrington & Thompson LLP, the applicable contingent legal expense is recorded as a cost of sale. In the event a non-exclusive intellectual property license is granted within the scope of a contracted app development project, ten percent (10%) of the contract amount is deemed to be payment for the license.  Revenue from software product licensing is recognized ratably over the license period.  Unearned income associated with Illume Mobile contracts of $36,971 was transferred to DecisionPoint Systems as part of the Illume Mobile asset sale in July 2012.

F-9

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

Solution services revenues, including advisory services, consist primarily of professional services contracted to third party customers or clients under contract for specific projects. Contracted projects that are fixed price are accounted for under the percentage-of-completion method of accounting. Revenue from contracted projects that are for provision of services is recognized at the time the service is provided. The Company no longer offers solutions services after the sale of Illume Mobile in July 2012.

Software Development Costs:

The Company accounts for software development costs in accordance with ASC 985-20, “Costs of Computer Software to be Sold, Leased, or Otherwise Marketed”.  Costs incurred prior to the establishment of technological feasibility are expensed as incurred as research and development costs.  Costs incurred after establishing technological feasibility and before the product is released for sale to customers are capitalized.  These costs are amortized over three years and are reviewed for impairment at each period end. The Company sold a total of $1,213,550 in gross capitalized software development costs and associated $194,070 in accumulated amortization, or a net of $1,019,480, to DecisionPoint Systems in July 2012. Amortization expense in 2012 totaled $500,910 and consisted of $161,037 in Illume Mobile development costs, $2,814 in patent costs and $337,059 related to Mobiz360, including a one-time amortization of $293,054 net capitalized development costs, In May 2012, MoBiz360, an incomplete prototype website marketplace for an amount of $337,059, was conveyed to Clint Parr, our former president and CEO, as consideration for an undetermined equity interest in Mr. Parr’s new company. As of December 31, 2013, Mr. Parr’s new company is still not operational. The net value of MoBiz360 for an amount of $293,054 was written off as amortization expense during the year ended December 31, 2012. The Company is not presently developing software.

Income Taxes:

The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (SFAS No. 109).  ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.  Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.  The effects of future changes in tax laws or rates are not included in the measurement.  The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns.  The Company currently has substantial net operating loss carry forwards. The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

Employee Stock-Based Compensation:

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.

Non-Employee Stock-Based Compensation:

The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), Share Based Payments to Non-Employees, and ASC 505 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.

F-10

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

Related Parties:

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

Earnings or Loss per Share:

The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the periods, basic and diluted loss per share is the same for the years ended December 31, 2013 and 2012, respectively.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

2. INVESTMENT IN DECISIONPOINT SYSTEMS, INC.

As further described in Footnote #17, on July 31, 2012, the Company sold the Illume Mobile assets and operations to DecisionPoint Systems, Inc. (DPSI) for $250,000 cash and 617,284 shares of DPSI stock. The shares were recorded at fair value on July 31, 2012 of $698,000. In accordance with ASC 320, the stock is classified as available-for-sale equity and the unrealized market gains or losses are recorded as Other Comprehensive Income. The shares were valued at fair value of $324,190 and $493,827 at December 31, 2013 and 2012, respectively, with the decrease in fair value of $169,637 and $204,173 at December 31, 2013 and 2012, respectively, recorded in Other Comprehensive Income.

3. INVESTMENT IN MEDL MOBILE HOLDINGS, INC.

On March 8, 2013, the Company entered into an agreement with MEDL Mobile Holdings, Inc. (MEDL) to bring forth a program that offers access to the Company’s ‘816’ patent to app developers. MEDL received the right to grant a license to its clients on a ‘per install’ basis on a revenue sharing arrangement with the Company. As a part of the agreement, each Company received $50,000 worth of the other’s stock with the price per share determined by the Volume Weighted Average Price (“VWAP”) for each stock for the last twenty trading days prior to execution of the agreement. The Company received 147,692 shares of MEDL stock priced at $0.34 per share and MEDL received 2,500,000 shares of the Company’s stock priced at $0.02 per share. The shares were recorded at fair value on March 8, 2013 of $58,338. In accordance with ASC 320, the stock is classified as available-for-sale equity and the unrealized market gains or losses are recorded as Other Comprehensive Income. The shares were valued at fair value of $39,537 at December 31, 2013 with the decrease in fair value of $18,801 at December 31, 2013 recorded in Other Comprehensive Income.

F-11

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

4.  INVESTMENT IN ENDEXX CORPORATION

On June 5, 2013, the Company entered into six month agreement with Endexx Corporation (EDXC) to coordinate business planning, investor interests and intellectual property for a mobile app venture that uniquely addresses advertising market analytics. Additionally, Endexx received a variable limited ‘816’ license during the course of the business advisory engagement while its app is in development with the agreement that a permanent license will be negotiated upon completion.  Endexx paid the Company $15,000 compensation by issuing 125,000 shares of EDXC restricted stock priced at $.12 per share and the balance in accounts receivable. The shares were recorded at fair value on June 5, 2013 for an amount of $15,000. In accordance with ASC 320, the stock is classified as available-for-sale equity and the unrealized market gains or losses are recorded as Other Comprehensive Income. The shares were valued at fair value of $7,675 at December 31, 2013 with the decrease in fair value of $7,325 at December 31, 2013 recorded in Other Comprehensive Income.

5.   LINE OF CREDIT

The Company had an advancing term loan with a financial institution of up to $100,000 with interest only payable monthly at the greater of 5.75% or prime rate plus 1.0% (4.25% at September 30, 2012), until September 2012, and secured by substantially all assets of the company and the personal guarantees of a company director. In exchange for the guaranty, the director receives a $3,000 commitment fee and a five year warrant to purchase $100,000 of stock with a strike price of ten cents ($0.10) per share. The loan was repaid in October 2012 and was not renewed.

6.  OKLAHOMA TECHNOLOGY COMMERCIALIZATION CENTER NOTE PAYABLE

The Company carries a note from the State of Oklahoma Technology Business Finance Program (OTCC loan) represented originally by a $150,000 refundable award to be repaid at two times the amount of the award.  The balance includes accrued interest (imputed at 14.27%), through September 2007.  The monthly payments were suspended in October 2008 and resumed in October 2012 in the amount of $7,500 per month. The Company repaid $22,500 in 2012 and $82,500 in 2013. The total balance due at December 31, 2013 is $132,500 with $112,500 classified as current liabilities and $20,000 classified as long-term debt. The total balance due at December 31, 2012 is $215,000 with $90,000 classified as current liabilities and $125,000 classified as long-term debt.

The aggregate minimum maturities of the note payable for each of the next two years are as follows:

2014	$	112,500
2015	$	20,000
Total	$	132,500

7.  NOTE PAYABLE – RELATED PARTY

On September 30, 2013, the Company reclassified $13,500 deferred compensation to a note payable due to Chief Financial Officer Kendall Carpenter as stipulated in her employment agreement. The note bears a 6% interest rate and is due by September 30, 2014.  On December 31, 2013, the Company reclassified $9,000 deferred compensation to a note payable due to Kendall Carpenter as stipulated in her employment agreement. The note bears a 6% interest rate and is due by December 31, 2014. There was no unpaid accrued interest at December 31, 2013.

F-12

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

8.  NOTE PAYABLE - SHAREHOLDERS

As of December 31, 2011, the Company had recorded $169,306 in notes payable to directors. During 2012, multiple directors advanced $778,300 on short-term notes bearing 12% interest rates and mature on September 30, 2012. Four directors agreed to amend their notes by $320,000 which were reclassified as long-term debt upon issuance of 2012 Convertible Debenture Series C, see note 9. During the same year, $115,000 in notes was repaid in cash and $21,075 in accrued interest was reclassified as note payable. The total amount due to multiple directors of $533,681, including accrued interest, was rolled over into new notes dated September 30, 2012. The new notes are secured by the unencumbered 75% of patent settlement license fees and provide for accrued interest at 6% payable on maturity at January 1, 2015. The total balance due at December 31, 2013 and 2012 is $533,681. The accrued interest at December 31, 2013, 2012 is $40,092 and $8,177, respectively.

The Company analyzed the modification of the term under ASC 470-60 “Trouble Debt Restructurings” and ASC 470-50 “Extinguishment of Debt”. The Company determined the modification is substantial and the transaction should be accounted for as an extinguishment with the old debt written off and the new debt initially  recorded at fair value with a new effective interest rate. The Company also determined that the fair value of the new debt is the same as the fair value of the old debt. Thus no gain or loss was recognized upon the extinguishment.

9. CONVERTIBLE DEBENTURES

2010 Convertible Debenture

During November 2010, a director invested $50,000 in the Convertible Debenture Series 2010 plus Series B Warrants. The debenture bore a 2% interest rate, a maturity date of December 31, 2015 and included a warrant for the right to purchase 95,493 shares at a $.2618 exercise price with a December 31, 2015 maturity date. Upon conversion, the director was entitled to receive the number of shares of Common Stock that could be purchased with two hundred percent (200%) of the face amount of the Debentures together with accrued interest and with the Common Stock valued using the weighted average price for the five-day trading period before the notice of conversion. The debenture became convertible on June 30, 2011.   On March 1, 2012, the debenture was converted to 940,734 shares of stock. Accrued interest of $1,285 was settled in full during September, 2012.

The Company analyzed the conversion option of all the 2010 convertible debt. As discussed in Footnote 13, the Company considered derivative accounting under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion feature should be classified as a liability due to there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. The embedded conversion feature was measured at fair value at the date of inception and at the end of each reporting period or termination of the instrument with the change in fair value recorded to earnings.

2011 Convertible Debenture – Series A Warrants

During April 2011, the Company began offering its Convertible Debentures - Series 2011 and Series A Warrants. The Debentures bore a 12% interest rate, a maturity date of December 31, 2016 and included warrants in an amount equal to the principal amount divided by 50% of the Debenture conversion price. Total numbers of warrants attached with the convertible debentures are 18,475,827 with a exercise price equal to 50% of the debenture conversion price. Upon conversion, the holder was entitled to receive the number of shares of Common Stock that could have been purchased with 200% of the principal amount of the Debenture, together with accrued and unpaid interest and the shares valued using the weighted average price for a five-day trading period preceding the Debenture investment. The Company issued $1,675,000 in debentures in 2011 to sixteen investors. During 2012, fifteen of the sixteen investors elected to convert a total of $1,575,000 Debenture Series 2011 into 16,831,553 shares of common stock. A total of $179,312 in accrued interest on the converted debentures was settled, $16,167 in cash and $163,145 with 870,543 shares of common stock. As of December 31, 2013 and 2012, there is one outstanding debenture for $100,000. The Company accounted for the intrinsic value of a Beneficial Conversion Feature inherent to a convertible note payable as a discount of $1,475,000 recorded to the convertible debenture. Amortization of debt discount of $18,182 and $1,402,273 was recognized in 2013 and 2012, respectively. The remaining balance of unamortized discount is $54,545 and $72,727 at December 31, 2013 and 2012, respectively. Accrued interest outstanding on the debenture as of December 31, 2013 and 2012 are $30,429 and $18,396, respectively.

F-13

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

As a result of the issuance of 2010 convertible debt to a director and because the debt became convertible on June 30, 2011, the conversion option of all other third party convertible notes became tainted. Under ASC 815-15“Derivatives and Hedging”, all other tainted share settleable instruments must be reclassified from equity to liability. As a result of the full conversion of 2010 convertible debts on March 1, 2012, the derivative treatment on these other third party convertible notes ended and the derivative liabilities for an amount of $ 683,602 must be reclassified back to equity. See discussion in Note 13.

2011 Convertible Debenture – Series B Warrants

During July 2011, the Company began offering its Convertible Debentures Series 2011 and Series B warrants. The Debentures bore a 12% interest rate, a maturity date of December 31, 2016 and included warrants in an amount equal to the principal amount divided by the Debenture conversion price. Total numbers of warrants attached with the convertible debentures are 8,961,614 with an exercise price equal to the debenture conversion price. Upon conversion, the holder was entitled to receive the number of shares of Common Stock that could have been purchased with 200% of the principal amount of the Debenture, together with accrued and unpaid interest and the shares valued using the weighted average price for a five-day trading period preceding the Debenture investment provided however, that the conversion price shall not be less than ten cents per share at any time and the conversion price shall not be more than ten cents per share for investments made prior to October 1, 2011. By resolution of the Board on December 16, 2011, the ten cent conversion price per share was extended to investments made after October 1, 2011. The Company issued $896,161 in debentures in 2011 to nineteen investors. During 2012, eighteen of the nineteen investors elected to convert a total of $846,161 Debenture Series 2011 into 16,923,227 shares of common stock. A total of $45,941 in accrued interest on the converted debentures was settled with 459,412 shares of common stock. As of December 31, 2013 and 2012 there is one outstanding debenture for $50,000. Accrued interest as December 31, 2013 and 2012 are $13,216 and $7,200, respectively.

As a result of the issuance of 2010 convertible debt to a director and because the debt became convertible on June 30, 2011, the conversion option of all other third party convertible notes became tainted. Under ASC 815-15“Derivatives and Hedging”, all other tainted share settleable instruments must be reclassified from equity to liability. As a result of the full conversion of 2010 convertible debts on March 1, 2012, the derivative treatment on these other third party convertible notes ended and the derivative liabilities for an amount of $663,160 must be reclassified back to equity. See discussion in Note 13.

2012 Convertible Debenture – Series C Warrants

On February 17, 2012, the Company began offering the Putable-Callable Debenture Series 2012 and Series C Warrants. The debentures bear interest at 8% per annum and mature on December 31, 2019. The convertible debenture is convertible at a conversion price equal to the weighted average price for the three-day trading period before the notice of conversion. The convertible note is also subject to dilutive adjustments for share issuances (full ratchet reset feature).On that date, the Company sold $500,000 of debentures to four directors of which $320,000 are converted from shareholders notes payable and invested $180,000 in new proceeds. Total numbers of warrants attached with the convertible debentures are 2,500,000 with an exercise price equal $0.1. On April 23, 2012, the directors converted $500,000 of debentures and $7,242 in accrued interest to 5,790,452 shares of restricted common stock and 2,500,000 Series C warrants were cancelled.

Because these convertible debentures have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15 “Determining whether an Instrument (or Embedded feature) is Indexed to an Entity's Own Stock”. ASC 815-40-15 require as of the date the convertible debenture issued, the derivative liability to be measured at fair value and $445,204 is recorded as a debt discount. As a result of full conversion on April 23, 2012, the derivative treatment on these convertible debentures ended and the derivative liabilities for an amount of $536,528 must be reclassified back to equity with the change in fair value of $91,324 recorded to loss on derivative liability.

F-14

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

10. STOCK OPTIONS

During 2012, 27,700,000 options were granted, 211,600 options vested and 26,595,804 were forfeited, as follows:

On May 18, 2012, five directors each received 40,000 options, for a total of 200,000 options, as compensation. The options were immediately vested with a expiration date of May 18, 2017 and a strike price of $.10. On May 18, 2012, 27,500,000 options were granted to directors and management as incentive bonuses. The options vesting schedule is tied to market performance, with strike prices ranging from $.125 and $.40, and bear a expiration date of May 18, 2018. The options are unvested at December 31, 2013.

Of the 211,600 options which vested in 2012: 49,600 have an expiration date of September 11, 2014 and a strike price of $2.21, 160,000 have an expiration date of May 18, 2017 and a strike price of $.10, and 2,000 have an expiration date of April 26, 2017 and a strike price of $.21.

Of the 26,595,804 options which were forfeited in 2012: 3,200,000 issued to directors and management had an expiration date of September 27, 2017 and a strike price of $.50, 280,000 issued to a former director had expiration dates ranging from September 11, 2014 to May 18, 2017 and strike prices ranging from $.03 to $.60, 395,804 were issued to former employees who voluntarily terminated with expiration dates ranging from September 11, 2014 and April 25, 2017 and strike prices ranging from $.21 to $2.50, and 22,720,000 were issued to former officers and employees who were not retained following the sale of Illume Mobile with expiration dates ranging from May 18, 2018 to October 6, 2017 and strike prices ranging from $0.125 and $2.50.

During 2013, no options were granted, 39,200 options vested, and 63,120 options expired, as follows:

Of the 39,200 options that vested in 2013: all had an expiration date of September 11, 2014 and a strike price of $2.21.

Of the 63,120 options that expired in 2013, expirations occurred between January 1, 2013 and July 1, 2013 and the strike prices were $.60.

The calculated value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, assuming maximum value, which values options based on the estimated fair value of the Company’s common stock at the grant date, the option strike price, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the expected life of the option.  The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted is based on the vesting period and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.  Stock based compensation expense of $90,020 and $94,738 was recognized in 2013 and 2012 for employee options based on the Black-Scholes computation.

F-15

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

A summary of stock option activity as of December 31, 2013 and 2012 and changes during the periods then ended is presented below:

	Stock Options
	Options			Weighted Average Exercise Price
Outstanding – December 31, 2011		11,829,507		$	0.52
Granted		27,700,000		$	0.26
Forfeited or Expired		(26,595,804	)	$	0.32
Outstanding – December 31, 2012		12,933,703		$	0.36
Exercisable – December 31, 2012		5,394,503		$	0.51
Granted		-		$	0.00
Forfeited or Expired		(63,120	)	$	0.60
Outstanding – December 31, 2013		12,870,584		$	0.37
Exercisable –  December 31, 2013		5,370,584		$	0.52

Total Options outstanding and exercisable at December 31, 2013 and 2012 had an aggregate intrinsic value of $-0- and a weighted-average remaining contractual term of 2.9 and 3.7 years, respectively.

A summary of the status of the Company’s nonvested options and restricted stock as of December 31, 2013 and 2012 is presented below:

	Stock Options
Nonvested Shares	Options
Nonvested - Beginning of Year 2012		6,028,450
2012 Granted		27,700,000
2012 Vested		(211,600	)
2012 Forfeited		(25,977,650	)
Nonvested – End of Year 2012		7,539,200
2013 Granted		-
2013 Vested		(39,200	)
2013 Forfeited		( -	)
Nonvested- End of Year 2013		7,500,000

As of December 31, 2013 and 2012, there was $290,938 and $380,958 unrecognized compensation cost related to nonvested share-based compensation arrangements under the stock bonus plan. The weighted-average remaining vesting period is 3 years.

F-16

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

11. COMMON STOCK WARRANTS

During 2012, 5,000,000 warrants were issued and 8,666,680 were expired, as follows:

In February 2012, investors in the Putable-Callable Debenture Series 2012 and Series C warrants acquired 2,500,000 common stock purchase warrants with a strike price of $.10. The warrants with a fair value of $237,500 were cancelled in April 2012 when the investors elected to convert the debentures to common stock. See Note 9.

In March 2012, investors in the 2012 Common Stock Private Offering acquired 2,500,000 Series C warrants. The warrants remain outstanding and expire December 31, 2017 and bear a $0.15 strike price.

During 2013 no warrants were issued or expired.

The following table summarizes information about outstanding warrants at December 31, 2013:

Year Issued	Number Outstanding		Remaining Contractual Life in Years		Number Currently Exercisable		Weighted Average  Exercise Price
2009		21,682,372		.6		21,682,372	$	0.10
2010		10,236,227		0.9		10,236,227	$	0.10
2011		29,680,086		3.0		29,680,086	$	0.10
2012		2,500,000		4.0		2,500,000	$	0.15
Total		64,098,685		1.9		64,098,685	$	0.10

12.  SHAREHOLDERS’ EQUITY

Shares issued for convertible notes:

During the year ended December 31, 2012, convertible debt of $2,971,161 along with accrued interest of $216,330 were converted into 41,815,921 common shares. See Note 9.

Shares issued for services:

During the year ended December 31, 2013, the Company issued 6,100,690 shares of common stock to employees and directors as compensation. The shares were valued at the market price on the respective dates of issuance, and the fair value of the shares was determined to be $140,000.

During the year ended December 31, 2012, the Company issued 15,523,747 shares of common stock to employees and third party consultants as compensation. The shares were valued at the market price on the respective dates of issuance, and the fair value of the shares was determined to be $779,168. The Company cancelled 62,666 unvested shares valued at $627 in various stock bonus programs upon the voluntary termination of several former employees.

F-17

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

Shares issued in exchange for available-for-sale securities

During the year ended December 31, 2013, the Company issued 2,500,000 shares of restricted common stock to MEDL Mobile Holdings, Inc. in exchange for 147,692 shares of MEDL stock. The shares issued were valued at the fair market value of MEDL stock on the agreement date, which is $58,338. See Footnote 3.

Shares issued for cash

During the year ended December 31, 2012, the Company issued 2,500,000 shares of restricted common stock in a 2012 Private Stock Sale for $250,000 cash.

13.  DERIVATIVE LIABILITIES

2010 Convertible Debenture

The Company issued a $50,000 2010 Convertible Debenture which became convertible on June 30, 2011.

As discussed in Note 9, the Company determined that the instruments embedded in the convertible note should be classified as liabilities and recorded at fair value due to there being no explicit limit to the number of shares to be delivered upon settlement of the above convertible debentures. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

As a result of full conversion on March 1, 2012, under ASC 815- 15 “Derivatives and Hedging”, the instruments are measured at fair value at the date of termination with the change in fair value recorded to earnings. The fair value of the instruments related to the 2010 convertible debenture was $40,182 and was recognized as loss on derivative and reclassified out of liabilities to equity.

2011 Convertible Debenture

The Company issued $1,675,000 and $896,161 in 2011 Convertible Debenture – Series A and B, respectively. As discussed in the Note 9, as a result of the issuance of 2010 convertible debt to a director and because the debt became convertible on June 30, 2011, the conversion option of all other third party convertible notes became tainted. On March 1, 2012 the 2010 convertible debenture was fully converted to common stock, the conversion feature of these other convertible debts was no longer tainted. Under ASC 815-15 “Derivatives and Hedging”, the conversion feature of these other convertible debts must be measured at fair value on termination date with the change in fair value recorded to earnings. The fair value of the conversion feature on these other convertible debts on March 1, 2012 was $1,346,762 and was recognized as loss on derivative and reclassified out of liabilities to equity. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

2012 Convertible Debenture

As discussed in note 9 on February 17, 2012, the Company issued $500,000 in 2012 Convertible Debenture Series C which had a reset to its conversion price. Under ASC 815-40-15 “Determining whether an Instrument (or Embedded feature) is Indexed to an Entity's Own Stock”, on the date the convertible debenture issued, the derivative liability was measured at fair value. The fair value of the conversion feature was determined to be $445,204 and was recognized as debt discount.

As a result of full conversion on April 23, 2012, the derivative treatment on these convertible debentures ended, the instruments are re-measured at fair value at the date of termination with the change in fair value recorded to earning. The fair value of the instrument was $536,528 and was re-classified out of liabilities to equity. The change in fair value of $91,324 was recognized as loss on derivative. Also the debt discount of $445,204 was fully amortized. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

F-18

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

Warrants

The Company had 67,765,365 warrants outstanding on December 31, 2011. On March 1, 2012, as a result of full conversion of the 2010 convertible debentures, under ASC 815- 15 “Derivatives and Hedging”, the instruments are measured at fair value at the date of termination with the change in fair value recorded to earnings. The fair value of the instruments related to the warrants was $2,507,317 and was recognized as loss on derivative and reclassified out of liabilities to equity. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

The Company issued 2,500,000 in warrants on February 17, 2012 which was during the period the 2010 Debenture created derivative accounting. Therefore, the Company recorded $195,000 as derivative liability on the issuance date and was reclassified out of equity to liabilities. On March 1, 2012, as a result of full conversion of the 2010 convertible debentures, under ASC 815- 15 “Derivatives and Hedging”, the instruments are measured at fair value at the date of termination with the change in fair value recorded to earnings. The fair value of the instruments related to the warrants was $237,500 and was reclassified out of liabilities to equity. The change in fair value of $42,500 was recognized as loss on derivative. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

The following table summarizes the derivative liabilities included in the balance sheet:

Balance at December 31, 2011	$	0
Record derivative liability as debt discount		445,204
Change in fair value of derivative liability		4,028,085
Settlement of derivative liability due to conversion of related notes		(4,473,289	)
Balance at December 31, 2012	$	0

14.  INCOME TAXES

The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.

During the years ended December 31, 2013 and 2012, the Company incurred net losses, and, therefore, had no tax liability. The net deferred asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward is approximately $13,576,705 and $13,586,303 for 2013 and 2012, respectively and will begin expiring in 2023.

Deferred tax assets consist of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability. Deferred tax assets consist of the following:

	December 31, 2013			December 31, 2012
Net operating loss carry-forwards	$	4,616,080		$	4,619,343
Valuation allowance		(4,616,080	)		(4,616,343	)
	$	-0-		$	-0-

15 .COMMITMENTS AND CONTINGENCIES

At December 31, 2013, the Company has no obligation under any operating leases.

As of March 28, 2014, the Company is not a party to any lawsuits.

F-19

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

The Company entered into an employment agreement on October 23, 2012 with its CFO, Kendall Carpenter. The agreement provides for an annual base salary of $150,000 and an annual cash salary of at least $96,000 with the difference between the base salary and actual cash salary rolled into short term notes which accrue interest at 6% per annum. On September 30, 2013, the Company issued a $13,500 note to Ms. Carpenter with a due date of September 30, 2014. On December 31, 2013, the Company issued a $9,000 note to Ms. Carpenter with a due date of December 31, 2014. The Company paid Ms. Carpenter $489 in interest during 2013 and there was no accrued interest due at December 31, 2013.

Rent expense in 2012 was $110,462.  The Company’s office lease was assumed by DecisionPoint Systems, Inc. on July 31, 2012 following their purchase of Illume Mobile. Due to the small number of employees, we no longer maintain a physical workspace, but allow our employees to work remotely.

16 .CONCENTRATIONS

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of trade receivables.  The Company performs ongoing credit evaluations of its customers and generally does not require collateral related to its receivables. At December 31, 2013, accounts receivable from one patent licensee comprised approximately 50% of the company’s total accounts receivable-trade. Revenues from twenty-six customers approximated 97% of total revenues for 2013. At December 31, 2012, accounts receivable from three patent licensees comprised approximately 74% of the Company’s total accounts receivable-trade. Revenues from twenty-eight customers approximated 77% of total revenues for 2012.

17.  DISCONTINUED OPERATIONS PURSUANT TO THE SALE OF ILLUME MOBILE ASSETS

In July 2012, the Company began negotiations with DecisionPoint Systems, Inc. to sell the Illume Mobile assets and operations. On July 31, 2012 (the “Closing Date”), MacroSolve, Inc. (the "Company”) entered into an asset purchase agreement (the “Purchase Agreement”) with DecisionPoint Systems, Inc. (the “Buyer”). Pursuant to the Purchase Agreement, effective on the Closing Date, the Company sold substantially all of the assets relating to its Illume Mobile business, for a purchase price of $948,000, of which $250,000 was paid in cash and $698,000 was paid in the form of 617,284 shares of the Buyer’s common stock (valued at $1.13 per share based on the fair value on closing date).

The Company has the right to receive an earn-out payment from the Buyer (the “Earn-Out Payment”) of up to $500,000 (of which 50% will be paid in cash, and 50% will be paid in shares of common stock of the Buyer, valued at the last closing price of the Buyer’s common stock on the one year anniversary of the Closing Date). The Earn-Out Payment is incremental based upon net revenues. If net revenue is $3,000,000 or more, the entire Earn-Out Payment will be due. During 2013, the Company determined that the Earn-Out payment was not achieved.

In connection with the Purchase Agreement, on the Closing Date, the Company and the Buyer entered into a patent license agreement (the “License Agreement”), pursuant to which the Company granted the Buyer a non-exclusive license under a patent held by the Company pertaining to information collection using mobile computers (the “Licensed Patent”) to make, have made, sell, offer for sale or import any product or service which in the absence of the License Agreement would infringe at least one claim of the Licensed Patent (including specifically the Company’s ReForm™ Development Platform) in and into the United States and to practice the Licensed Methods (as defined in the License Agreement), in the United States, during the term of the Licensed Patent. The Buyer agreed to pay the Company a licensing fee/royalty payment of (i) 7.5% of Net Revenues (as defined in the License Agreement) received from the sale of Software Products (as defined in the License Agreement) and/or Licensed Methods, and (ii) 5% of Net Revenues from the sale of Custom Development Services (as defined in the License Agreement). The Company also granted the Buyer an option to purchase a non-exclusive perpetual license under the Licensed Patent at a purchase price of $500,000. The Company has received approximately $97,684 in royalties through December 31, 2013.

F-20

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

In connection with the Purchase Agreement, on the Closing Date, the Company and the Buyer entered into a non-competition and non-solicitation agreement (the “Non-Competition Agreement”). Pursuant to the Non-Competition Agreement, for a period of three years commencing on the Closing Date, the Company agreed not to engage in activities in the United States and Canada competitive with the products sold by the Company’s Illume Mobile business as of July 31, 2012, and the Buyer agreed not to engage in activities in the United States and Canada competitive with the products sold by the Company (not related to the assets sold pursuant to the Purchase Agreement). The Company also agreed, for a period of three years, commencing on the Closing Date, not to solicit or hire (unless such employee has been terminated by the Buyer) employees of the Buyer, and the Buyer agreed, for a period of three years commencing on the Closing Date, not to solicit employees of the Company (except as contemplated by the Purchase Agreement).

The following table summarized the book value of the assets sold and liabilities assumed by DecisionPoint Systems, Inc. at the acquisition date.

Cash received	$	250,000
Stock received	$	698,000
Liabilities assumed by DecisionPoint Systems, Inc.
Accrued liabilities	$	25,000
Accounts payable	$	13,838
Deferred revenue	$	36,971
Assets sold to DecisionPoint Systems, Inc.
Prepaid expenses	$	(14,885	)
Property and Equipment, net	$	(83,507	)
Software development costs	$	(1,019,480	)
Accounts receivable	$	(12,475	)
Loss on sales of discontinued operations	$	(106,538	)

The following table summarized the results of discontinued operations for the year ended December 31, 2012.

	Year Ended
	December 31, 2012
Revenue	$	637,507
Cost of revenues	$	351,654
Gross profit	$	285,853
General and administrative expense	$	2,383,793
Loss from discontinued operations	$	(2,097,940	)

18. Restatement

During the course of the re-audit of 2012, errors were discovered in previously reported asset, liability, equity, revenue and expense accounts, further described as follows:

a.   In July 2012, the Company recorded $500,000 in unearned income related to the potential earn-out after twelve months associated with the sale of Illume Mobile.  The earn-out was not achieved during 2013, so the original balance sheet entry was reversed effective July 31, 2012.

F-21

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

b.   As part of the sale of Illume Mobile on July 31, 2012, the Company received $750,000 in common stock of DecisionPoint Systems, Inc. with the number of shares determined by a twenty day value-weighted average computation (VWAP). The actual fair market value of the shares on July 31, 2012 was less than the twenty-day VWAP, resulting in a $52,000 reduction in the originally-recorded value of the investment in DecisionPoint Systems, Inc. common stock.

c.   On December 31, 2012, the Company valued its investment in DecisionPoint based on the VWAP for the fourth quarter. The actual fair market value of the shares on December 31, 2012 was less than the fourth quarter VWAP, resulting in a $34,048 reduction in the originally-reported investment on that date offset by the Other Comprehensive Income account.

d.   The Company previously recorded $9,909 on December 31, 2012 in liability related to fourth quarter 2012 stock based compensation for shares that were issued in January 2013 and recorded as expense at the recipients’ taxable basis. These shares were restated as issued in 2012, the offsetting liability of $9,909 was reversed, and $23,318 was recognized as an increase in common stock and $23,319 was recognized as additional paid in capital. Also $8,073 of accrued interest was re-classified from long term debt to accrued liabilities.

e.   The outstanding 2011 Convertible Debenture Series A was determined to have been issued at a discount, resulting in a $72,727 contra liability to the debenture liability. Also additional $1,475,000 was recorded as additional paid-in capital for debt discount recorded for beneficial conversion feature and $1,402,273 was recorded as interest expense for amortization of debt discount.

f.   In 2012, the Company issued 1,850,000 shares of stock to a financial advisory service firm in exchange for services valued at $168,000. The actual fair market value of the shares on the date issued was $30,950 greater resulting in an increase in additional paid-in capital and G&A expense.

g.    The Company issued 750,000 shares to another financial advisory service firm in 2012 in exchange for services valued at $45,000. The actual fair market value of the shares on the date issued was $24,000 greater resulting in an increase in additional paid in capital and G&A.

h.    The Company discovered $12,574 in legal and travel expenses that had been charged to additional paid-in capital as financing expenses which should have been charged to G&A expense and reclassified that amount to expense.

i.   The Company previously recorded first, second and third quarter 2012 stock based compensation as expense at the recipients’ taxable basis. As a result, an additional $356,369 was recorded as additional paid-in capital and G&A expense.

j.   The Company issued 7,500,000 options in 2012 which only vest under certain market conditions which have not been met but did not record an expense for the options. Under ASC 718, these unvested options have been recorded with a $94,738 increase in additional paid-in capital and G&A expense.

k.   Under ASC 815-15, the 2010 Debenture which didn’t convert until March 2012 had a conversion feature which caused the 2011 Debenture Series A, 2011 Debenture Series B instruments to be deemed derivative instruments as well as warrants outstanding at that date. Under ASC 815, the 2012 Debenture Series C is deemed to be derivative instrument due to a reset provision in the conversion price. As a result, the Company recorded $4,028,085 as loss on derivative liability, $4,473,289 as derivative liabilities written off to additional paid-in capital and $445,204 to interest expense for amortization of debt discount.

l.   The Company previously reported the operations of Illume Mobile as continuing operations from January 1, 2012 through June 30, 2012. Illume Mobile’s 2012 $2,204,478 loss from operations has been restated resulting in a reclassifications of net revenues, cost of revenues, operating expenses and G&A expenses to discontinued operations.

F-22

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

The restatements as of December 31, 2012 are as follows:

	As of December 31, 2012
	As Reported					Adjustments			Restated
Cash	$	659,204				$	-		$	659,204
Accounts receivable - trade		74,056					-			74,056
Prepaid expenses and other		519,330			a		(500,000	)		19,330
Net property and equipment		2,189					-			2,189
Available-for-sale investment - DecisionPoint Systems, Inc.		579,875			b, c		(86,048	)		493,827
Intangible assets, net of amortization		64,227								64,227
TOTAL ASSETS	$	1,898,881				$	(586,048	)	$	1,312,833
Note Payable - Oklahoma Technology Commercialization Center- Current	$	90,000				$	-		$	90,000
Accounts payable - trade and accrued liabilities		84,062			d		(1,836	)		82,226
Unearned income		500,000			a		(500,000	)		-
TOTAL LONG-TERM DEBT, less current maturities		816,752			d, e, k		(80,798	)		735,954
TOTAL LIABILITIES		1,490,814					(582,634	)		908,180
Common stock		1,798,320			d		23,318			1,821,638
Additional paid-in capital		13,230,111		d, e, f, g, h, i, j, k			6,490,208			19,720,319
Accumulated other comprehensive income		(170,125	)		c		(34,048	)		(204,173	)
Accumulated deficit		(14,450,239	)				(6,482,892	)		(20,933,131	)
TOTAL STOCKHOLDER'S EQUITY		408,067					(3,414	)		404,653
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	1,898,881				$	(586,048	)	$	1,312,833
	As of December 31, 2012
	As Reported					Adjustments			Restated
Net revenues	$	2,988,393			l	$	(554,648	)	$	2,433,745
Cost of revenues		1,305,853			l		(275,868	)		1,029,985
Gross profit		1,682,540					(278,780	)		1,403,760
General and administrative expense		3,025,071		d, f, g, h, i, j, l			(1,593,202	)		1,431,869
Loss from operations		(1,342,531	)				1,314,422			(28,109	)
Total other expense		(238,906	)		e, k		(5,787,444	)		(6,026,350	)
Net loss from continuing operations		(1,581,437	)				(4,473,022	)		(6,054,459	)
DISCONTINUED OPERATIONS		(194,608	)		b, l		(2,009,870	)		(2,204,478	)
NET LOSS		(1,776,045	)				(6,482,892	)		(8,258,937	)
OTHER COMPREHENSIVE INCOME		(170,125	)		c		(34,048	)		(204,173	)
COMPREHENSIVE LOSS	$	(1,946,170	)			$	(6,516,940	)	$	(8,463,110	)

F-23

MACROSOLVE, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2013 and 2012

19. Subsequent Event

On March 7, 2014, the United States Patent and Trademark Office (“USPTO”) sent the Company an office action related to an ex parte reexamination of the Company’s 7,822,816 patent, which rejected all the claims in the patent (the “USPTO Office Action”). The Company has two months to file a request for the patent examiners to reconsider the USPTO Office Action. As a result of the USPTO Office Action, the Company has withdrawn all outstanding litigation relating the ‘816 patent without prejudice, which will allow it to refile such pending suits if the USPTO Office Action is rescinded or the Company’s rights under the ‘816 patent are restored. The Company will be unable to pursue any new lawsuits until the USPTO Office Action is resolved.  The Company is presently conferring with its legal counsel and evaluating its options with regard to the USPTO Office Action.

F-24

EX-31.01

EXHIBIT 31.01

CERTIFICATION

I, James C. McGill, certify that:

1.   I have reviewed this annual report on Form 10-K of MacroSolve, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: March 28, 2014

/s/ JAMES C. McGILL

James C. McGill

Chief Executive Officer

EX-31.02

EXHIBIT 31.02

CERTIFICATION

I, Kendall Carpenter, certify that:

1.   I have reviewed this annual report on Form 10-K of MacroSolve, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.   The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: March 28, 2014

/s/ KENDALL CARPENTER

Kendall Carpenter

Chief Financial Officer

EX-32.01

 Exhibit 32.01

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, James C. McGill, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of MacroSolve, Inc. on Form 10-K for the fiscal year ended December 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of MacroSolve, Inc.

	By:	/s/ JAMES C. McGILL
Date: March 28, 2014	Name:	James C. McGill
	Title:	Chief Executive Officer

I, Kendall Carpenter, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of MacroSolve, Inc. on Form 10-K for the fiscal year ended December 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of MacroSolve, Inc.

	By:	/s/ KENDALL CARPENTER
Date: March 28, 2014	Name:	Kendall Carpenter
	Title:	Chief Financial Officer

XML

Line of Credit (Details) (USD $)	0 Months Ended	12 Months Ended
	Sep. 30, 2012	Dec. 31, 2013
Interest Rate Calculation Greater Of [Abstract]
Strike price of warrants		0.10
Line of credit
Interest Rate Calculation Greater Of [Abstract]
Advancing term loan		$ 100,000
Description of variable rate basis		$100,000
Basis spread on variable rate		1.00%
Interest payable on loan interest percentage	4.25%	5.75%
Commitment fee amount		3,000
Term period of warrant		5 years
Purchase of stock		$ 100,000
Strike price of warrants		0.10

XML

Commitments and Contingencies (Detail Textuals) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 Kendall Carpenter [Member]	Sep. 30, 2013 Kendall Carpenter [Member]	Oct. 23, 2012 Kendall Carpenter [Member]
Commitments And Contingencies [Line Items]
Rent expense		$ 110,462
Deferred compensation			9,000	13,500	150,000
Interest rate, notes payable			6.00%	6.00%	6.00%
Accrued interest on notes payable	489
Debentures Meturity Date	May 31, 2014		Dec. 31, 2014	Sep. 30, 2014
Basic salary					$ 96,000

XML

Common Stock Warrants (Detail Textuals) (USD $)	1 Months Ended	12 Months Ended
	Apr. 30, 2012	Dec. 31, 2012	Dec. 31, 2013	Apr. 30, 2011	Dec. 31, 2013 Line of Credit [Member]	Mar. 31, 2012 Debenture Series 2012 Plus Series C Warrants	Feb. 29, 2012 Debenture Series 2012 Plus Series C Warrants
Class of Warrant or Right [Line Items]
Number of warrants issued		5,000,000
Class of warrant or right expired		8,666,680
Fair value of warrant cancelled	$ 237,500
Number of common stock called by warrants				1,575,000		2,500,000	2,500,000
Strike price of warrants			0.10		0.10	0.15	0.10

XML

Concentrations (Detail Textuals) (Concentrations of credit risk)	12 Months Ended
	Dec. 31, 2013 Customer	Dec. 31, 2012 Customer
Accounts receivable
Concentration Risk [Line Items]
Number of customers	1	3
Percentage of concentrations of credit risk	50.00%	74.00%
Revenue
Concentration Risk [Line Items]
Number of customers	26	28
Percentage of concentrations of credit risk	97.00%	77.00%

XML

Stock Options (Details Textual) (USD $)	1 Months Ended	12 Months Ended
	May 18, 2012	Dec. 31, 2013	Dec. 31, 2012 Director
Stock Options (Textual)
Number of options granted	200,000		27,700,000
Number of options vested.		(39,200)	(211,600)
Number of options forfeited		(63,120)	(26,595,804)
Number of directors			4
Expiration Date	May 18, 2018
Exercise price of options granted		$ 0.00	$ 0.26
Stock based compensation		$ 140,000	$ 779,168
Weighted average grant date fair value
Weighted-average remaining contractual term of options exercisable			2 years
Unrecognized compensation cost		290,938	380,958
Weighted-average remaining vesting period		3 years
Strike price 2.21
Stock Options (Textual)
Number of options vested.		39,200	49,600
Expiration Date		Sep. 11, 2014	Sep. 11, 2014
Exercise price of options granted		$ 2.21	$ 2.21
Strike price 0.10
Stock Options (Textual)
Number of options vested.			160,000
Expiration Date			May 18, 2017
Exercise price of options granted			$ 0.10
Strike price 0.21
Stock Options (Textual)
Number of options vested.			2,000
Expiration Date			Apr. 26, 2017
Exercise price of options granted			$ 0.21
Strike price 0.60
Stock Options (Textual)
Number of options forfeited		63,120
Exercise price of options granted		$ 0.60
Minimum | Strike price 0.60
Stock Options (Textual)
Expiration Date		Jan. 01, 2013
Maximum | Strike price 0.60
Stock Options (Textual)
Expiration Date		Jul. 01, 2013
Former director
Stock Options (Textual)
Number of options forfeited			280,000
Exercise price of options granted			$ 0.50
Exercise price, lower range			$ 0.03
Exercise price, upper range			$ 0.60
Former director | Minimum
Stock Options (Textual)
Expiration Date			Sep. 11, 2014
Former director | Maximum
Stock Options (Textual)
Expiration Date			Apr. 25, 2017
Former employee
Stock Options (Textual)
Number of options forfeited			395,804
Expiration Date			May 18, 2018
Exercise price, lower range			$ 0.21
Exercise price, upper range			$ 2.50
Former employee | Minimum
Stock Options (Textual)
Expiration Date			Sep. 11, 2014
Former employee | Maximum
Stock Options (Textual)
Expiration Date			Apr. 25, 2017
Former officers and employees
Stock Options (Textual)
Number of options forfeited			22,720,000
Expiration Date			Oct. 06, 2017
Former officers and employees | Maximum
Stock Options (Textual)
Expiration Date			Dec. 31, 2015
Exercise price, lower range			$ 0.125
Exercise price, upper range			$ 2.50
Employee Stock Option [Member]
Stock Options (Textual)
Stock based compensation		90,020	94,738
Aggregate intrinsic value		$ 0	$ 0
Weighted-average remaining contractual term of options exercisable		2 years 10 months 24 days	3 years 8 months 12 days
Employee Stock Option [Member] | Director
Stock Options (Textual)
Number of options granted	40,000
Number of directors	5
Expiration Date	May 18, 2017
Exercise price of options granted	$ 0.10
Exercise price, lower range	$ 0.125
Exercise price, upper range	$ 0.40
Stock based compensation		$ 0	$ 0

XML

Summary of Significant Accounting Policies - Summary of property and equipment (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]
Property and equipment,Gross	$ 4,237	$ 21,651
Less - accumulated depreciation	1,586	19,462
Net property and equipment	2,651	2,189
Computer Hardware
Property, Plant and Equipment [Line Items]
Property and equipment,Gross	3,639	16,197
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment,Gross	$ 598	$ 5,454

XML

Discontinued Operations Pursuant To The Sale of Illume Mobile Assets (Details 1) (Decision Point System, USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2012
Decision Point System
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	$ 637,507
Cost of revenues	351,654
Gross profit	285,853
General and administrative expense	2,383,793
Loss from discontinued operations	$ (2,097,940)

XML

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Schedule of property and equipment

	2013		2012
Computer hardware	$	3,639	$	16,197
Furniture and fixtures		598		5,454
		4,237		21,651
Less - accumulated depreciation		1,586		19,462
	$	2,651	$	2,189

Schedule of fair value, assets and liabilities

Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
December 31, 2013
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	371,402		-		-	$	371,402
December 31, 2012
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	493,827		-		-	$	493,827

XML

Derivative Liabilities (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 11, 2012	Feb. 17, 2012
Derivative Liabilities [Abstract]
Balance at December 31, 2011	$ 0	$ 0	$ 237,500	$ 195,000
Record derivative liability as debt discount		445,204
Change in fair value of derivative liability		4,028,085
Settlement of derivative liability due to conversion of related notes		(4,473,289)
Balance at December 31, 2012	$ 0	$ 0	$ 237,500	$ 195,000

XML

Note Payable - Shareholder (Details) (USD $)	12 Months Ended				12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012 Director	Dec. 31, 2013 New Promissory Notes	Dec. 31, 2012 New Promissory Notes	Dec. 31, 2012 Director [Member]	Dec. 31, 2013 Director [Member]	Dec. 31, 2011 Director [Member]
Related Party Transaction [Line Items]
Notes payable					$ 533,681	$ 533,681	$ 169,306
Short - term notes advanced by multiple directors					778,300
Interest rate, notes payable			6.00%		12.00%
Number of directors		4
Re-classification of shareholders loan from long term to convertible debt		320,000
Repayments of shareholder loan		115,000
Re-classification of accrued interest to note payable - shareholders		21,075
Long term notes payable	533,681	533,681
Percentage of patent settlement license fees			75.00%
Maturity date	May 31, 2014		Jan. 01, 2015		Sep. 30, 2012
Accrued interest on notes payable	$ 489		$ 40,092	$ 8,177

XML

Investment in Medl Mobile Holdings, Inc. (Details) (USD $)	12 Months Ended		0 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 08, 2013 MEDL Mobile Holdings, Inc	Dec. 31, 2013 MEDL Mobile Holdings, Inc
Investment [Line Items]
Value of share received			$ 50,000
Number of share received			2,500,000
Number of shares issued			147,692
Equity issuance price per share			$ 0.34
Nature of transaction			Company entered into an agreement with MEDL Mobile Holdings, Inc. (MEDL) to bring forth a program that offers access to the Company's 816' patent to app developers
Shares valued at fair value	324,190	493,827	58,338	39,537
Unrealized holding loss arising during the period	$ (195,763)	$ (204,173)		$ 18,801
Share price			$ 0.02

XML

Income Taxes - Summary of components of the company's net deferred taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:
Net operating loss carry forwards	$ 4,616,080	$ 4,619,343
Valuation allowance	(4,616,080)	(4,619,343)
Total deferred tax assets	$ 0	$ 0

XML

Restatement (Details Textuals) (USD $)	12 Months Ended						7 Months Ended	1 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 2011 Convertible Debenture Series A	Dec. 31, 2012 Common Stock	Dec. 31, 2013 Additional Paid-in Capital	Dec. 31, 2012 Additional Paid-in Capital	Jul. 31, 2012 Illume Mobile Assets And Operations	Jul. 31, 2012 Decisionpoint Systems Inc	Dec. 31, 2012 Decisionpoint Systems Inc	Dec. 31, 2012 Financial Advisory Firm	Dec. 31, 2012 Financial Advisory Firm One	Dec. 31, 2012 Reported	Dec. 31, 2012 Restatement
Restatement [Textual]
Unearned income							$ 500,000					$ 500,000	$ (500,000)
Earn-out payment from the buyer								52,000	34,048
Stock based compensation, Liability				23,318		23,319						9,909	9,909
Number of shares issued for services				2,800,000						1,850,000	750,000
Common Stock issued for Services		278,450		28,000		250,450				168,000	45,000
Legal and travel expenses		12,574
Debenture liability			72,727
Initial additional paid-in capital		24,000	1,475,000
Increase in additional paid-in capital		30,950
Debt interest expense			1,402,273
Additional paid-in capital and G&A expense		356,369
Additional paid-in capital and other expense		4,473,289				4,473,289
Option expense	90,020	94,738			90,020	94,738
Loss from operations	$ (240,684)	$ (6,054,459)					$ 2,204,478

XML

Common Stock Warrants - Information about outstanding warrants (Details)	12 Months Ended
	Dec. 31, 2013	Feb. 17, 2012
Class of Warrant or Right [Line Items]
Number Outstanding	64,098,685	2,500,000
Remaining Contractual Life in Years	1 year 10 months 24 days
Number Currently Exercisable	64,098,685
Weighted Average Exercise Price	0.10
Warrant issued in 2009
Class of Warrant or Right [Line Items]
Number Outstanding	21,682,372
Remaining Contractual Life in Years	7 months 6 days
Number Currently Exercisable	21,682,372
Weighted Average Exercise Price	0.10
Warrant issued in 2010
Class of Warrant or Right [Line Items]
Number Outstanding	10,236,227
Remaining Contractual Life in Years	10 months 24 days
Number Currently Exercisable	10,236,227
Weighted Average Exercise Price	0.10
Warrant issued in 2011
Class of Warrant or Right [Line Items]
Number Outstanding	29,680,086
Remaining Contractual Life in Years	3 years
Number Currently Exercisable	29,680,086
Weighted Average Exercise Price	0.10
Warrant issued in 2012
Class of Warrant or Right [Line Items]
Number Outstanding	2,500,000
Remaining Contractual Life in Years	4 years
Number Currently Exercisable	2,500,000
Weighted Average Exercise Price	0.15

XML

Line of Credit

12 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

LINE OF CREDIT

5.   LINE OF CREDIT

The Company had an advancing term loan with a financial institution of up to $100,000 with interest only payable monthly at the greater of 5.75% or prime rate plus 1.0% (4.25% at September 30, 2012), until September 2012, and secured by substantially all assets of the company and the personal guarantees of a company director. In exchange for the guaranty, the director receives a $3,000 commitment fee and a five year warrant to purchase $100,000 of stock with a strike price of ten cents ($0.10) per share. The loan was repaid in October 2012 and was not renewed.

XML

Subsequent Event (Details)

12 Months Ended

Dec. 31, 2013

Subsequent Events [Abstract]

Subsequent event, Description

the United States Patent and Trademark Office (“USPTO”) sent the Company an office action related to an ex parte reexamination of the Company’s 7,822,816 patent, which rejected all the claims in the patent (the “USPTO Office Action”). The Company has two months to file a request for the patent examiners to reconsider the USPTO Office Action. As a result of the USPTO Office Action, the Company has withdrawn all outstanding litigation relating the ‘816 patent without prejudice, which will allow it to refile such pending suits if the USPTO Office Action is rescinded or the Company’s rights under the ‘816 patent are restored.

XML

Convertible Debentures (Details)	1 Months Ended		12 Months Ended		13 Months Ended				12 Months Ended		13 Months Ended	0 Months Ended	1 Months Ended		12 Months Ended		1 Months Ended
	Feb. 17, 2012 USD ($)	Jul. 31, 2011 Investors	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)	Apr. 30, 2011 Investors	Mar. 11, 2012 USD ($)	Dec. 31, 2011 USD ($)	Apr. 30, 2011 Convertible Debenture Series 2011 Plus	Dec. 31, 2013 Warrant A Convertible Debenture Series 2011 Plus USD ($)	Dec. 31, 2012 Warrant A Convertible Debenture Series 2011 Plus USD ($)	Apr. 30, 2011 Warrant A Convertible Debenture Series 2011 Plus USD ($) Investors	Mar. 01, 2012 Warrant B Convertible Debenture Series 2010 Plus USD ($)	Nov. 30, 2010 Warrant B Convertible Debenture Series 2010 Plus USD ($)	Jul. 31, 2011 Warrant B Convertible Debenture Series 2011 Plus USD ($) Investors	Dec. 31, 2013 Warrant B Convertible Debenture Series 2011 Plus USD ($)	Dec. 31, 2012 Warrant B Convertible Debenture Series 2011 Plus USD ($)	Apr. 23, 2012 Warrant C Convertible Debenture Series 2012 Plus USD ($)	Feb. 17, 2012 Warrant C Convertible Debenture Series 2012 Plus USD ($) Director	Feb. 17, 2012 Warrant C Convertible Debenture Series 2012 Plus EUR (€)
Investment of Directors											$ 1,675,000		$ 50,000	$ 896,161				$ 180,000
Debentures Interest Rate											12.00%		2.00%	12.00%				8.00%
Debentures Meturity Date			May 31, 2014								Dec. 31, 2016		Dec. 31, 2015	Dec. 31, 2016				Dec. 31, 2019
Debt instrument shares purchases													95,493
Debt Conversion Converted Instrument Exercise Price													$ 0.2618
Debt instrument amortization expense									18,182	1,402,273
Debt instrument discount			54,545	72,727					54,545	72,727	1,475,000						445,204
Debt conversion, converted instrument, amount									100,000	100,000				846,161			500,000	320,000
Number of common stock called by warrants					1,575,000			16,831,553
Percentage of principal amount of debentures											200.00%			200.00%
Debt conversion price per share																			€ 0.1
Debt conversion settlement value											163,145
Debt conversion settlement in cash											16,167
Debt conversion settlement shares											870,543			459,412				2,500,000
Debetures converted into shares												940,734		16,923,227				5,790,452
Accrued interest on converted debentures									30,429	18,396	179,312	1,285		45,941	13,216	7,200	7,242
Total numbers of warrants attached with convertible debentures											18,475,827							2,500,000
Percentage of Conversion Price											50.00%		200.00%
Number of trading period											5 days		5 days	5 days
Shares issued for conversion of debenture and warrants											163,145			50,000				500,000
Number of investors elected to convert debentures into common stock		18			15						16			19				4
Accrued interest on notes payable			489
Derivative liabilities	195,000		0	0		237,500	0		683,602						663,160		536,528
Convertible debenture ,Conversion price, Description																		The convertible debenture is convertible at a conversion price equal to the weighted average price for the three-day trading period before the notice of conversion.
Loss on derivatives	42,500		0	4,028,085													91,324
Convertible debt														$ 8,961,614

XML

Derivative Liabilities (Tables)

12 Months Ended

Dec. 31, 2013

Derivative Liabilities [Abstract]

Summarizes derivative liabilities

Balance at December 31, 2011	$	0
Record derivative liability as debt discount		445,204
Change in fair value of derivative liability		4,028,085
Settlement of derivative liability due to conversion of related notes		(4,473,289	)
Balance at December 31, 2012	$	0

XML

Common Stock Warrants (Tables)

12 Months Ended

Dec. 31, 2013

Common Stock Warrants [Abstract]

Schedule of outstanding warrant

Year Issued	Number Outstanding		Remaining Contractual Life in Years		Number Currently Exercisable		Weighted Average  Exercise Price
2009		21,682,372		.6		21,682,372	$	0.10
2010		10,236,227		0.9		10,236,227	$	0.10
2011		29,680,086		3.0		29,680,086	$	0.10
2012		2,500,000		4.0		2,500,000	$	0.15
Total		64,098,685		1.9		64,098,685	$	0.10

XML

Discontinued Operations Pursuant To The Sale of Illume Mobile Assets (Details) (Decision Point System, USD $)	Dec. 31, 2013
Decision Point System
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash received	$ 250,000
Stock received	698,000
Liabilities assumed by DecisionPoint Systems, Inc.
Accrued liabilities	25,000
Accounts payable	13,838
Deferred revenue	36,971
Assets sold to DecisionPoint Systems, Inc.
Prepaid expenses	(14,885)
Property and Equipment, net	(83,507)
Software development costs	(1,019,480)
Accounts receivable	(12,475)
Loss on sales of discontinued operations	$ (106,538)

XML

Stock Options - Schedule of stock option activity (Details) (USD $)	1 Months Ended	12 Months Ended
	May 18, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Options
Outstanding - Beginning Balance		12,933,703	11,829,507
Granted	200,000		27,700,000
Forfeited or Expired		(63,120)	(26,595,804)
Outstanding - Ending balance		12,870,584	12,933,703
Exercisable - Ending balance		5,370,584	5,394,503	5,801,057
Stock Options Weighted Average Exercise Price
Outstanding - Beginning balance		$ 0.36	$ 0.52
Exercisable - Beginning balance		$ 0.51	$ 0.52
Granted		$ 0.00	$ 0.26
Forfeited or Expired		$ 0.60	$ 0.32
Outstanding - Beginning balance		$ 0.37	$ 0.36
Exercisable - Ending balance		$ 0.52	$ 0.51
Employee Stock Plans | Stock Options
Stock Options
Outstanding - Beginning Balance				11,829,507
Outstanding - Ending balance			15,441,703	11,829,507
Exercisable - Ending balance			5,394,503	5,801,057
Stock Options Weighted Average Exercise Price
Outstanding - Beginning balance				$ 0.52
Exercisable - Beginning balance				$ 0.52
Outstanding - Beginning balance			$ 0.35	$ 0.52
Exercisable - Ending balance			$ 0.51	$ 0.52

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2013

Income Taxes [Abstract]

Schedule of components of the Company's net deferred taxes

	December 31, 2013			December 31, 2012
Net operating loss carry-forwards	$	4,616,080		$	4,619,343
Valuation allowance		(4,616,080	)		(4,616,343	)
	$	-0-		$	-0-

XML

Discontinued Operations Pursuant To The Sale of Illume Mobile Assets (Tables)

12 Months Ended

Dec. 31, 2013

Discontinued Operations and Disposal Groups [Abstract]

Schedule of disposal groups Including discontinued operations, balance sheet

Cash received	$	250,000
Stock received	$	698,000
Liabilities assumed by DecisionPoint Systems, Inc.
Accrued liabilities	$	25,000
Accounts payable	$	13,838
Deferred revenue	$	36,971
Assets sold to DecisionPoint Systems, Inc.
Prepaid expenses	$	(14,885	)
Property and Equipment, net	$	(83,507	)
Software development costs	$	(1,019,480	)
Accounts receivable	$	(12,475	)
Loss on sales of discontinued operations	$	(106,538	)

Schedule of disposal groups Including discontinued operations, income statement

	Year Ended
	December 31, 2012
Revenue	$	637,507
Cost of revenues	$	351,654
Gross profit	$	285,853
General and administrative expense	$	2,383,793
Loss from discontinued operations	$	(2,097,940	)

XML

Investment

12 Months Ended

Dec. 31, 2013

DecisionPoint Systems, Inc

Investment [Line Items]

Investments in advance to affiliates subsidiaries associates and joint ventures

2. INVESTMENT IN DECISIONPOINT SYSTEMS, INC.

As further described in Footnote #17, on July 31, 2012, the Company sold the Illume Mobile assets and operations to DecisionPoint Systems, Inc. (DPSI) for $250,000 cash and 617,284 shares of DPSI stock. The shares were recorded at fair value on July 31, 2012 of $698,000. In accordance with ASC 320, the stock is classified as available-for-sale equity and the unrealized market gains or losses are recorded as Other Comprehensive Income. The shares were valued at fair value of $324,190 and $493,827 at December 31, 2013 and 2012, respectively, with the decrease in fair value of $169,637 and $204,173 at December 31, 2013 and 2012, respectively, recorded in Other Comprehensive Income.

MEDL Mobile Holdings, Inc

Investment [Line Items]

Investments in advance to affiliates subsidiaries associates and joint ventures

3. INVESTMENT IN MEDL MOBILE HOLDINGS, INC.

On March 8, 2013, the Company entered into an agreement with MEDL Mobile Holdings, Inc. (MEDL) to bring forth a program that offers access to the Company’s ‘816’ patent to app developers. MEDL received the right to grant a license to its clients on a ‘per install’ basis on a revenue sharing arrangement with the Company. As a part of the agreement, each Company received $50,000 worth of the other’s stock with the price per share determined by the Volume Weighted Average Price (“VWAP”) for each stock for the last twenty trading days prior to execution of the agreement. The Company received 147,692 shares of MEDL stock priced at $0.34 per share and MEDL received 2,500,000 shares of the Company’s stock priced at $0.02 per share. The shares were recorded at fair value on March 8, 2013 of $58,338. In accordance with ASC 320, the stock is classified as available-for-sale equity and the unrealized market gains or losses are recorded as Other Comprehensive Income. The shares were valued at fair value of $39,537 at December 31, 2013 with the decrease in fair value of $18,801 at December 31, 2013 recorded in Other Comprehensive Income.

ENDEXX CORPORATION

Investment [Line Items]

Investments in advance to affiliates subsidiaries associates and joint ventures

4.  INVESTMENT IN ENDEXX CORPORATION

On June 5, 2013, the Company entered into six month agreement with Endexx Corporation (EDXC) to coordinate business planning, investor interests and intellectual property for a mobile app venture that uniquely addresses advertising market analytics. Additionally, Endexx received a variable limited ‘816’ license during the course of the business advisory engagement while its app is in development with the agreement that a permanent license will be negotiated upon completion.  Endexx paid the Company $15,000 compensation by issuing 125,000 shares of EDXC restricted stock priced at $.12 per share and the balance in accounts receivable. The shares were recorded at fair value on June 5, 2013 for an amount of $15,000. In accordance with ASC 320, the stock is classified as available-for-sale equity and the unrealized market gains or losses are recorded as Other Comprehensive Income. The shares were valued at fair value of $7,675 at December 31, 2013 with the decrease in fair value of $7,325 at December 31, 2013 recorded in Other Comprehensive Income.

XML

Restatement (Tables)

12 Months Ended

Dec. 31, 2013

Restatement [Abstract]

Schedule of restated financial statements

   

	As of December 31, 2012
	As Reported					Adjustments			Restated
Cash	$	659,204				$	-		$	659,204
Accounts receivable - trade		74,056					-			74,056
Prepaid expenses and other		519,330			a		(500,000	)		19,330
Net property and equipment		2,189					-			2,189
Available-for-sale investment - DecisionPoint Systems, Inc.		579,875			b, c		(86,048	)		493,827
Intangible assets, net of amortization		64,227								64,227
TOTAL ASSETS	$	1,898,881				$	(586,048	)	$	1,312,833
Note Payable - Oklahoma Technology Commercialization Center- Current	$	90,000				$	-		$	90,000
Accounts payable - trade and accrued liabilities		84,062			d		(1,836	)		82,226
Unearned income		500,000			a		(500,000	)		-
TOTAL LONG-TERM DEBT, less current maturities		816,752			d, e, k		(80,798	)		735,954
TOTAL LIABILITIES		1,490,814					(582,634	)		908,180
Common stock		1,798,320			d		23,318			1,821,638
Additional paid-in capital		13,230,111		d, e, f, g, h, i, j, k			6,490,208			19,720,319
Accumulated other comprehensive income		(170,125	)		c		(34,048	)	(204,173	)
Accumulated deficit		(14,450,239	)				(6,482,892	)		(20,933,131	)
TOTAL STOCKHOLDER'S EQUITY		408,067					(3,414	)	404,653
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$	1,898,881				$	(586,048	)	$	1,312,833
	As of December 31, 2012
	As Reported					Adjustments			Restated
Net revenues	$	2,988,393			l	$	(554,648	)	$	2,433,745
Cost of revenues		1,305,853			l		(275,868	)		1,029,985
Gross profit		1,682,540					(278,780	)		1,403,760
General and administrative expense		3,025,071		d, f, g, h, i, j, l			(1,593,202	)		1,431,869
Loss from operations		(1,342,531	)				1,314,422			(28,109	)
Total other expense		(238,906	)		e, k		(5,787,444	)		(6,026,350	)
Net loss from continuing operations		(1,581,437	)				(4,473,022	)		(6,054,459	)
DISCONTINUED OPERATIONS		(194,608	)		b, l		(2,009,870	)		(2,204,478	)
NET LOSS		(1,776,045	)				(6,482,892	)		(8,258,937	)
OTHER COMPREHENSIVE INCOME		(170,125	)		c		(34,048	)		(204,173	)
COMPREHENSIVE LOSS	$	(1,946,170	)			$	(6,516,940	)	$	(8,463,110	)

XML

Oklahoma Technology Commercialization Center Note Payable (Details) (USD $)	Dec. 31, 2013
Maturities of Long-term Debt [Abstract]
2014	$ 112,500
2015	20,000
Total	$ 132,500

XML

Income Taxes (Detail Textuals) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Abstract]
Net operating loss carryforwards	$ 13,576,705	$ 13,586,303
Operating loss carry-forward expiration period	begin expiring in 2023

XML

BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS:
Cash	$ 706,211	$ 659,204
Accounts receivable - trade	38,791	74,056
Prepaid expenses and notes receivable	32,594	19,330
Total current assets	777,596	752,590
PROPERTY AND EQUIPMENT, at cost:	4,237	21,651
Less - accumulated depreciation	(1,586)	(19,462)
Net property and equipment	2,651	2,189
OTHER ASSETS:
Available-for-sale investment - DecisionPoint Systems, Inc	324,190	493,827
Available-for-sale investment - MEDL Mobile Holdings, Inc	39,537
Available-for-sale Investment - Endexx Corporation	7,675
Intangible assets, net of amortization	70,223	64,227
Total other assets	441,625	558,054
TOTAL ASSETS	1,221,872	1,312,833
CURRENT LIABILITIES:
Note Payable - Oklahoma Technology Commercialization Center- Current	112,500	90,000
Accounts payable - trade and accrued liabilities	181,172	82,226
Note payable - Related party	22,500
Total current liabilities	316,172	172,226
LONG-TERM DEBT, less current maturities
Note Payable - Shareholders	533,681	533,681
Note Payable - Oklahoma Technology Commercialization Center	20,000	125,000
Convertible debentures, net of discount of $54,545 and $72,727 respectively	95,455	77,273
Total long-term debt, less current maturities	649,136	735,954
TOTAL LIABILITIES	965,308	908,180
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Preferred stock, $.01 par value; authorized 10,000,000 shares; 0 shares issued and outstanding, at December 31, 2013 and 2012, respectively
Common stock, $.01 par value; authorized 500,000,000 shares; issued and outstanding 190,764,586 and 182,163,896 shares, at December 31, 2013 and 2012, respectively	1,907,645	1,821,638
Additional paid-in capital	19,922,670	19,720,319
Accumulated other comprehensive income	(399,936)	(204,173)
Accumulated deficit	(21,173,815)	(20,933,131)
Total stockholders' equity	256,564	404,653
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,221,872	$ 1,312,833

XML

Stock Options - Summary of status of the company's nonvested options and restricted stock (Details 1) (USD $)	1 Months Ended	12 Months Ended
	May 18, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012 Employee Stock Plans Stock Options	Dec. 31, 2011 Employee Stock Plans Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Nonvested- Beginning of Year		7,539,200	6,028,450	10,047,200	6,028,450
Granted	200,000		27,700,000
Vested		(39,200)	(211,600)
Forfeited			(25,977,650)
Nonvested-End of year		7,500,000	7,539,200	10,047,200	6,028,450
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Nonvested - Beginning of Year
Granted
Vested
Forfeited
Nonvested- End of year

XML

STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
OPERATING ACTIVITIES:
Net loss	$ (240,684)	$ (8,258,937)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	3,384	517,509
Loss on disposal of fixed assets	435	4,245
Loss on sales of assets to DecisionPoint		106,538
Bad debt expense		141,277
Amortization of debt discount	18,182	1,847,477
Loss on derivative liability		4,028,085
Equity based compensation	140,000	779,168
Option expense	90,020	94,738
Cancellation of shares		(627)
Stock received from Endexx Corporation for revenue	(15,000)
Changes in current assets and liabilities:
Decrease in accounts receivable - trade	9,998	195,969
Decrease (Increase) in prepaid expenses and other	(543)	223,747
Increase (decrease) in accounts payable - trade and accrued liabilities	121,446	(272,950)
(Decrease) increase in unearned income		5,571
Net cash provided by (used in) operating activities	127,238	(588,190)
INVESTING ACTIVITIES:
Cash received from notes receivable	12,546
Purchase of equipment	(1,467)	(8,580)
Cash received from sale of Illume Mobile		250,000
Software development costs		(233,390)
Patent application fees	(8,810)	(4,568)
Net cash provided by investing activities	2,269	3,462
FINANCING ACTIVITIES:
Proceeds from convertible debt		180,000
Proceeds from shareholder loan		778,300
Proceeds from sale of common stock		250,000
Repayments of shareholder loan		(115,000)
Repayments of notes payable	(82,500)	(22,500)
Repayment of bank line of credit		(100,000)
Net cash (used in) provided by financing activities	(82,500)	970,800
NET INCREASE IN CASH	47,007	386,072
CASH, beginning of period	659,204	273,132
CASH, end of period	706,211	659,204
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid interest	1,059	27,071
Cash paid income taxes
Noncash investing and financing activities for the year ended December 31:
Stock issued for conversion of debt and accrued interest		3,187,491
Stock issued in exchange for available-for-sale securities	58,338
Stock received from DecisionPoint Systems for sale of Illume Mobile assets		698,000
Change in fair value for available-for-sale securities	(195,763)	(204,173)
Re-classification of accounts receivable to note receivable	25,267
Re-classification of accrued salary to noted payable to related party	22,500
Re-classification of shareholders loan from Short term to Long term		169,306
Re-classification of shareholders loan from long term to convertible debt		320,000
Re-classification of accrued interest to note payable - shareholders		21,075
Debt discount recorded for derivative liability		100,000
Debt discount recorded for beneficial conversion feature		1,475,000
Derivative liabiilties written off to additional paid-in capital		$ 4,473,289

XML

Restatement (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash	$ 706,211	$ 659,204	$ 273,132
Accounts receivable - trade	38,791	74,056
Prepaid expenses and other	32,594	19,330
Net property and equipment	2,651	2,189
Available-for-sale investment - DecisionPoint Systems, Inc	324,190	493,827
Intangible assets, net of amortization	70,223	64,227
TOTAL ASSETS	1,221,872	1,312,833
Note Payable - Oklahoma Technology Commercialization Center- Current	112,500	90,000
Accounts payable - trade and accrued liabilities	181,172	82,226
Unearned income
TOTAL LONG-TERM DEBT, less current maturities	649,136	735,954
TOTAL LIABILITIES	965,308	908,180
Common stock	1,907,645	1,821,638
Additional paid-in capital	19,922,670	19,720,319
Accumulated other comprehensive income	(399,936)	(204,173)
Accumulated deficit	(21,173,815)	(20,933,131)
TOTAL STOCKHOLDER'S EQUITY	256,564	404,653	(1,391,296)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	1,221,872	1,312,833
As Reported
Cash		659,204
Accounts receivable - trade		74,056
Prepaid expenses and other		519,330
Net property and equipment		2,189
Available-for-sale investment - DecisionPoint Systems, Inc		579,875
Intangible assets, net of amortization		64,227
TOTAL ASSETS		1,898,881
Note Payable - Oklahoma Technology Commercialization Center- Current		90,000
Accounts payable - trade and accrued liabilities		84,062
Unearned income		500,000
TOTAL LONG-TERM DEBT, less current maturities		816,752
TOTAL LIABILITIES		1,490,814
Common stock		1,798,320
Additional paid-in capital		13,230,111
Accumulated other comprehensive income		(170,125)
Accumulated deficit		(14,450,239)
TOTAL STOCKHOLDER'S EQUITY		408,067
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		1,898,881
Adjustments
Cash
Accounts receivable - trade
Prepaid expenses and other		(500,000)
Net property and equipment
Available-for-sale investment - DecisionPoint Systems, Inc
Intangible assets, net of amortization		(86,048)
TOTAL ASSETS		(586,048)
Note Payable - Oklahoma Technology Commercialization Center- Current
Accounts payable - trade and accrued liabilities		(1,836)
Unearned income		(500,000)
TOTAL LONG-TERM DEBT, less current maturities		(80,798)
TOTAL LIABILITIES		(582,634)
Common stock		23,318
Additional paid-in capital		6,490,208
Accumulated other comprehensive income		(34,048)
Accumulated deficit		(6,482,892)
TOTAL STOCKHOLDER'S EQUITY		(3,414)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$ (586,048)

XML

Summary of Significant Accounting Policies (Detail Textuals) (USD $)	12 Months Ended				12 Months Ended						12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jun. 01, 2013	Dec. 31, 2012 Patents	Dec. 31, 2012 Mobiz 360	May 31, 2012 Mobiz 360	Jul. 31, 2012 Decision Point System	Dec. 31, 2012 Illume Mobile Development	Dec. 31, 2012 Illume Mobile Assets and Operations	Jul. 31, 2012 Illume Mobile Assets and Operations	Dec. 31, 2013 Hardware Maximum	Dec. 31, 2013 Hardware Minimum	Dec. 31, 2013 Furniture and fixtures Maximum	Dec. 31, 2013 Furniture and fixtures Minimum	Dec. 31, 2013 Office equipment Maximum	Dec. 31, 2013 Office equipment Minimum	Dec. 31, 2013 Software Maximum	Dec. 31, 2013 Software Minimum	Dec. 31, 2013 Leasehold improvements
Property, Plant and Equipment [Line Items]
Depreciation method	Straight-line method
Estimated Useful Lives (in years)											7 years	3 years	7 years	3 years	7 years	3 years	7 years	3 years
Period of threshold limit for payment	30 days
Percentage of contract amount for payment for license	10.00%
Percentage of valuation allowance	100.00%
Bad debt expense		$ 141,277
Amortization period	3 years																		7 years
Unearned income									135,577	36,971
Capitalized computer software, gross							1,213,550
Amortization expenses of capitalized computer software		500,910		2,814	337,059		194,070	161,037
Capitalized computer software, net					293,054	337,059	1,019,480
Amortization of capitalized computer software		337,059
Amortization expense					293,054
Uncollectibles	0	5,700
Issuance of promissory notes			25,268
Notes Receivable	$ 12,721
Maturity date	May 31, 2014

XML

Restatement

12 Months Ended

Dec. 31, 2013

Restatement [Abstract]

Restatement

18. Restatement

During the course of the re-audit of 2012, errors were discovered in previously reported asset, liability, equity, revenue and expense accounts, further described as follows:

a.   In July 2012, the Company recorded $500,000 in unearned income related to the potential earn-out after twelve months associated with the sale of Illume Mobile.  The earn-out was not achieved during 2013, so the original balance sheet entry was reversed effective July 31, 2012.

b.   As part of the sale of Illume Mobile on July 31, 2012, the Company received $750,000 in common stock of DecisionPoint Systems, Inc. with the number of shares determined by a twenty day value-weighted average computation (VWAP). The actual fair market value of the shares on July 31, 2012 was less than the twenty-day VWAP, resulting in a $52,000 reduction in the originally-recorded value of the investment in DecisionPoint Systems, Inc. common stock.

c.   On December 31, 2012, the Company valued its investment in DecisionPoint based on the VWAP for the fourth quarter. The actual fair market value of the shares on December 31, 2012 was less than the fourth quarter VWAP, resulting in a $34,048 reduction in the originally-reported investment on that date offset by the Other Comprehensive Income account.

d.   The Company previously recorded $9,909 on December 31, 2012 in liability related to fourth quarter 2012 stock based compensation for shares that were issued in January 2013 and recorded as expense at the recipients’ taxable basis. These shares were restated as issued in 2012, the offsetting liability of $9,909 was reversed, and $23,318 was recognized as an increase in common stock and $23,319 was recognized as additional paid in capital. Also $8,073 of accrued interest was re-classified from long term debt to accrued liabilities.

e.   The outstanding 2011 Convertible Debenture Series A was determined to have been issued at a discount, resulting in a $72,727 contra liability to the debenture liability. Also additional $1,475,000 was recorded as additional paid-in capital for debt discount recorded for beneficial conversion feature and $1,402,273 was recorded as interest expense for amortization of debt discount.

f.   In 2012, the Company issued 1,850,000 shares of stock to a financial advisory service firm in exchange for services valued at $168,000. The actual fair market value of the shares on the date issued was $30,950 greater resulting in an increase in additional paid-in capital and G&A expense.

g.    The Company issued 750,000 shares to another financial advisory service firm in 2012 in exchange for services valued at $45,000. The actual fair market value of the shares on the date issued was $24,000 greater resulting in an increase in additional paid in capital and G&A.

h.    The Company discovered $12,574 in legal and travel expenses that had been charged to additional paid-in capital as financing expenses which should have been charged to G&A expense and reclassified that amount to expense.

i.   The Company previously recorded first, second and third quarter 2012 stock based compensation as expense at the recipients’ taxable basis. As a result, an additional $356,369 was recorded as additional paid-in capital and G&A expense.

j.   The Company issued 7,500,000 options in 2012 which only vest under certain market conditions which have not been met but did not record an expense for the options. Under ASC 718, these unvested options have been recorded with a $94,738 increase in additional paid-in capital and G&A expense.

k.   Under ASC 815-15, the 2010 Debenture which didn’t convert until March 2012 had a conversion feature which caused the 2011 Debenture Series A, 2011 Debenture Series B instruments to be deemed derivative instruments as well as warrants outstanding at that date. Under ASC 815, the 2012 Debenture Series C is deemed to be derivative instrument due to a reset provision in the conversion price. As a result, the Company recorded $4,028,085 as loss on derivative liability, $4,473,289 as derivative liabilities written off to additional paid-in capital and $445,204 to interest expense for amortization of debt discount.

l.   The Company previously reported the operations of Illume Mobile as continuing operations from January 1, 2012 through June 30, 2012. Illume Mobile’s 2012 $2,204,478 loss from operations has been restated resulting in a reclassifications of net revenues, cost of revenues, operating expenses and G&A expenses to discontinued operations.

   The restatements as of December 31, 2012 are as follows:

 )  e, k

		As of December 31, 2012
		As Reported						Adjustments				Restated
Cash		$	659,204					$	-			$	659,204
Accounts receivable - trade			74,056						-				74,056
Prepaid expenses and other			519,330			a			(500,000	)			19,330
Net property and equipment			2,189						-				2,189
Available-for-sale investment - DecisionPoint Systems, Inc.			579,875			b, c			(86,048	)			493,827
Intangible assets, net of amortization			64,227										64,227
TOTAL ASSETS		$	1,898,881					$	(586,048	)		$	1,312,833
Note Payable - Oklahoma Technology Commercialization Center- Current		$	90,000					$	-			$	90,000
Accounts payable - trade and accrued liabilities			84,062			d			(1,836	)			82,226
Unearned income			500,000			a			(500,000	)			-
TOTAL LONG-TERM DEBT, less current maturities			816,752		d, e, k			(80,798	)			735,954
TOTAL LIABILITIES			1,490,814						(582,634	)			908,180
Common stock			1,798,320			d			23,318				1,821,638
Additional paid-in capital			13,230,111		d, e, f, g, h, i, j, k				6,490,208				19,720,319
Accumulated other comprehensive income			(170,125	)		c			(34,048	)			(204,173	)
Accumulated deficit			(14,450,239	)					(6,482,892	)			(20,933,131	)
TOTAL STOCKHOLDER'S EQUITY			408,067						(3,414	)			404,653
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY		$	1,898,881					$	(586,048	)		$	1,312,833
		As of December 31, 2012
	As Reported						Adjustments				Restated
Net revenues		$	2,988,393			l		$	(554,648	)		$	2,433,745
Cost of revenues			1,305,853			l			(275,868	)			1,029,985
Gross profit			1,682,540						(278,780	)			1,403,760
General and administrative expense			3,025,071		d, f, g, h, i, j, l				(1,593,202	)			1,431,869
Loss from operations			(1,342,531	)					1,314,422				(28,109	)
Total other expense			(238,906	)				(5,787,444	)			(6,026,350	)
Net loss from continuing operations			(1,581,437	)					(4,473,022	)			(6,054,459	)
DISCONTINUED OPERATIONS			(194,608	)		b, l			(2,009,870			(2,204,478	)
NET LOSS			(1,776,045	)					(6,482,892	)			(8,258,937	)
OTHER COMPREHENSIVE INCOME			(170,125	)		c			(34,048	)			(204,173	)
COMPREHENSIVE LOSS		$	(1,946,170	)				$	(6,516,940	)		$	(8,463,110	)

XML

Investment in Decisionpoint Systems, Inc. (Details) (USD $)	0 Months Ended	12 Months Ended
	Jul. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Investment [Line Items]
Unrealized holding loss arising during the period		$ (195,763)	$ (204,173)
DecisionPoint Systems, Inc
Investment [Line Items]
Cash received from sale of assets	250,000
Number of share received	617,284
Nature of transaction	Company sold the Illume Mobile assets and operations to DecisionPoint Systems, Inc.
Fair value of shares	698,000	324,190	493,827
Unrealized holding loss arising during the period		$ 169,637	$ 204,173

XML

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Nature of Operations:

Nature of Operations:

MacroSolve, Inc. is an Oklahoma corporation formed on January 17, 1997, under the laws of the State of Oklahoma.  We are focused on intellectual property licensing and enforcement of our patent in the mobile app market development space.  We also offer consulting services related to mobile app development, marketing and financing of mobile app businesses. In addition, until July 31, 2012, we conducted business as Illume Mobile, engaged in the design, delivery and integration of custom solutions for the application of mobile technology in business processes.

Reclassifications:

Reclassifications:

Certain prior year amounts have been reclassified to conform to the current year presentation.

Use of Estimates:

Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Concentration of Credit Risk:

Concentration of Credit Risk:

Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.

Cash Equivalents:

Cash Equivalents:

Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2013 and 2012.

Accounts Receivable and Credit Policies:

Accounts and Notes Receivable and Credit Policies:

Trade accounts receivable consist of amounts due from the sale of solution services and software licenses.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  At December 31, 2013 and 2012, the Company deems $0 and $5,700 as uncollectible, respectively. Bad debts expense was $0 in 2013 and $141,277 in 2012 of which $135,577 consisted of a customer note receivable that the Company deemed uncollectible following the sale of Illume Mobile.

On June 1, 2013, one customer issued a promissory note for an amount of $25,268 to the Company, to replace the accounts receivable owed to the Company. As of December 31, 2013, the note receivable has a balance of $12,721, will mature on May 31, 2014 and with interest calculated at the prime interest rate published in the Wall Street Journal plus five percent.

Property and Equipment:

Property and Equipment:

Property and equipment is recorded at cost when acquired.  Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.  Leasehold improvements are being amortized over a 7 year estimated useful life.  A majority of the company’s fixed assets were associated with Illume Mobile, a division which was sold to DecisionPoint Systems, Inc. on July 31, 2012. Property and equipment consists of the following at December 31, 2013 and 2012:

	2013		2012
Computer hardware	$	3,639	$	16,197
Furniture and fixtures		598		5,454
		4,237		21,651
Less - accumulated depreciation		1,586		19,462
	$	2,651	$	2,189

Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.

Marketable Securities:

Marketable Securities:

All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss.

Long-Lived Assets:

Long-Lived Assets:

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  No impairment charges were incurred during the periods ended December 31, 2013 and 2012.

Derivative Financial Instruments:

Derivative Financial Instruments:

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, assuming maximum value, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Beneficial Conversion Features:

Beneficial Conversion Features:

The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.

Fair Value of Financial Instruments:

Fair Value of Financial Instruments:

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1    –                              Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

Level 2     -                              Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

Level 3     –                              Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of December 31, 2013 and 2012:

Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
December 31, 2013
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	371,402		-		-	$	371,402
December 31, 2012
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	493,827		-		-	$	493,827

Revenue Recognition and Unearned Revenue:

Revenue Recognition and Unearned Revenue:

The Company recognizes revenue only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. Revenues from intellectual property licenses are recognized upon issuance of the license. When intellectual property licenses are received under a contingent fee agreement with the law firm of Antonelli, Harrington & Thompson LLP, the applicable contingent legal expense is recorded as a cost of sale. In the event a non-exclusive intellectual property license is granted within the scope of a contracted app development project, ten percent (10%) of the contract amount is deemed to be payment for the license.  Revenue from software product licensing is recognized ratably over the license period.  Unearned income associated with Illume Mobile contracts of $36,971 was transferred to DecisionPoint Systems as part of the Illume Mobile asset sale in July 2012.

Solution services revenues, including advisory services, consist primarily of professional services contracted to third party customers or clients under contract for specific projects. Contracted projects that are fixed price are accounted for under the percentage-of-completion method of accounting. Revenue from contracted projects that are for provision of services is recognized at the time the service is provided. The Company no longer offers solutions services after the sale of Illume Mobile in July 2012.

Software Development Costs:

Software Development Costs:

The Company accounts for software development costs in accordance with ASC 985-20, “Costs of Computer Software to be Sold, Leased, or Otherwise Marketed”.  Costs incurred prior to the establishment of technological feasibility are expensed as incurred as research and development costs.  Costs incurred after establishing technological feasibility and before the product is released for sale to customers are capitalized.  These costs are amortized over three years and are reviewed for impairment at each period end. The Company sold a total of $1,213,550 in gross capitalized software development costs and associated $194,070 in accumulated amortization, or a net of $1,019,480, to DecisionPoint Systems in July 2012. Amortization expense in 2012 totaled $500,910 and consisted of $161,037 in Illume Mobile development costs, $2,814 in patent costs and $337,059 related to Mobiz360, including a one-time amortization of $293,054 net capitalized development costs, In May 2012, MoBiz360, an incomplete prototype website marketplace for an amount of $337,059, was conveyed to Clint Parr, our former president and CEO, as consideration for an undetermined equity interest in Mr. Parr’s new company. As of December 31, 2013, Mr. Parr’s new company is still not operational. The net value of MoBiz360 for an amount of $293,054 was written off as amortization expense during the year ended December 31, 2012. The Company is not presently developing software.

Income Taxes Costs:

Income Taxes:

The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (SFAS No. 109).  ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.  Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.  The effects of future changes in tax laws or rates are not included in the measurement.  The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns.  The Company currently has substantial net operating loss carry forwards. The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

Employee Stock-Based Compensation:

Employee Stock-Based Compensation:

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.

Non-Employee Stock-Based Compensation:

Non-Employee Stock-Based Compensation:

The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), Share Based Payments to Non-Employees, and ASC 505 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.

Related Parties:

Related Parties:

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

Earnings or Loss per Share:

Earnings or Loss per Share:

The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the periods, basic and diluted loss per share is the same for the years ended December 31, 2013 and 2012, respectively.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

XML

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations:

MacroSolve, Inc. is an Oklahoma corporation formed on January 17, 1997, under the laws of the State of Oklahoma.  We are focused on intellectual property licensing and enforcement of our patent in the mobile app market development space.  We also offer consulting services related to mobile app development, marketing and financing of mobile app businesses. In addition, until July 31, 2012, we conducted business as Illume Mobile, engaged in the design, delivery and integration of custom solutions for the application of mobile technology in business processes.

Reclassifications:

Certain prior year amounts have been reclassified to conform to the current year presentation.

Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.

Concentration of Credit Risk:

Financial instruments which potentially subject the Company to concentrations of credit risk consist of cash and trade receivables. The Company places its cash with high credit quality financial institutions. At times such cash may be in excess of the FDIC limit. With respect to trade receivables, the Company routinely assesses the financial strength of its customers and, as a consequence, believes that the receivable credit risk exposure is limited.

Cash Equivalents:

Cash equivalents are represented by operating accounts or money market accounts maintained with insured financial institutions, including all highly-liquid investments with maturities of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2013 and 2012.

Accounts and Notes Receivable and Credit Policies:

Trade accounts receivable consist of amounts due from the sale of solution services and software licenses.  Accounts receivable are uncollateralized customer obligations due under normal trade terms requiring payment within 30 days of receipt of the invoice.  The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts based on historical collection experience and a review of the current status of trade accounts receivable.  At December 31, 2013 and 2012, the Company deems $0 and $5,700 as uncollectible, respectively. Bad debts expense was $0 in 2013 and $141,277 in 2012 of which $135,577 consisted of a customer note receivable that the Company deemed uncollectible following the sale of Illume Mobile.

On June 1, 2013, one customer issued a promissory note for an amount of $25,268 to the Company, to replace the accounts receivable owed to the Company. As of December 31, 2013, the note receivable has a balance of $12,721, will mature on May 31, 2014 and with interest calculated at the prime interest rate published in the Wall Street Journal plus five percent.

Property and Equipment:

Property and equipment is recorded at cost when acquired.  Depreciation is provided principally on the straight-line method over the estimated useful lives of the related assets, which is 3-7 years for equipment, furniture and fixtures, hardware and software.  Leasehold improvements are being amortized over a 7 year estimated useful life.  A majority of the company’s fixed assets were associated with Illume Mobile, a division which was sold to DecisionPoint Systems, Inc. on July 31, 2012. Property and equipment consists of the following at December 31, 2013 and 2012:

	2013		2012
Computer hardware	$	3,639	$	16,197
Furniture and fixtures		598		5,454
		4,237		21,651
Less - accumulated depreciation		1,586		19,462
	$	2,651	$	2,189

Expenditures for maintenance and repairs are charged to expense as incurred, whereas expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized.

Marketable Securities:

All marketable securities are classified as available-for-sale securities. Available-for-sale securities are carried at fair value with resulting unrealized gains and losses, reported as a component of accumulated other comprehensive loss.

Long-Lived Assets:

The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, “Impairment or Disposal of Long-lived Assets”.  This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  No impairment charges were incurred during the periods ended December 31, 2013 and 2012.

Derivative Financial Instruments:

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing model, assuming maximum value, in accordance with ASC 815-15 “Derivative and Hedging” to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Beneficial Conversion Features:

The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing the effective conversion price, after considering the relative fair value of detachable instruments included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon conversion.

Fair Value of Financial Instruments:

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1    –                              Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

Level 2     -                              Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

Level 3     –                              Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

The following table sets forth by level within the fair value hierarchy the Company’s financial assets and liabilities that were accounted for at fair value as of December 31, 2013 and 2012:

Recurring Fair Value Measures	Level 1		Level 2		Level 3		Total
December 31, 2013
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	371,402		-		-	$	371,402
December 31, 2012
Derivative liability		-		-	$	0	$	0
Available-for-sale securities	$	493,827		-		-	$	493,827

Revenue Recognition and Unearned Revenue:

The Company recognizes revenue only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. Revenues from intellectual property licenses are recognized upon issuance of the license. When intellectual property licenses are received under a contingent fee agreement with the law firm of Antonelli, Harrington & Thompson LLP, the applicable contingent legal expense is recorded as a cost of sale. In the event a non-exclusive intellectual property license is granted within the scope of a contracted app development project, ten percent (10%) of the contract amount is deemed to be payment for the license.  Revenue from software product licensing is recognized ratably over the license period.  Unearned income associated with Illume Mobile contracts of $36,971 was transferred to DecisionPoint Systems as part of the Illume Mobile asset sale in July 2012.

Solution services revenues, including advisory services, consist primarily of professional services contracted to third party customers or clients under contract for specific projects. Contracted projects that are fixed price are accounted for under the percentage-of-completion method of accounting. Revenue from contracted projects that are for provision of services is recognized at the time the service is provided. The Company no longer offers solutions services after the sale of Illume Mobile in July 2012.

Software Development Costs:

The Company accounts for software development costs in accordance with ASC 985-20, “Costs of Computer Software to be Sold, Leased, or Otherwise Marketed”.  Costs incurred prior to the establishment of technological feasibility are expensed as incurred as research and development costs.  Costs incurred after establishing technological feasibility and before the product is released for sale to customers are capitalized.  These costs are amortized over three years and are reviewed for impairment at each period end. The Company sold a total of $1,213,550 in gross capitalized software development costs and associated $194,070 in accumulated amortization, or a net of $1,019,480, to DecisionPoint Systems in July 2012. Amortization expense in 2012 totaled $500,910 and consisted of $161,037 in Illume Mobile development costs, $2,814 in patent costs and $337,059 related to Mobiz360, including a one-time amortization of $293,054 net capitalized development costs, In May 2012, MoBiz360, an incomplete prototype website marketplace for an amount of $337,059, was conveyed to Clint Parr, our former president and CEO, as consideration for an undetermined equity interest in Mr. Parr’s new company. As of December 31, 2013, Mr. Parr’s new company is still not operational. The net value of MoBiz360 for an amount of $293,054 was written off as amortization expense during the year ended December 31, 2012. The Company is not presently developing software.

Income Taxes:

The Company accounts for income taxes utilizing ASC 740, “Income Taxes” (SFAS No. 109).  ASC 740 requires the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary differences.  Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law.  The effects of future changes in tax laws or rates are not included in the measurement.  The Company recognizes the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and transactions that have been recognized in the Company’s financial statements or tax returns.  The Company currently has substantial net operating loss carry forwards. The Company has recorded a 100% valuation allowance against net deferred tax assets due to uncertainty of their ultimate realization.  Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

Employee Stock-Based Compensation:

The Company accounts for stock-based compensation in accordance with ASC 718, “Compensation-Stock Compensation”. ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award, usually the vesting period.

Non-Employee Stock-Based Compensation:

The Company accounts for stock-based compensation in accordance with the provision of ASC 505, “Equity Based Payments to Non-Employees” (“ASC 505”), Share Based Payments to Non-Employees, and ASC 505 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.

Related Parties:

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.

Earnings or Loss per Share:

The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share, which requires disclosure on the financial statements of "basic" and "diluted" earnings (loss) per share. Basic earnings (loss) per share are computed by dividing net income (loss) by the weighted average number of common shares outstanding for the year. Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. As there was a net loss for the periods, basic and diluted loss per share is the same for the years ended December 31, 2013 and 2012, respectively.

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial statements.

XML

BALANCE SHEETS (Parentheticals) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]
Convertible debentures, net of discount	$ 54,545	$ 72,727
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	190,764,586	182,163,896
Common stock, shares outstanding	190,764,586	182,163,896

XML

Derivative Liabilities

12 Months Ended

Dec. 31, 2013

Derivative Liabilities [Abstract]

DERIVATIVE LIABILITIES

13.  DERIVATIVE LIABILITIES

 2010 Convertible Debenture

The Company issued a $50,000 2010 Convertible Debenture which became convertible on June 30, 2011.

As discussed in Note 9, the Company determined that the instruments embedded in the convertible note should be classified as liabilities and recorded at fair value due to there being no explicit limit to the number of shares to be delivered upon settlement of the above convertible debentures. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

As a result of full conversion on March 1, 2012, under ASC 815- 15 “Derivatives and Hedging”, the instruments are measured at fair value at the date of termination with the change in fair value recorded to earnings. The fair value of the instruments related to the 2010 convertible debenture was $40,182 and was recognized as loss on derivative and reclassified out of liabilities to equity.

2011 Convertible Debenture

The Company issued $1,675,000 and $896,161 in 2011 Convertible Debenture – Series A and B, respectively. As discussed in the Note 9, as a result of the issuance of 2010 convertible debt to a director and because the debt became convertible on June 30, 2011, the conversion option of all other third party convertible notes became tainted. On March 1, 2012 the 2010 convertible debenture was fully converted to common stock, the conversion feature of these other convertible debts was no longer tainted. Under ASC 815-15 “Derivatives and Hedging”, the conversion feature of these other convertible debts must be measured at fair value on termination date with the change in fair value recorded to earnings. The fair value of the conversion feature on these other convertible debts on March 1, 2012 was $1,346,762 and was recognized as loss on derivative and reclassified out of liabilities to equity. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

2012 Convertible Debenture

As discussed in note 9 on February 17, 2012, the Company issued $500,000 in 2012 Convertible Debenture Series C which had a reset to its conversion price. Under ASC 815-40-15 “Determining whether an Instrument (or Embedded feature) is Indexed to an Entity's Own Stock”, on the date the convertible debenture issued, the derivative liability was measured at fair value. The fair value of the conversion feature was determined to be $445,204 and was recognized as debt discount.

As a result of full conversion on April 23, 2012, the derivative treatment on these convertible debentures ended, the instruments are re-measured at fair value at the date of termination with the change in fair value recorded to earning. The fair value of the instrument was $536,528 and was re-classified out of liabilities to equity. The change in fair value of $91,324 was recognized as loss on derivative. Also the debt discount of $445,204 was fully amortized. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

Warrants

The Company had 67,765,365 warrants outstanding on December 31, 2011. On March 1, 2012, as a result of full conversion of the 2010 convertible debentures, under ASC 815- 15 “Derivatives and Hedging”, the instruments are measured at fair value at the date of termination with the change in fair value recorded to earnings. The fair value of the instruments related to the warrants was $2,507,317 and was recognized as loss on derivative and reclassified out of liabilities to equity. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

The Company issued 2,500,000 in warrants on February 17, 2012 which was during the period the 2010 Debenture created derivative accounting. Therefore, the Company recorded $195,000 as derivative liability on the issuance date and was reclassified out of equity to liabilities. On March 1, 2012, as a result of full conversion of the 2010 convertible debentures, under ASC 815- 15 “Derivatives and Hedging”, the instruments are measured at fair value at the date of termination with the change in fair value recorded to earnings. The fair value of the instruments related to the warrants was $237,500 and was reclassified out of liabilities to equity. The change in fair value of $42,500 was recognized as loss on derivative. The fair value of the instruments was determined by using Black-Scholes option-pricing model, assuming maximum value.

The following table summarizes the derivative liabilities included in the balance sheet:

Balance at December 31, 2011	$	0
Record derivative liability as debt discount		445,204
Change in fair value of derivative liability		4,028,085
Settlement of derivative liability due to conversion of related notes		(4,473,289	)
Balance at December 31, 2012	$	0

XML

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 24, 2014	Jun. 28, 2013
Document and Entity Information [Abstract]
Entity Registrant Name	MACROSOLVE INC
Entity Central Index Key	0001178727
Trading Symbol	mcve
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	FY
Entity Well-Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 3,588,179
Entity Common Stock, Shares Outstanding		190,764,559

XML

Income Taxes

12 Months Ended

Dec. 31, 2013

Income Taxes [Abstract]

INCOME TAXES

14.  INCOME TAXES

The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.

During the years ended December 31, 2013 and 2012, the Company incurred net losses, and, therefore, had no tax liability. The net deferred asset generated by the loss carry-forward has been fully reserved. The cumulative net operating loss carry-forward is approximately $13,576,705 and $13,586,303 for 2013 and 2012, respectively and will begin expiring in 2023.

Deferred tax assets consist of the tax effect of NOL carry-forwards. The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability. Deferred tax assets consist of the following:

	December 31, 2013			December 31, 2012
Net operating loss carry-forwards	$	4,616,080		$	4,619,343
Valuation allowance		(4,616,080	)		(4,616,343	)
	$	-0-		$	-0-

XML

STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Revenues	$ 1,454,337	$ 2,433,745
Cost of revenues	854,471	1,029,985
Gross profit	599,866	1,403,760
General and administrative expense	777,920	1,431,869
Loss from operations	(178,054)	(28,109)
Other income (expense)
Interest income	6,681	164
Interest expense	(69,311)	(1,998,429)
Loss on Derivatives		(4,028,085)
Total other expense	(62,630)	(6,026,350)
Net loss from continuing operations	(240,684)	(6,054,459)
DISCONTINUED OPERATIONS
Loss from operations of discontinued Illume Mobile Operations		(2,097,940)
Loss on sales of discontinued operations		(106,538)
Net loss from discontinued operations		(2,204,478)
NET LOSS	(240,684)	(8,258,937)
OTHER COMPREHENSIVE INCOME, net of tax
Unrealized holding loss arising during the period	(195,763)	(204,173)
COMPREHENSIVE INCOME	(436,447)	(8,463,110)
LOSS ALLOCABLE TO COMMON STOCKHOLDERS:
Net loss	(240,684)	(8,258,937)
Loss allocable to common stockholders	$ (240,684)	$ (8,258,937)
Weighted average number of common shares outstanding	185,938,398	163,405,338
Basic and diluted net income (loss) from continuing operations per share	$ 0.00	$ (0.04)
Basic and diluted net loss from discontinued operations per share		$ (0.01)
Basic and diluted net income (loss) per share	$ 0.00	$ (0.05)

XML

Note Payable Shareholders (Shareholders [Member])

12 Months Ended

Dec. 31, 2013

Shareholders [Member]

Short-term Debt [Line Items]

NOTE PAYABLE - SHAREHOLDERS

8.  NOTE PAYABLE - SHAREHOLDERS

As of December 31, 2011, the Company had recorded $169,306 in notes payable to directors. During 2012, multiple directors advanced $778,300 on short-term notes bearing 12% interest rates and mature on September 30, 2012. Four directors agreed to amend their notes by $320,000 which were reclassified as long-term debt upon issuance of 2012 Convertible Debenture Series C, see note 9. During the same year, $115,000 in notes was repaid in cash and $21,075 in accrued interest was reclassified as note payable. The total amount due to multiple directors of $533,681, including accrued interest, was rolled over into new notes dated September 30, 2012. The new notes are secured by the unencumbered 75% of patent settlement license fees and provide for accrued interest at 6% payable on maturity at January 1, 2015. The total balance due at December 31, 2013 and 2012 is $533,681. The accrued interest at December 31, 2013, 2012 is $40,092 and $8,177, respectively.

The Company analyzed the modification of the term under ASC 470-60 “Trouble Debt Restructurings” and ASC 470-50 “Extinguishment of Debt”. The Company determined the modification is substantial and the transaction should be accounted for as an extinguishment with the old debt written off and the new debt initially  recorded at fair value with a new effective interest rate. The Company also determined that the fair value of the new debt is the same as the fair value of the old debt. Thus no gain or loss was recognized upon the extinguishment.

XML

Note Payable Related Party (Related Party [Member])

12 Months Ended

Dec. 31, 2013

Related Party [Member]

Short-term Debt [Line Items]

NOTE PAYABLE - RELATED PARTY

7.  NOTE PAYABLE – RELATED PARTY

On September 30, 2013, the Company reclassified $13,500 deferred compensation to a note payable due to Chief Financial Officer Kendall Carpenter as stipulated in her employment agreement. The note bears a 6% interest rate and is due by September 30, 2014.  On December 31, 2013, the Company reclassified $9,000 deferred compensation to a note payable due to Kendall Carpenter as stipulated in her employment agreement. The note bears a 6% interest rate and is due by December 31, 2014. There was no unpaid accrued interest at December 31, 2013.

XML

Subsequent Event

12 Months Ended

Dec. 31, 2013

Subsequent Events [Abstract]

Subsequent Event

19. Subsequent Event

On March 7, 2014, the United States Patent and Trademark Office (“USPTO”) sent the Company an office action related to an ex parte reexamination of the Company’s 7,822,816 patent, which rejected all the claims in the patent (the “USPTO Office Action”). The Company has two months to file a request for the patent examiners to reconsider the USPTO Office Action. As a result of the USPTO Office Action, the Company has withdrawn all outstanding litigation relating the ‘816 patent without prejudice, which will allow it to refile such pending suits if the USPTO Office Action is rescinded or the Company’s rights under the ‘816 patent are restored. The Company will be unable to pursue any new lawsuits until the USPTO Office Action is resolved.  The Company is presently conferring with its legal counsel and evaluating its options with regard to the USPTO Office Action.

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2013

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINENGENCIES

15 .COMMITMENTS AND CONTINGENCIES

At December 31, 2013, the Company has no obligation under any operating leases.

As of March 28, 2014, the Company is not a party to any lawsuits.

The Company entered into an employment agreement on October 23, 2012 with its CFO, Kendall Carpenter. The agreement provides for an annual base salary of $150,000 and an annual cash salary of at least $96,000 with the difference between the base salary and actual cash salary rolled into short term notes which accrue interest at 6% per annum. On September 30, 2013, the Company issued a $13,500 note to Ms. Carpenter with a due date of September 30, 2014. On December 31, 2013, the Company issued a $9,000 note to Ms. Carpenter with a due date of December 31, 2014. The Company paid Ms. Carpenter $489 in interest during 2013 and there was no accrued interest due at December 31, 2013.

Rent expense in 2012 was $110,462.  The Company’s office lease was assumed by DecisionPoint Systems, Inc. on July 31, 2012 following their purchase of Illume Mobile. Due to the small number of employees, we no longer maintain a physical workspace, but allow our employees to work remotely.

XML

Common Stock Warrants

12 Months Ended

Dec. 31, 2013

Common Stock Warrants [Abstract]

COMMON STOCK WARRANTS

11. COMMON STOCK WARRANTS

During 2012, 5,000,000 warrants were issued and 8,666,680 were expired, as follows:

In February 2012, investors in the Putable-Callable Debenture Series 2012 and Series C warrants acquired 2,500,000 common stock purchase warrants with a strike price of $.10. The warrants with a fair value of $237,500 were cancelled in April 2012 when the investors elected to convert the debentures to common stock. See Note 9.

In March 2012, investors in the 2012 Common Stock Private Offering acquired 2,500,000 Series C warrants. The warrants remain outstanding and expire December 31, 2017 and bear a $0.15 strike price.

During 2013 no warrants were issued or expired.

The following table summarizes information about outstanding warrants at December 31, 2013:

Year Issued	Number Outstanding		Remaining Contractual Life in Years		Number Currently Exercisable		Weighted Average  Exercise Price
2009		21,682,372		.6		21,682,372	$	0.10
2010		10,236,227		0.9		10,236,227	$	0.10
2011		29,680,086		3.0		29,680,086	$	0.10
2012		2,500,000		4.0		2,500,000	$	0.15
Total		64,098,685		1.9		64,098,685	$	0.10

XML

Restatement (Details 1) (USD $)	3 Months Ended			12 Months Ended
	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Revenues				$ 1,454,337	$ 2,433,745
Cost of revenues				854,471	1,029,985
Gross profit				599,866	1,403,760
General and administrative expense	356,369	24,000	30,950	777,920	1,431,869
Loss from operations				(178,054)	(28,109)
Total other expense				(62,630)	(6,026,350)
Net loss from continuing operations				(240,684)	(6,054,459)
DISCONTINUED OPERATIONS					(2,204,478)
NET LOSS				(240,684)	(8,258,937)
OTHER COMPREHENSIVE INCOME				(195,763)	(204,173)
COMPREHENSIVE INCOME				(436,447)	(8,463,110)
As Reported
Revenues					2,988,393
Cost of revenues					1,305,853
Gross profit					1,682,540
General and administrative expense					3,025,071
Loss from operations					(1,342,531)
Total other expense					(238,906)
Net loss from continuing operations					(1,581,437)
DISCONTINUED OPERATIONS					(194,608)
NET LOSS					(1,776,045)
OTHER COMPREHENSIVE INCOME					(170,125)
COMPREHENSIVE INCOME					(1,946,170)
Adjustments
Revenues					(554,648)
Cost of revenues					(275,868)
Gross profit					(278,780)
General and administrative expense					(1,593,202)
Loss from operations					1,314,422
Total other expense					(5,787,444)
Net loss from continuing operations					(4,473,022)
DISCONTINUED OPERATIONS					(2,009,870)
NET LOSS					(6,482,892)
OTHER COMPREHENSIVE INCOME					(34,048)
COMPREHENSIVE INCOME					$ (6,516,940)

XML

Convertible Debentures (Convertible Debt [Member])

12 Months Ended

Dec. 31, 2013

Convertible Debt [Member]

Short-term Debt [Line Items]

CONVERTIBLE DEBENTURES

9. CONVERTIBLE DEBENTURES

2010 Convertible Debenture

During November 2010, a director invested $50,000 in the Convertible Debenture Series 2010 plus Series B Warrants. The debenture bore a 2% interest rate, a maturity date of December 31, 2015 and included a warrant for the right to purchase 95,493 shares at a $.2618 exercise price with a December 31, 2015 maturity date. Upon conversion, the director was entitled to receive the number of shares of Common Stock that could be purchased with two hundred percent (200%) of the face amount of the Debentures together with accrued interest and with the Common Stock valued using the weighted average price for the five-day trading period before the notice of conversion. The debenture became convertible on June 30, 2011.   On March 1, 2012, the debenture was converted to 940,734 shares of stock. Accrued interest of $1,285 was settled in full during September, 2012.

The Company analyzed the conversion option of all the 2010 convertible debt. As discussed in Footnote 13, the Company considered derivative accounting under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion feature should be classified as a liability due to there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. The embedded conversion feature was measured at fair value at the date of inception and at the end of each reporting period or termination of the instrument with the change in fair value recorded to earnings.

2011 Convertible Debenture – Series A Warrants

During April 2011, the Company began offering its Convertible Debentures - Series 2011 and Series A Warrants. The Debentures bore a 12% interest rate, a maturity date of December 31, 2016 and included warrants in an amount equal to the principal amount divided by 50% of the Debenture conversion price. Total numbers of warrants attached with the convertible debentures are 18,475,827 with a exercise price equal to 50% of the debenture conversion price. Upon conversion, the holder was entitled to receive the number of shares of Common Stock that could have been purchased with 200% of the principal amount of the Debenture, together with accrued and unpaid interest and the shares valued using the weighted average price for a five-day trading period preceding the Debenture investment. The Company issued $1,675,000 in debentures in 2011 to sixteen investors. During 2012, fifteen of the sixteen investors elected to convert a total of $1,575,000 Debenture Series 2011 into 16,831,553 shares of common stock. A total of $179,312 in accrued interest on the converted debentures was settled, $16,167 in cash and $163,145 with 870,543 shares of common stock. As of December 31, 2013 and 2012, there is one outstanding debenture for $100,000. The Company accounted for the intrinsic value of a Beneficial Conversion Feature inherent to a convertible note payable as a discount of $1,475,000 recorded to the convertible debenture. Amortization of debt discount of $18,182 and $1,402,273 was recognized in 2013 and 2012, respectively. The remaining balance of unamortized discount is $54,545 and $72,727 at December 31, 2013 and 2012, respectively. Accrued interest outstanding on the debenture as of December 31, 2013 and 2012 are $30,429 and $18,396, respectively.

As a result of the issuance of 2010 convertible debt to a director and because the debt became convertible on June 30, 2011, the conversion option of all other third party convertible notes became tainted. Under ASC 815-15“Derivatives and Hedging”, all other tainted share settleable instruments must be reclassified from equity to liability. As a result of the full conversion of 2010 convertible debts on March 1, 2012, the derivative treatment on these other third party convertible notes ended and the derivative liabilities for an amount of $ 683,602 must be reclassified back to equity. See discussion in Note 13.

2011 Convertible Debenture – Series B Warrants

During July 2011, the Company began offering its Convertible Debentures Series 2011 and Series B warrants. The Debentures bore a 12% interest rate, a maturity date of December 31, 2016 and included warrants in an amount equal to the principal amount divided by the Debenture conversion price. Total numbers of warrants attached with the convertible debentures are 8,961,614 with an exercise price equal to the debenture conversion price. Upon conversion, the holder was entitled to receive the number of shares of Common Stock that could have been purchased with 200% of the principal amount of the Debenture, together with accrued and unpaid interest and the shares valued using the weighted average price for a five-day trading period preceding the Debenture investment provided however, that the conversion price shall not be less than ten cents per share at any time and the conversion price shall not be more than ten cents per share for investments made prior to October 1, 2011. By resolution of the Board on December 16, 2011, the ten cent conversion price per share was extended to investments made after October 1, 2011. The Company issued $896,161 in debentures in 2011 to nineteen investors. During 2012, eighteen of the nineteen investors elected to convert a total of $846,161 Debenture Series 2011 into 16,923,227 shares of common stock. A total of $45,941 in accrued interest on the converted debentures was settled with 459,412 shares of common stock. As of December 31, 2013 and 2012 there is one outstanding debenture for $50,000. Accrued interest as December 31, 2013 and 2012 are $13,216 and $7,200, respectively.

As a result of the issuance of 2010 convertible debt to a director and because the debt became convertible on June 30, 2011, the conversion option of all other third party convertible notes became tainted. Under ASC 815-15“Derivatives and Hedging”, all other tainted share settleable instruments must be reclassified from equity to liability. As a result of the full conversion of 2010 convertible debts on March 1, 2012, the derivative treatment on these other third party convertible notes ended and the derivative liabilities for an amount of $663,160 must be reclassified back to equity. See discussion in Note 13.

2012 Convertible Debenture – Series C Warrants

On February 17, 2012, the Company began offering the Putable-Callable Debenture Series 2012 and Series C Warrants. The debentures bear interest at 8% per annum and mature on December 31, 2019. The convertible debenture is convertible at a conversion price equal to the weighted average price for the three-day trading period before the notice of conversion. The convertible note is also subject to dilutive adjustments for share issuances (full ratchet reset feature).On that date, the Company sold $500,000 of debentures to four directors of which $320,000 are converted from shareholders notes payable and invested $180,000 in new proceeds. Total numbers of warrants attached with the convertible debentures are 2,500,000 with an exercise price equal $0.1. On April 23, 2012, the directors converted $500,000 of debentures and $7,242 in accrued interest to 5,790,452 shares of restricted common stock and 2,500,000 Series C warrants were cancelled.

Because these convertible debentures have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under ASC 815-40-15 “Determining whether an Instrument (or Embedded feature) is Indexed to an Entity's Own Stock”. ASC 815-40-15 require as of the date the convertible debenture issued, the derivative liability to be measured at fair value and $445,204 is recorded as a debt discount. As a result of full conversion on April 23, 2012, the derivative treatment on these convertible debentures ended and the derivative liabilities for an amount of $536,528 must be reclassified back to equity with the change in fair value of $91,324 recorded to loss on derivative liability.

XML

Stock Options

12 Months Ended

Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

STOCK OPTIONS

10. STOCK OPTIONS

During 2012, 27,700,000 options were granted, 211,600 options vested and 26,595,804 were forfeited, as follows:

On May 18, 2012, five directors each received 40,000 options, for a total of 200,000 options, as compensation. The options were immediately vested with a expiration date of May 18, 2017 and a strike price of $.10. On May 18, 2012, 27,500,000 options were granted to directors and management as incentive bonuses. The options vesting schedule is tied to market performance, with strike prices ranging from $.125 and $.40, and bear a expiration date of May 18, 2018. The options are unvested at December 31, 2013.

Of the 211,600 options which vested in 2012: 49,600 have an expiration date of September 11, 2014 and a strike price of $2.21, 160,000 have an expiration date of May 18, 2017 and a strike price of $.10, and 2,000 have an expiration date of April 26, 2017 and a strike price of $.21.

Of the 26,595,804 options which were forfeited in 2012: 3,200,000 issued to directors and management had an expiration date of September 27, 2017 and a strike price of $.50, 280,000 issued to a former director had expiration dates ranging from September 11, 2014 to May 18, 2017 and strike prices ranging from $.03 to $.60, 395,804 were issued to former employees who voluntarily terminated with expiration dates ranging from September 11, 2014 and April 25, 2017 and strike prices ranging from $.21 to $2.50, and 22,720,000 were issued to former officers and employees who were not retained following the sale of Illume Mobile with expiration dates ranging from May 18, 2018 to October 6, 2017 and strike prices ranging from $0.125 and $2.50.

During 2013, no options were granted, 39,200 options vested, and 63,120 options expired, as follows:

Of the 39,200 options that vested in 2013: all had an expiration date of September 11, 2014 and a strike price of $2.21.

Of the 63,120 options that expired in 2013, expirations occurred between January 1, 2013 and July 1, 2013 and the strike prices were $.60.

The calculated value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, assuming maximum value, which values options based on the estimated fair value of the Company’s common stock at the grant date, the option strike price, the expected life of the option, the estimated volatility of the stock, the expected dividend payments, and the risk-free interest rate over the expected life of the option.  The Company uses historical data to estimate option exercise and employee termination within the valuation model. The expected term of options granted is based on the vesting period and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.  Stock based compensation expense of $90,020 and $94,738 was recognized in 2013 and 2012 for employee options based on the Black-Scholes computation.

A summary of stock option activity as of December 31, 2013 and 2012 and changes during the periods then ended is presented below:

 

	Stock Options
	Options			Weighted Average Exercise Price
Outstanding – December 31, 2011		11,829,507		$	0.52
Granted		27,700,000		$	0.26
Forfeited or Expired		(26,595,804	)	$	0.32
Outstanding – December 31, 2012		12,933,703		$	0.36
Exercisable – December 31, 2012		5,394,503		$	0.51
Granted		-		$	0.00
Forfeited or Expired		(63,120	)	$	0.60
Outstanding – December 31, 2013		12,870,584		$	0.37
Exercisable –  December 31, 2013		5,370,584		$	0.52

Total Options outstanding and exercisable at December 31, 2013 and 2012 had an aggregate intrinsic value of $-0- and a weighted-average remaining contractual term of 2.9 and 3.7 years, respectively.

A summary of the status of the Company’s nonvested options and restricted stock as of December 31, 2013 and 2012 is presented below:

	Stock Options
Nonvested Shares	Options
Nonvested - Beginning of Year 2012		6,028,450
2012 Granted		27,700,000
2012 Vested		(211,600	)
2012 Forfeited		(25,977,650	)
Nonvested – End of Year 2012		7,539,200
2013 Granted		-
2013 Vested		(39,200	)
2013 Forfeited		( -	)
Nonvested- End of Year 2013		7,500,000

As of December 31, 2013 and 2012, there was $290,938 and $380,958 unrecognized compensation cost related to nonvested share-based compensation arrangements under the stock bonus plan. The weighted-average remaining vesting period is 3 years.

XML

Shareholders' Equity

12 Months Ended

Dec. 31, 2013

Stockholders Equity Note [Abstract]

SHAREHOLDERS' EQUITY

12.  SHAREHOLDERS’ EQUITY

Shares issued for convertible notes:

During the year ended December 31, 2012, convertible debt of $2,971,161 along with accrued interest of $216,330 were converted into 41,815,921 common shares. See Note 9.

Shares issued for services:

During the year ended December 31, 2013, the Company issued 6,100,690 shares of common stock to employees and directors as compensation. The shares were valued at the market price on the respective dates of issuance, and the fair value of the shares was determined to be $140,000.

During the year ended December 31, 2012, the Company issued 15,523,747 shares of common stock to employees and third party consultants as compensation. The shares were valued at the market price on the respective dates of issuance, and the fair value of the shares was determined to be $779,168. The Company cancelled 62,666 unvested shares valued at $627 in various stock bonus programs upon the voluntary termination of several former employees.

Shares issued in exchange for available-for-sale securities

During the year ended December 31, 2013, the Company issued 2,500,000 shares of restricted common stock to MEDL Mobile Holdings, Inc. in exchange for 147,692 shares of MEDL stock. The shares issued were valued at the fair market value of MEDL stock on the agreement date, which is $58,338. See Footnote 3.

Shares issued for cash

During the year ended December 31, 2012, the Company issued 2,500,000 shares of restricted common stock in a 2012 Private Stock Sale for $250,000 cash.

XML

Summary of Significant Accounting Policies - Schedule of fair value assets and liabilities(Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Mar. 11, 2012	Feb. 17, 2012	Dec. 31, 2011
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Derivative liability	$ 0	$ 0	$ 237,500	$ 195,000	$ 0
Available-for-sale Securities	371,402	493,827		493,827
Level 1
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Derivative liability
Available-for-sale Securities	(371,402)	493,827
Level 2
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Derivative liability
Available-for-sale Securities
Level 3
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]
Derivative liability	0	0
Available-for-sale Securities

XML

Derivative Liabilities (Detail Textuals) (USD $)	1 Months Ended	12 Months Ended				1 Months Ended					0 Months Ended	1 Months Ended	0 Months Ended	12 Months Ended	1 Months Ended	12 Months Ended	1 Months Ended		1 Months Ended
	Feb. 17, 2012	Dec. 31, 2013	Dec. 31, 2012	Mar. 11, 2012	Dec. 31, 2011	Jun. 30, 2011 Convertible Debenture	Jun. 30, 2011 Series A Convertible Debenture First Issuance	Mar. 31, 2011 Series A Convertible Debenture First Issuance	Jun. 30, 2011 Series A Convertible Debenture Second Issuance	Mar. 31, 2011 Series A Convertible Debenture Second Issuance	Mar. 01, 2012 Series A Convertible Debenture Third Issuance	Jun. 30, 2011 Series A Convertible Debenture Third Issuance	Mar. 01, 2012 Series B Convertible Debenture	Dec. 31, 2011 Series B Convertible Debenture	Apr. 23, 2012 Series C Convertible Debenture First Issuance	Dec. 31, 2012 Series C Convertible Debenture First Issuance	Apr. 23, 2012 Series C Convertible Debenture Second Issuance	Apr. 23, 2012 Series C Convertible Debenture Second Conversion	Jun. 30, 2011 Warrant
Derivative [Line Items]
Convertible Debenture issued						$ 50,000	$ 1,675,000		$ 100,000			$ 200,000		$ 896,161		$ 500,000
Loss on derivatives	42,500	0	4,028,085			40,182		519,157		1,346,762	105,714		663,160				91,324		2,507,317
Derivative liability issuance date						Mar. 01, 2012									Feb. 17, 2017
Warrants outstanding	2,500,000	64,098,685																	67,765,365
Derivative liability	$ 195,000	$ 0	$ 0	$ 237,500	$ 0										$ 445,204			$ 536,528

XML

Discontinued Operations Pursuant To The Sale of Illume Mobile Assets

12 Months Ended

Dec. 31, 2013

Discontinued Operations and Disposal Groups [Abstract]

DISCONTINUED OPERATIONS PURSUANT TO THE SALE OF ILLUME MOBILE ASSETS

17.  DISCONTINUED OPERATIONS PURSUANT TO THE SALE OF ILLUME MOBILE ASSETS

In July 2012, the Company began negotiations with DecisionPoint Systems, Inc. to sell the Illume Mobile assets and operations. On July 31, 2012 (the “Closing Date”), MacroSolve, Inc. (the "Company”) entered into an asset purchase agreement (the “Purchase Agreement”) with DecisionPoint Systems, Inc. (the “Buyer”). Pursuant to the Purchase Agreement, effective on the Closing Date, the Company sold substantially all of the assets relating to its Illume Mobile business, for a purchase price of $948,000, of which $250,000 was paid in cash and $698,000 was paid in the form of 617,284 shares of the Buyer’s common stock (valued at $1.13 per share based on the fair value on closing date).

The Company has the right to receive an earn-out payment from the Buyer (the “Earn-Out Payment”) of up to $500,000 (of which 50% will be paid in cash, and 50% will be paid in shares of common stock of the Buyer, valued at the last closing price of the Buyer’s common stock on the one year anniversary of the Closing Date). The Earn-Out Payment is incremental based upon net revenues. If net revenue is $3,000,000 or more, the entire Earn-Out Payment will be due. During 2013, the Company determined that the Earn-Out payment was not achieved.

In connection with the Purchase Agreement, on the Closing Date, the Company and the Buyer entered into a patent license agreement (the “License Agreement”), pursuant to which the Company granted the Buyer a non-exclusive license under a patent held by the Company pertaining to information collection using mobile computers (the “Licensed Patent”) to make, have made, sell, offer for sale or import any product or service which in the absence of the License Agreement would infringe at least one claim of the Licensed Patent (including specifically the Company’s ReForm™ Development Platform) in and into the United States and to practice the Licensed Methods (as defined in the License Agreement), in the United States, during the term of the Licensed Patent. The Buyer agreed to pay the Company a licensing fee/royalty payment of (i) 7.5% of Net Revenues (as defined in the License Agreement) received from the sale of Software Products (as defined in the License Agreement) and/or Licensed Methods, and (ii) 5% of Net Revenues from the sale of Custom Development Services (as defined in the License Agreement). The Company also granted the Buyer an option to purchase a non-exclusive perpetual license under the Licensed Patent at a purchase price of $500,000. The Company has received approximately $97,684 in royalties through December 31, 2013.

In connection with the Purchase Agreement, on the Closing Date, the Company and the Buyer entered into a non-competition and non-solicitation agreement (the “Non-Competition Agreement”). Pursuant to the Non-Competition Agreement, for a period of three years commencing on the Closing Date, the Company agreed not to engage in activities in the United States and Canada competitive with the products sold by the Company’s Illume Mobile business as of July 31, 2012, and the Buyer agreed not to engage in activities in the United States and Canada competitive with the products sold by the Company (not related to the assets sold pursuant to the Purchase Agreement). The Company also agreed, for a period of three years, commencing on the Closing Date, not to solicit or hire (unless such employee has been terminated by the Buyer) employees of the Buyer, and the Buyer agreed, for a period of three years commencing on the Closing Date, not to solicit employees of the Company (except as contemplated by the Purchase Agreement).

The following table summarized the book value of the assets sold and liabilities assumed by DecisionPoint Systems, Inc. at the acquisition date.

Cash received	$	250,000
Stock received	$	698,000
Liabilities assumed by DecisionPoint Systems, Inc.
Accrued liabilities	$	25,000
Accounts payable	$	13,838
Deferred revenue	$	36,971
Assets sold to DecisionPoint Systems, Inc.
Prepaid expenses	$	(14,885	)
Property and Equipment, net	$	(83,507	)
Software development costs	$	(1,019,480	)
Accounts receivable	$	(12,475	)
Loss on sales of discontinued operations	$	(106,538	)

The following table summarized the results of discontinued operations for the year ended December 31, 2012.

	Year Ended
	December 31, 2012
Revenue	$	637,507
Cost of revenues	$	351,654
Gross profit	$	285,853
General and administrative expense	$	2,383,793
Loss from discontinued operations	$	(2,097,940	)

XML

Oklahoma Technology Commercialization Center Note Payable (Tables)

12 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

Summary of maturities of long-term debt

2014	$	112,500
2015	$	20,000
Total	$	132,500

XML

Shareholders' Equity (Detail) (USD $)	12 Months Ended				12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013 MEDL Mobile Holdings, Inc	Mar. 08, 2013 MEDL Mobile Holdings, Inc	Dec. 31, 2012 Common Stock [Member] Private Sale of Stock [Member]	Dec. 31, 2013 Common Stock [Member] Employees and Directors [Member]	Dec. 31, 2012 Common Stock [Member] Employees and Third Party Consultants [Member]	Dec. 31, 2012 Common Stock [Member] Convertible notes [Member]
Common Stock issued for conversion of debt and accrued interest		$ 3,187,491						$ 2,971,161
Common Stock issued for conversion of debt and accrued interest (in shares)								41,815,921
Accrued interest on notes payable	489							216,330
Compensation expense related to stock awards	140,000	500,718				140,000	779,168
Compensation expense related to stock awards (in shares)						6,100,690	15,523,747
Cancellation of shares		(627)					627
Cancellation of shares (in shares)							62,666
Number of shares of restricted common stock granted			2,500,000		2,500,000
Number of share received				2,500,000
Fair value of shares			39,536	58,338
Cash recieved by sale of restricted common stock					$ 250,000

XML

Note Payable - Related Party (Details) (USD $)	12 Months Ended	1 Months Ended
	Dec. 31, 2013	Dec. 31, 2013 Kendall Carpenter [Member]	Sep. 30, 2013 Kendall Carpenter [Member]	Oct. 23, 2012 Kendall Carpenter [Member]
Related Party Transaction [Line Items]
Deferred compensation		$ 9,000	$ 13,500	$ 150,000
Interest rate, notes payable		6.00%	6.00%	6.00%
Accrued interest on notes payable	$ 489
Maturity date	May 31, 2014	Dec. 31, 2014	Sep. 30, 2014

XML

STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
BALANCE, at Dec. 31, 2011	$ (1,391,296)	$ 1,223,869	$ 10,059,029		$ (12,674,194)
BALANCE ( in shares) at Dec. 31, 2011		122,386,894
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(8,258,937)				(8,258,937)
Comprehensive Loss	(8,463,110)			(204,173)
Derivative liabiilties written off to additional paid-in capital	4,473,289		4,473,289
Debt discount recorded for beneficial conversion feature	1,475,000		1,475,000
Common Stock issued for Services	278,450	28,000	250,450
Common Stock issued for Services (in shares)		2,800,000
Common Stock issued for cash	250,000	25,000	225,000
Common Stock issued for cash (in shares)		2,500,000
Common Stock issued for conversion of debt and accrued interest	3,187,491	418,159	2,769,332
Common Stock issued for conversion of debt and accrued interest (in shares)		41,815,921
Compensation expense related to stock awards	500,718	127,237	373,481
Compensation expense related to stock awards (in shares)		12,723,747
Option expense	94,738		94,738
Cancellation of shares	(627)	(627)
Cancellation of shares (in shares)		(62,666)
BALANCE, at Dec. 31, 2012	404,653	1,821,638	19,720,319	(204,173)	(20,933,131)
BALANCE ( in shares) at Dec. 31, 2012		182,163,896
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(240,684)				(240,684)
Comprehensive Loss	(436,447)			(195,763)
Derivative liabiilties written off to additional paid-in capital
Debt discount recorded for beneficial conversion feature
MEDL Holdings investment
Stock issued in exchange for available-for-sale securities	58,338	25,000	33,338
Stock issued in exchange for available for sale securities (in shares)		2,500,000
Compensation expense related to stock awards	140,000	61,007	78,993
Compensation expense related to stock awards (in shares)		6,100,690
Option expense	90,020		90,020
BALANCE, at Dec. 31, 2013	$ 256,564	$ 1,907,645	$ 19,922,670	$ (399,936)	$ (21,173,815)
BALANCE ( in shares) at Dec. 31, 2013		190,764,586

XML

Oklahoma Technology Commercialization Center Note Payable

12 Months Ended

Dec. 31, 2013

Debt Disclosure [Abstract]

OKLAHOMA TECHNOLOGY COMMERCIALIZATION CENTER NOTE PAYABLE

6.  OKLAHOMA TECHNOLOGY COMMERCIALIZATION CENTER NOTE PAYABLE

The Company carries a note from the State of Oklahoma Technology Business Finance Program (OTCC loan) represented originally by a $150,000 refundable award to be repaid at two times the amount of the award.  The balance includes accrued interest (imputed at 14.27%), through September 2007.  The monthly payments were suspended in October 2008 and resumed in October 2012 in the amount of $7,500 per month. The Company repaid $22,500 in 2012 and $82,500 in 2013. The total balance due at December 31, 2013 is $132,500 with $112,500 classified as current liabilities and $20,000 classified as long-term debt. The total balance due at December 31, 2012 is $215,000 with $90,000 classified as current liabilities and $125,000 classified as long-term debt.

The aggregate minimum maturities of the note payable for each of the next two years are as follows:

2014	$	112,500
2015	$	20,000
Total	$	132,500

XML

Discontinued Operations Pursuant ToThe Sale of Illume Mobile Assets (Details Textual) (USD $)	1 Months Ended
	Jul. 31, 2012	Dec. 31, 2013
Assets Sold Under Agreements To Purchase [Line Items]
Licensed patent at purchase price	$ 500,000
Other receivables		97,684
Description buyer agreed to pay company licensing fee royalty payment	i) 7.5% of Net Revenues (as defined in the License Agreement) received from the sale of Software Products (as defined in the License Agreement) and/or Licensed Methods, and (ii) 5% of Net Revenues from the sale of Custom Development Services (as defined in the License Agreement).
Net revenue from sale of software products	7.50%
Net revenues from sale of customer development services	5.00%
"Earn-Out Payment" from buyer
Assets Sold Under Agreements To Purchase [Line Items]
Earn-out payment from the buyer	500,000
Percent of "Earn-Out Payment" paid in cash	50.00%
Percentage of "Earn Out Payment" paid in shares	50.00%
Net revenue in earn out payment	3,000,000
Illume Mobile Assets and Operations
Assets Sold Under Agreements To Purchase [Line Items]
Purchase price	948,000
Cash received from sale of assets	250,000
Share received from sale assets	617,284
Value for shares received from sale of assets	$ 698,000
Share price	$ 1.13

XML

Stock Options (Tables)

12 Months Ended

Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of stock option activity

	Stock Options
	Options			Weighted Average Exercise Price
Outstanding – December 31, 2011		11,829,507		$	0.52
Granted		27,700,000		$	0.26
Forfeited or Expired		(26,595,804	)	$	0.32
Outstanding – December 31, 2012		12,933,703		$	0.36
Exercisable – December 31, 2012		5,394,503		$	0.51
Granted		-		$	0.00
Forfeited or Expired		(63,120	)	$	0.60
Outstanding – December 31, 2013		12,870,584		$	0.37
Exercisable –  December 31, 2013		5,370,584		$	0.52

Schedule of nonvested options and restricted stock

	Stock Options
Nonvested Shares	Options
Nonvested - Beginning of Year 2012		6,028,450
2012 Granted		27,700,000
2012 Vested		(211,600	)
2012 Forfeited		(25,977,650	)
Nonvested – End of Year 2012		7,539,200
2013 Granted		-
2013 Vested		(39,200	)
2013 Forfeited		( -	)
Nonvested- End of Year 2013		7,500,000

XML

Investment in Endexx Corporation (Details) (USD $)	12 Months Ended		0 Months Ended	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jun. 05, 2013 ENDEXX CORPORATION	Dec. 31, 2013 ENDEXX CORPORATION
Investment [Line Items]
Value of share received			$ 15,000
Number of share received			125,000
Share price			$ 0.12
Nature of transaction			Company entered into six month agreement with Endexx Corporation (EDXC) to coordinate business planning, investor interests and intellectual property for a mobile app venture that uniquely addresses advertising market analytics.
Fair value of shares			15,000	7,675
Unrealized holding loss arising during the period	$ (195,763)	$ (204,173)		$ 7,325

XML

Concentrations

12 Months Ended

Dec. 31, 2013

Concentrations [Abstract]

CONCENTRATIONS

16 .CONCENTRATIONS

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of trade receivables.  The Company performs ongoing credit evaluations of its customers and generally does not require collateral related to its receivables. At December 31, 2013, accounts receivable from one patent licensee comprised approximately 50% of the company’s total accounts receivable-trade. Revenues from twenty-six customers approximated 97% of total revenues for 2013. At December 31, 2012, accounts receivable from three patent licensees comprised approximately 74% of the Company’s total accounts receivable-trade. Revenues from twenty-eight customers approximated 77% of total revenues for 2012.